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Abstract
This thesis describes the study of antibody class responses 
in the serum and tracheal mucosa of virus infected chickens.
It examines the use of a rapid method for the detection of 
virus-specific IgM antibody, as a means for the detection of recent 
infection, as a tool for serological diagnosis or for research into 
virus infections.
SPF chickens were infected with infectious bronchitis virus 
(IBV), infectious laryngotracheitis virus (ILTV) or infectious bursal 
disease virus (IBDV) and serum, collected at regular intervals, was 
fractionated by gel chromatography, for the separation of IgM and IgG or 
treated with igM-immunoadsorbents, for the affinity chromatography 
purification of IgM. Fractions of sera and eluants from the 
immunoadsorbents were assayed by ELISA to identify and quantify 
virus-specific antibodies and their immunoglobulin class.
The separation of IgM using the IgM-immunoadsorbents was 
achieved and the results compared favourably with those obtained by gel 
chromatography as regards rapidity and simplicity.
Viruses of three distinct pathogeneses were studied and it was 
shown that IgM always appeared first and rapidly reached the highest 
serum concentration, declining also rapidly. The IgM response to ILTV 
was shown to recur, invalidating the use of IgM detection for the 
diagnosis of recent infection. IgM response to IBV and IBDV could 
be associated to the recent infection and its detection could be
ii
validated for the diagnosis of recent infection.
In these studies, the profiles of antibody seemed to be 
independent of many aspects relating to viral pathogeneses, e.g., 
target cell and organ of replication, and although ILTV induced a state 
of intermittent IgM antibody response, its initial profile was also 
characterized by a rapid rise and decline following infection, which 
period compared to the response to the other viruses.
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Chapter 1
INTRODüCnOî
1. Introduction
1.1 Avian Immune System
This review is based on the relevant literature available for 
the chicken (Gallus), except in particular cases of interest concerning 
the other genera of class Aves.
1.1.1 Lyn^hoid Tissue
The immune system in Aves is considered, in evolutionary 
terms, to be classified between the lower vertebrates of class Reptilia 
and the higher vertebrates of class Mammalia. Anatomically and 
functionally the immune system is organized into primary lymphoid 
organs and secondary lymphoid organs or tissues. Primary lymphoid 
organs provide the appropriate histologic microenvironment for the 
differentiation of the immunocompetent cells. The bone marrow, thymus 
and bursa of Fabricius are the primary lymphoid organs in Aves and are 
involved in differentiating pluripotent stem cells into immunocompetent 
cells. Immunocompetent cells are capable of reacting specifically 
against antigen (non-self) by producing cellular immune responses (T 
cells: thymus derived) or humoral (antibody) immune responses (B cells: 
bursa derived). Secondary lymphoid organs and tissues include the
Harderian gland or gland of the nictitating membrane, caecal tonsils. 
Payer's patches, spleen, lymph nodes, pineal gland and the lymphoid 
nodules scattered throughout the organs and tissues. These are 
populated with cells that migrate from the primary lymphoid organs.
1.1.1.1 Thymus
In chickens (Callus) the thymus is a paired lobulated organ
situated alongside the neck and forming from four to seven lobes on
each side (Rose, 1981). During the embryonic development haematopoietic
stem cells migrate to the thymus arriving from the embryonic yolk
sac. Cells from the embryonic mesenchyme migrate to the yolk sac when
anci 5ubse<^ue.n^ly po p u la te  th e  thyrnuç
the blood circulation is estabilished (Lassila et ^., 1978)^ In the
thymus stem cells differentiate into T cells. T cells mediate the
Cellular immune response (CMI). The effector mechanisms of the cellular
response are the generation of cytotoxic or Killer cells and the
release of soluble factors, the lymphokines, which modulate the
activity of other cells, especially macrophages and monocytes, in the
effort of rejecting the antigen. Several lymphokines, each mediating a
different biological activity are released into body fluids. Cytotoxic
or Killer T cells act directly onto cells expressing surface antigen,
for example virus infected cells expressing virus antigens on the
plasma membrane. The thymus is at its maximum weight between 4 and 17
weeks of age and regresses with the onset of sexual maturity (Wolfe et
al., 1962).
1.1.1.2 Bursa of Fabricius
The bursa of Fabricius is an organ of the immune system 
unique to Aves . It is located dorsally to the cloaca continuous with 
it and consists of a single pouch-like organ. Bursa of Fabricius stem 
cells are present in the yolk sac at 7 days of incubation (Moore and 
Owen, 1967), start to migrate from about day 8 of embryonation 
(Houssaint et ^ ., 1976) to a prevascular bursa of Fabricius and remain 
pluripotent until 12 to 13 days of incubation (Toivanen et ^., 1981), 
when a specialized follicle-associated epithelium appears. The bursa of 
Fabricius provides the adequate microenvironment for the stem cells to 
mature into B-cells. Stem cell differentiation requires contact with 
the specialized bursa epithelium (Toivanen and Toivanen, 1973), 
production of bursapoietin, a bursal hormone (Brand et ^., 1976) and 
another factor for late differentiation (Baba and Okuno, 1976). The 
bursa is at its greatest size relative to body weight between 3 and 6 
weeks of age and undergoes a gradual involution from 8 to 12 weeks of 
age which is completed by sexual maturity (Rose, 1981; Payne and 
Powell, 1984).
1.1.1.3 Bone marrow
As in mammals, the bone marrow has been considered a primary 
lymphoid tissue for B cell differentiation, and an alternative to the 
bursa (Toivanen et al., 1981). 27 % of bone marrow cells were observed
to present a B cell marker, but only 2 % presented surface 
immunoglobulin and no cell had detectable T cell markers (Hudson and 
Roitt, 1973). It has been considered a source of thymic stem cells 
(Weber and Mausner, 1977) and bone marrow cells express T cell 
functions, e.g., graft-versus-host reaction (Solomon, 1961). It was 
shown to contain B cells derived from the bursa of Fabricius (Eskola, 
1977) which are capable of both restoring B cell competence in 
bursectomized birds and producing antibodies (Ivanyi et ^., 1972). 
However, the bone marrow functions also as a secondary lymphoid organ 
as its cells can express T and B functions (Eskola, 1977; Solomon, 
1961). The major function of the bone marrow is haematopoiesis, the 
production of the blood cell constituents. It is involved in blood cell 
synthesis from soon before hatching and continues for the rest of 
bird's life (Glavits et al., 1981).
1.1.1.4 Secondary lymphoid tissue
The gland of Harder or Harderian gland is an acino-tubular
gland containing lymphocytes and plasma cells and it is located
dorso-medially to the eyeball (Bang and Bang, 1968 ; Payne and Powell,
1984). The development of the gland starts in the embryo from day 11
and by day 17 of embryonic life its glands start to be secretory
(Niedorf and Wolters, 1978). After hatching blast cells develop
gradually into plasma cells, which increase to large numbers by day 45
(Wight et ^., 1971). In the Harderian gland the major immunocompetent
an
cell is the plasma cell,/immunoglobulin-producing B cell (Click et al..
1977). Bursectomy reduces or eliminates the small lymphocyte and plasma 
cell populations of the Harderian gland (Mueller et 1971). T cells 
are also present in it (Albini and Wick, 1974). At least 80 % of the 
cell population is immunoglobulin positive small lymphocytes (B cells),
which declines to 12 % at 14 weeks of age and to less than 2 % in the
• the
next 8 months (Click, 1986). Most of/B cells in the Harderian gland 
secrete IgM during the first 4 weeks of life, followed later by a 
majority of IgA and IgC-bearing cells. The gland of Harder secretes 
mucoid substances Wiich lubricate and clean the cornea and nictitating 
membrane. In chickens, plasma cells adjacent to collecting tubules of 
the glands secrete antibodies that mix with the tears. These secretions 
containing antibodies play an important role in the protection of the 
ocular and nasal mucosae. Antigenic stimulus of the gland of Harder was 
required for the development of local upper respiratory immunity
against Newcastle disease virus (Powell et j^., 1979) and infectious 
bronchitis (IB) (Davelaar et ^., 1982; Hawkes et ^., 1983; Holmes, 
1978; Lutticken et al., 1987).
The caecal tonsils are polycryptic organs similar to the
mammalian palatine tonsil (Click et ^., 1978) and, located as wall 
enlargements in the proximal region of each caecum, act as a sentinel 
lymphoid tissue site through permanent exposure of its villi to faecal 
material (Click and Olah, 1981). They possess both T and B cells
(Albini and Wick, 1974) and produce antibody to soluble antigens
(Orlans and Rose, 1970). T and B cells are in equal proportions up to 
the fifth week but B cells predominate later. The caecal tonsils are 
strategically situated to enable specific compromising of 
immunocompetent cells against a large population of microorganisms
which grow in this area and to develop specific defence for the 
intestinal mucosa (e.g., surface IgA).
Structures analogous to mammalian Payer's patches are
located in the distal part of the ileum, vdiich as caecal tonsils, 
possess lymphocytes beneath the epithelium (Befus et ^., 1980).
Peyer's patches were identified by their thickened villi, flattened 
epithelium which lacked globet cells and by accumulations of 
lymphocytes in the form of encapsulated germinal centres and diffuse 
lymphoid tissue (Burns, 1982). Bursectomy depopulates the lymphoid 
areas (Befus et al., 1980), suggesting that the lymphocytes that 
populate these areas migrate from the bursa. A similar role to that of 
the caecal tonsils may be attributed to the Peyer's patches.
The spleen is located in the abdomen by the junction of the 
proventricuius and gizzard. Accessory spleens are observed caudal, 
adjacent and cranial to the spleen (Click and Sato, 1964) and become 
hypertrophic after splenectony (Click, 1970) attempting to compensate 
for the absence of the spleen. During embryogenesis, IgM-bearing 
lymphocytes have been detected in the spleen from day 12, IgC-bearing 
lymphocytes appear around hatching and T cells from day 16 of embryonic 
development (Payne and Powell, 1984). Antigens and antigen-antibody 
complexes leave the blood circulation and go into the ellipsoids, where 
complexes accumulate. Reticular cells become coated with antigen and 
close membrane contact between reticular cells and B lymphocytes 
occurs, which induces the formation of germinal centres, where 
compromized B-cells are produced. The spleen facilitates the intimate 
contact of T and B cells. Ellipsoid-associated (reticular) cells bind
antigens which enter channels formed by endothelial cells and migrate 
to a B cell area. These cells may transmit activation for T and B cells 
of the spleen (Olah and Click, 1982).
Lynph nodes in birds are limited to mainly aquatic avian 
species (Lawn and Rose, 1981). In chickens mural lymphoid nodules are 
present in lymphatic vessels (Payne, 1971) and in the tibio-popliteal 
and femoral veins (Olah and Click, 1983). Femoral lyirphatics enlarge 
after injection of sheep red blood cells in the footpad and contain 
more B cells than T cells (McCorkle et ad., 1979). The lymphatic 
vessels develop early in the embryonic development and may permit the 
migration of stem cells into the primitive bursa and thymus (Payne and 
Powell, 1984). The avian lymph nodes may function to ensure intimate 
contact between antigen and lymphocytes (White, 1981).
The pineal gland is located in the triangular space between 
the cerebral hemispheres and the cerebellum (Wight, 1971). It is now 
considered one of the secondary lymphoid tissues in the chicken (Click, 
1986). The pineal gland in chickens does not contain neurons (Click,
1986). Plasma cells which synthesize antibody to bovine serum albumin 
(BSA) were identified in the gland 3 to 5 days after carotid artery 
injection of BSA (Cogburn and Click, 1983). Bursa and thymus 
lymphocytes contribute similarly to the lymphoid mass of the pineal 
gland as observed by labelled T and B lymphocytes injected into 4- and 
5-week-old naive chicks, identified as approximately 42 % B lymphocytes 
and 51 % T lymphocytes (Cogburn and Click, 1983). Soluble antigens such 
as BSA but not particulated antigens (sheep red blood cells) stimulate 
antibody production in the pineal gland of 6-week-old chickens (Cogburn
and Click, 1983). The biological clock, which is mediated by melatonin 
(Wight, 1971), may supply immunocompetent cells for the surveillance of 
the central nervous system (Click, 1986).
1.2 Immunoglobulins
Immunoglobulins (Ig) are glycoproteins synthesized by resting 
and activated (plasma cells) B cells. The function of immunoglobulins 
is associated with antibody activity. The basic structure of 
immunoglobulins is the monomer, which contains two identical heavy and 
two identical light polypeptide chains linked together by disulphide 
bonds. According to the amino acid composition both heavy and light 
chains can be divided into one constant and one variable region. The 
constant region of the heavy chains is associated with complement 
fixation and its antigenic epitopes characterize the antibody class, 
i.e. IgM, IgG, IgA, IgD or IgE heavy chains. Variable regions of both 
light and heavy chains are the antigen binding sites and contain 
domains of hypervariation in the sequences of amino acids. Two 
functional areas have been shown in the variable regions: 
antigen-binding site (paratope) and antigenic determinants (idiotype). 
The idiotypes are normally recognized as foreign by the immune system 
and anti-idiotype antibodies are generated in succession forming the 
idiotypic networks (Jerne, 1974) and a given network disturbed by 
antigen will condition the response. The idiotypic networks are
considered to prolong the immune response and to maintain the memory 
cell population (Roitt, 1984), as the idiotypic region of anti-idiotype 
antibodies mimic the antigen. T helper cells primed with the idiotype 
will enhance the mobilization of the corresponding idiotype-bearing 
memory B-cells, resulting in anamnestic response (Roitt, 1984). 
Antibody diversity capable of matching virtually all environmental 
antigens is achieved by reasserting the sequences of the variable 
regions guided by antigenic instruction (Roitt, 1984). In chickens, the 
rearrangement of the variable region was shown to occur in small 
numbers in the bursa of Fabricius (Weill et ^., 1986; Parvari et al.,
1987) and the small repertoire of variable region genes is suggested to 
be compensated by accumulation of somatic mutations in the stem cells 
(Weill et ^ ., 1986).
Changes in immunoglobulin production is believed to involve, 
in order, switches from IgM to IgG and to IgA and migration of the B 
immunocompetent cells into the peripheral lymphoid tissues during late 
stages of embryogenesis follows the same order (Payne and Powell, 
1984). These sequential changes are based on evidence that treatment of 
13-day embryos with an anti-IgM serum followed by bursectomy suppresses 
the appearance of all classes of immunoglobulins (Kincade and Cooper,
1973). Bursectomy at 19 days often results in normal or enhanced 
amounts of IgM and suppression of other immunoglobulin classes (Cooper 
let al^, 1969). Neonatal bursectomy results in exclusive deficiency of 
IgA (Kincade and Cooper, 1973), as IgM and IgG-producing cells have 
seeded out to secondary lymphoid organs and tissues (Payne and Powell, 
1984). IgG-producing cells develop exclusively from IgM-producing cells 
in the bursa of Fabricius and rarely in peripheral tissues (Kincade et 
al., 1970).
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Two modes of transfer of antibodies from hen to chick were 
demonstrated in studies on immunoglobulin classes in hen's egg (Rose et 
al., 1974). IgM and IgA are acquired from the oviduct during egg 
formation and appear in the egg white. The egg white becomes available 
to the embryo at the 11th day of incubation by flowing from the albumin 
sac to the amniotic sac were it is swallowed by the embryo. Chick 
intestine will contain maternal IgM and IgA acquired exclusively from 
the amniotic fluid. Maternal IgG is transferred from the hen's serum to 
the yolk via an oocyte receptor for IgG. The yolk will reach the 
intestine of the chick and maternal IgG, in addition to IgM and IgA, 
can be available to the digestive tract. Intact IgG will pass from the 
intestine to blood circulation and IgG is the only maternally derived 
antibody to be found in the serum. From serum, maternal IgG can reach 
the mucosa of the trachea, where, for example, it was found to induce 
protective immunity to IBV (Mockett et ^., 1987). Two antigen-binding 
subclasses of IgG derived from the hen serum and transmited to the 
chick were found (Rose et al., 1974).
1.2.1 I ^
In the ontogeny and phylogeny of the immune system, IgM is 
the first immunoglobulin to be found. In chickens, the first cells to 
express surface and/or cytoplasmic immunoglobulin contain IgM (heavy 
and light chains) and w_iere found in the lymphoid follicles of the 
bursa of Fabricius of 12 to 14-day-old chicken embryos (Kincade and
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Cooper, 1971; Hudson and Roitt, 1973)).
The high molecular weight immunoglobulin (IgM) in chickens 
was identified as a molecule of approximate molecular weight (MW)
890.000 daltons (Da), closely resembling mammalian IgM, having heavy 
chains of approximately 70,000 Da and light chains of approximately
22.000 Da (Leslie and Clem, 1969). Further details of the structure of 
chicken IgM are described by Leslie and Clem (1969), Schranner and 
Losch (1986) and Kobaiashi and Hirai (1980). Polymeric IgM is held 
together by a joining chain, the J chain.
Immunoglobulin M (IgM) is the first immunoglobulin to be 
produced and cells capable of producing IgM do not require the bursal 
microenvironment for development (Claflin «et aly, 1966; Subba Rao et 
al., 1978; Lerner et ^., 1971) as it was observed that bursectomy 
induced dysgammaglobulinaemia (Frommel et ^., 1970), a state of
elevated serum IgM and decreased serum IgG. Normal chickens develop 
highest concentrations of IgM antibodies before IgG antibodies and 
bursectomy at hatching had no effect on circulating IgM (Meter et al., 
1969). Testosterone propionate treatment of embryonating eggs prevents 
the development of the bursa, results in elevated titres of IgM but no 
IgG between 2 and 4 weeks after hatching, suggesting that IgM-producing 
cells are bursa independent and that the bursa provides the appropriate 
microenvironment for the normal switch from IgM to IgG production 
(Subba Rao et ^., 1978). IgM half-life averaged 36 hours for normal, 
dysgammaglobulinaemi c and hypogamma-globulinaemi c chickens, also 
indicating that IgM catabolism is independent of serum concentration of 
IgM (Frommel et ^., 1970). The shorter half life of IgM in chickens 
as compared to mammals could reflect its higher intravascular 
distribution and reduced extravascular concentration (Frommel et al..
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1970).
IgM concentration in normal chicken serum ranged from 1.26 to
4.04 mg/ml in individual serum with a mean of 2.506 mg/ml and 2.55 
mg/ml in a mean of two pools of 100 birds each. The concentration of 
IgM in the serum corresponded to approximately 30 % of total
immunoglobulin concentration. IgM in the bile reached a concentration 
of 0.28 mg/ml, while in the seminal plasma, saliva and tears the 
concentration was not greater than 0.01 mg/ml (Lebacq-Verheyden et al.,
1974). IgM is present in the oviduct of laying hens and is acquired by 
the egg (fully formed yolk surrounded by the vitelline membrane) as it 
passes in the region \diere the egg white is formed, becoming available 
for the chick exclusively in the gut (Rose ^  ^., 1974).
Determinations of IgM concentrations in the hen and hen's egg (Rose et 
al., 1974) showed approximately 1.3 mg/ml in hen's serum, approximately 
0.15 mg/ml in the egg white and qualitative demonstration of the 
antibody in the oviduct secretions. 0.3 mg/ml of IgM was detected in 
the serum of 7 day-old chicks (Rose et ^ ., 1974).
Anti-chicken IgM heavy chain specific monoclonal antibodies 
were used to prepare an immunoadsorbent to harvest chicken-IgM, 
turkey-IgM and duck-IgM and to assay eluted fractions in an indirect 
ELISA (Mockett, 1986-b). Cross reactivity was observed between IgM of 
all three species although the heavy chain from turkey IgM was smaller 
than that of chicken and duck. Chicken IgM was confirmed to appear in 
the bile in a concentration of approximately 0.08 to 0.1 mg/ml using an 
IgM immunoadsorbent column and bile IgM was suggested to be 
pentameric. A concentration of approximately 0.4 mg/ml was recovered 
from chicken serum using the immunoadsorbent (Mockett, 1986-b).
IgM is considered to have lower affinity to antigens than
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IgG, however, this is compensated for by the multi valency of the 
molecule, between 5 and 10 combining sites according to the antigen. 
Valency 10 resulting from the combination of all 10 combining sites is 
only observed when reacting to small haptens. The usual combining 
valency of IgM is 5, as when binding to antigens with multiple 
epitopes, the reduction in valency being due to restrictions in the 
flexibility of the molecule.
1.2.2 IgA
Chicken immunoglobulin A is analogous to mammalian IgA in the 
sense that it is the predominant immunoglobulin class present in 
external secretions such as mucosal surfaces of the digestive tract, 
respiratory tract and oviduct, and secreted in the bile.
In the sequences of events of switches of antibody synthesis 
IgA is the third class of immunoglobulin synthesized and only appears 
in the plasma of chickens 10 days after hatching (Martin and Leslie,
1973).
After purifying immunoglobulins from whole chicken serum, IgA 
was demonstrated in a dimeric state with a MW of 340,000 Da and in a 
monomeric state of 170,000 Da (Schranner and Losch, 1986). The 
secretory component of IgA has been described as a 48 glycoprotein 
(Parry and Porter, 1978), MW 80kDa and pi (isoelectric point) 4.6,
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similar to that of the human secretory component (Peppard et al., 
1986). Secretory IgA has been identified as a 15S molecule (Parry and 
Porter, 1978). Serum IgA included a 7S monomer (approximately 20 % of 
serum IgA) and a polymer of approximately 19S (possibly a pentamer). No 
monomeric IgA was detected in secretions and the predominant form of 
IgA was polymeric (Lebacq-Verheyden et ^., 1974). Chicken IgA in the 
bile appears to be mainly tetrameric (Peppard et ^ . , 1986).
The serum concentration of IgA is low, approximately 3.93 % 
of total immunoglobulin, but its concentration in secretions is higher 
than other classes, e.g., bile (3.15 mg/ml IgA compared to 0.20 mg/ml 
IgG) and intestinal fluids (1.66 mg/ml IgA versus 0.61 mg/ml IgG) 
contained 15.7 and 2.7 times more IgA than IgG, respectively. The ratio 
of secretion-versus-serum concentrations is always higher for IgA, 
e.g., the ratio IgA-versus-IgG in secretions was calculated as 
approximately 15.7 in the bile and 2.72 in the intestinal globulins. 
Serum IgA showed great variability in concentration ranging from 0.03 
to 1.28 mg/ml (Lebacq-Verheyden et ^ . , 1974). The concentration of IgA 
in individual chicken serum ranged from 0.03 to 1.28 mg/ml, with a mean 
of 0.377 mg/ml in 20 birds and in a mean of two pools (100 birds each) 
of 0.33 mg/ml. (Lebacq-Verheyden et ^., 1974). IgA was found at a 
concentration of approximately 0.6 mg/ml in hen's serum, approximately 
0.7 mg/ml in the egg white, while the amniotic fluid of 12-day-old 
embryos contained less than 0.03 mg/ml. However, by the 17th-day of 
incubation the amniotic fluid contained greater than 0.3 mg/ml. The 
digestive tract of 19-day-old embryos contained a concentration greater
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than 0.15 mg/embryo but none in the serum. None was found in the serum 
or intestine of 7-day-old chicks (Rose et 1974).
Polymeric IgA is joined together by a J chain, similarly to 
IgM. Secretory IgA contains a J chain joining the monomers and 
secretory component (SC) which stabilizes the molecule against adverse 
effects of the mucosa. The increased stability of secretory IgA is 
associated with the disulphide bonds of SC. A receptor/transporter/ SC 
for IgA is found in the surface of epithelial cells and hepatocytes. 
The receptor-IgA complex is internalized by the cell and transported 
within the cell in special vesicles to be secreted in external fluids 
(Rose et , 1974). Blood-borne polymeric IgA is believed to be
actively transferred to the bile after acquiring membrane SC of 
hepatocytes and flows via cystic and hepatic (colledocus) ducts (Rose 
et ^., 1981). Interrupting the flow to the duodenum by ligating the 
biliary ducts results in increased levels of serum IgA, indicating that 
although transport from serum to bile is the norm, transport from bile 
to serum may occur (Rose ^  , 1981).
Mucosal IgA correlates with resistance to infection. Local 
IgA was shown to protect chickens against respiratory infections such 
as IB and Newcastle disease (Davelaar et ^., 1982; Lutticken et al., 
1987; Parry and Aitken, 1977; Yoshida et ^., 1971). IgA antibody does 
not activate complement, possibly blocking or reducing availability of 
antigen to IgG and IgM, avoiding hypersensitive reactions in the mucosa 
(Bienenstock et ^., 1981). Secretory IgA activity has been postulated 
also to be associated to the regulation of antigen uptake, in which 
antigens gaining access by the mucosa could be reverted back and
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eliminated through the epithelial IgA transport (Bienenstock et al., 
1981).
1.2.3 IgG
IgG is the major antibody in the serum and extracellular 
spaces in the activity of neutralization and aiding the elimination of 
antigens due to its biological properties.
Purified IgG had a sedimentation coefficient of 7.IS at 
approximately 7 mg/ml (Leslie and Clem, 1969). IgG MW is 173,800- 
174,100 Da (Rose et ^ ., 1974). The half-life of IgG in normal chickens 
averaged 51 hours and IgG catabolism was dependent on the serum 
concentration of IgG (Frommel et ^ . , 1970).
IgG-producing cell differentiation in the bursa is possibly a 
result of interacting bursal factor on IgM-producing cell under the 
influence of antigen, T lymphocyte and macrophage (Subba Rao et al.,
1978).
The concentration of IgG in normal serum from individual 
chickens was shown to range from 4.4 to 10.0 mg/ml, with a mean of 6.9 
mg/ml, and a concentration of 5.5 mg/ml in a mean of two pools of 100 
birds each (Lebacq-Verheyden et ^., 1974). Measurements of IgG
concentrations in external fluids found values of 0.61 mg/ml in 
intestinal secretions, 0.20 mg/ml in the bile, 0.44 mg/ml in the 
seminal plasma, 0.28 mg/ml in the saliva and 0.87 mg/ml in tears
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(Lebacq-Verheyden et al., 1974). Rose et éd. (1974) determined the 
concentration of IgG to be approximately 6 mg/ml in hen's serum, 
approximately 25 mg/ml in egg yolk, approximately 0.03 mg/ml in the 
amniotic fluid of 17-day-old embryos. In 19-day-old embryos the 
concentration was approximately 0.05 mg/embryo (or greater) in the 
digestive tract and approximately 0.6 mg/ml (or greater) in the serum, 
while in the serum of 7-day-old chicks the concentration was at least
0.6 mg/ml. No detectable IgG was found in the egg white and in the 
amniotic fluid of 12-day-old embryos. IgG was qualitatively 
demonstrated in the oviduct although it did not appear in the egg white 
(Rose et al., 1974).
An alternative nomenclature (IgY) was suggested for chicken 
low molecular immunoglobulin based on polypeptide chain molecular 
weights and electrophoretic mobilities of the heavy chain which were 
shown not to have a counterpart in mammals (Leslie and Clem, 1969). 
However, its equivalent role as antibody supported the continuation of 
IgG nomenclature (Butler, 1983). IgG is the most abundant circulating 
antibody and prolonged antibody responses are often associated with the 
presence of IgG. The biological properties of immunoglobulins are 
associated to the heavy chain, particularly the fragment 
crystallizable (Fc), and this is especially valid for IgG. IgG diffuses 
more easily to extracellular spaces than other immunoglobulins, where 
it acts in neutralizing bacterial toxins and enhancing phagocytosis by 
binding to antigens (opsonization). Also, IgG is the only 
immunoglobulin that can be transferred to the progeny via the yolk, by 
binding to an IgG receptor on the oocyte, and can reach the chick's 
blood circulation. Protection against certain infectious diseases of 
chicken is achieved by high levels of circulating IgG, for example IBD
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(Lucio and Hitchner, 1979-a). IgG activates complement, thereby 
attracting polymorphonucleated phagocytic cells to the site of 
interaction with antigen.
1.2.4 Other immunoglobulin classes
An IgD-homologue was described in chicken lymphocytes from 
spleen and bursa and in a B cell line RAV-1 but not in lymphocytes from 
thymus or blood from agammaglobulinaemic chickens (Chen et al., 1982) 
and an IgE-homologue was suggested to exist in birds Wiich received 
multiple inoculations of horse serum detected by a radioimmunoassay 
using an antiserum to human IgE (Burns and Maxwell, 1981).
1.3 Defence mechanisms of the respiratory system
The antibody response in the upper respiratory system of 
chickens is produced by localized lymphoid structures. The nasal 
passages, including the mucosa of the eye (conjunctiva), receive 
antibody produced chiefly by the Harderian gland (HG) (Davelaar, 1980), 
or from the lachrymal gland, after the removal of the HG (Burns, 1979; 
Davelaar, 1980; Davelaar and Kouwenhoven, 1980). Small aggregates of 
lymphoid follicles (foci) are distributed throughout many organs 
(Payne, 1971), including the respiratory system and are responsible for 
the synthesis of local antibody. At the local site of deposition of
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antigen, germinal centres develop, or are created when required, 
following the antigenic stimulation (Payne and Powell, 1984). Although 
chickens do not have lymph nodes (mammalian-type), this is compensated 
for by the widespread distribution of lymphocytes in tissues and the 
ability to respond with the formation of new lymphoid follicles (Biggs, 
1957).
In the protection of the respiratory tract, the first defence 
to evade particulate antigen penetration into the lower tracts of the 
system are mechanical barriers, performed by anatomical features of the 
nasal passages, acting as a filter. Particles which enter further into 
the system may be adsorbed by mucus and then moved upwards by the 
counter beating of the cilia up to the pharynx where, by coughing, they 
are expelled (Quinn, 1981) or swallowed. Mucus is secreted onto the 
mucosa and prevents further progress of particulated antigens into the 
system, helping in the prevention of infection by localizing 
microorganisms andpt^ veniing their epithelial adherence (Clamp, 1981). 
The successful microorganism which adheres to the epithelium elicits 
more sophisticated defence mechanisms which include phagocytosis by 
polymorph nucleated leukocytes and macrophages, the latter aiding the 
initiation of the specific response by lymphocytes. Macrophages perform 
the antigen surveillance front which is responsible for the 
presentation of antigens to lymphocytes. Lymphocytes in the respiratory 
tract are located within exocrine glands, such as the lachrymal gland 
and HG, or scattered through the submucosa, constantly sampling the 
antigens directly or through macrophages. Surface specific response is 
mediated by antibodies.
In humans IgM and IgA polymeric antibodies produced by plasma 
cells travel through the serous-type epithelial cell (Brandtzaeg, 1981)
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from which the SC is acquired, linking to the J-chain. Monomers such as 
IgG and monomeric IgA and IgM also occur in secretions having been 
secreted originally as monomers or arise from the breakdown of polymers 
which lack SC. IgA but not IgM is resistant to proteolysis, inhibits 
the adherence of microorganisms, virus adsorption and bacterial 
colonization, prevents the hypersensitivity reactions, acts as blocking 
antibody preventing complement fixation (IgA does not activate 
complement) and may reduce the epithelial uptake of antigen by "immune 
exclusion" (Bienenstock et al., 1981).
The importance of antibody in the protection of the mucosal 
surfaces of the respiratory tract has been thoroughly demonstrated in 
chickens. Davelaar et cd. (1982) showed that the vaccination of day-old 
chicks with a live IBV vaccine strain ocularly resulted in the 
formation of IgA and IgG plasma cells in the HG. The local induction of 
antibody synthesis in the upper respiratory tract, pharynx and eye 
required local administration of IBV (Holmes, 1978; Hawkes et al., 
1983; Lutticken et al., 1987).
1.4 Detection of IgM
The classical profile of synthesis of the different classes 
of immunoglobulins is characterized by first the production of specific 
IgM, which is followed by a gradual switch to IgG or IgA (Roitt, 1984). 
The detection of specific IgM has been used for the diagnosis of recent 
infections, such as rubella (Enders and Knotek, 1986; Mortimer et al., 
1981-a) and hepatitis A (Mortimer et al., 1981-b) in humans, and in
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chickens was suggested for the detection of IBV infection (Mockett and 
Cook, 1986).
The detection of IgM can be impaired by the presence of IgG 
antibodies. IgG antibodies can compete with IgM by occupying antigen 
epitopes, reducing the availability of epitopes for IgM, so that fewer 
IgM molecules can be assayed. The reduced sensitivity of the assay can 
be overcome by separating IgM from IgG.
Another aspect of the detection of IgM relates to the 
specificity of the assay. Reagents should detect IgM without cross­
detection of IgG. This can be achieved by using M.Abs. to chicken IgM.
IgM may be detected by various techniques including radial 
immunodiffusion (Mancini et ^., 1965; Lebacq-Verheiden et ^ . , 1974; 
Subba Rao et ^., 1978), Ouchterlony analyses, agar gel double
diffusion test (Leslie and Clem, 1969; Rose et ^ . , 1974; Kobaiashi and 
Hirai, 1980), fluorescent antibody technique using anti-globulin 
conjugate (Kincade and Cooper, 1971), crossed Immunoelectrophoresis 
(Laurell, 1965; Schranner and Losch, 1986) and enzyme-linked 
immunosorbent assay (ELISA) (Mockett, 1986-a). IgM antibody capture 
assays to detect specific IgM were described and hâve been used for 
certain human diseases, e.g., for rubella, using monoclonal antibodies 
specific to human IgM, with an enzyme-labelled antigen (Bonfanti et 
al., 1985), in an antibody-capture radio-immunoassay (Mortimer et al., 
1981), antibody class capture assay and indirect ELISA (Enders and 
Knotek, 1986).
In order to improve the results obtained in an indirect ELISA 
and to avoid competition between IgM and IgG for the epitopes of an 
antigen, the separation of IgM from IgG in chicken serum has been 
performed by gel chromatography and fractions subsequently assayed by
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ELISA (Mockett and Cook, 1986).
Anti-chicken IgM monoclonal antibody (M.Ab.) was used to 
prepare an immunoadsorbent and also to assay the purity of fractions in 
the ELISA (Mockett, 1986-b). The immunoadsorbent consisted of combining 
the gammaglobulin fraction of ascitic fluids collected from iu vivo 
production of M.Abs. against chicken IgM (in the peritoneal cavity of 
mice) and cyanogen bromide-activated Sepharose. Reacting chicken serum 
and the immunoadsorbent and subsequently eluting the harvested fraction 
using ammonium thiocyanate resulted in the demonstration of pure 
extracts of chicken IgM (Mockett, 1986-b). Another approach to overcome 
competition between IgM and IgG would be to remove the IgG fraction and 
keep the remaining serum for. the assay of IgM. This could be done in 
essentially the same manner as described for the separation of IgM. A 
M.Ab. specific to chicken IgG could be used to prepare the 
immunoadsorbent.
Separation of immunoglobulins from the serum can also be 
achieved by sucrose density gradient centrifugation followed by the 
assay of IgM against the antigen (Gillette, 1974).
1.5 Reasons for selecting to study IBDV, ILT7 and IBV virus
infections
IBV infection has been selected for the preliminary studies 
of characterization of affinity chromatography for the purification of 
the IgM class from chicken serum because data was available on the 
profile and duration of IBV-specific IgM response (Mockett and Cook,
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1986) for comparison with the present results. The new proposed 
technique of rapid purification of IgM using IgM-immunoadsorbents could 
be compared to gel chromatography fractionation of serum to separate 
IgM. In addition, the IBV-specific IgM response was known to be 
short-lived and a method for the rapid detection of IgM could have 
immediate applicability in the diagnosis of a recent IBV infection, 
with advantages over, for example virus isolation.
ILT produces clinical signs which resemble so many other 
respiratory diseases that a good diagnostic test would be valuable. 
ILTV has been known to induce a carrier state of infection (Komarov and 
Beaudette, 1932; Bagust, 1986; Hughes et al., 1987). No information was 
available on the profiles of the antibody classes specific to ILTV. It 
was considered important to know the effect of such persistent 
infection on the antibody response, especially IgM, with reference to 
examining the use of detection of IgM to diagnose a recent ILTV 
infection.
IBDV is typically an immunosuppressive viral infection of 
chickens. It affects principally the antibody response. However, most 
of the available information on IBDV concerns its effect on the immune 
response to other antigens or on the total immunoglobulin synthesis. It 
was considered important to determine the IBDV-specific antibody 
response to a virus which is both inducing an immune response as an 
antigen and depleting B cells in the bursa of Fabricius.
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1.6 Review of the relevant literature on the investigated 
viral diseases
1.6.1 Infectious bursal disease (IBD)
1.6.1.1 Definition
Infectious bursal disease (IBD) or Gumboro disease is a viral 
condition of young chickens caused by a virus of the Birnaviridae 
family (Dobos et , 1979) first described in Gumboro, Delaware (USA) 
(Cosgrove, 1962). The disease severely affects the bursa of Fabricius 
in chickens infected in the first 1-2 weeks of age, causing an 
immunosuppressive effect on humoral immunity (Allan et ^ . , 1972) and 
depression of cellular immune response (Sivanandan and Maheswaran, 
1981) and causes a severe clinical disease on 3 to 6 week-old chickens. 
(Lukert and Hitchner, 1984).
1.6.1.2 Aetiology
The viral aetiology for IBD was described by Winter field et 
al. (1962). IBD is caused by a double-stranded bi-segmented RNA virus 
(IBDV) classified in a new family the Birnaviridae ("Bi" for double 
stranded bi-segmented genome and "rna" for the type of nucleic acid) 
together with the infectious pancreatic necrosis virus of fish, tellina 
virus of bivalve molluscs and Drosophila X virus of the fruit fly 
(Dobos et al., 1979). The morphology of the virus is icosahedral and
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the capsid is an arrangement of 32 capsomeres composed of four major 
structural polypeptides (Dobos et , 1979). The particle diameter is 
approximately 58-65 nm (Cheville, 1967; Dobos et ^ ., 1979).
Studies on antigenic relationships among several isolates of 
IBDV using a virus neutralization (VN) test in CEF, resulted in the 
description of two serotypes. Serotype I tends to group chicken 
isolates while serotype II are usually turkey isolates, although 
chicken isolates can infect turkeys (McFerran et ^., 1980). Serotypes 
I and II could not be distinguished in fluorescent antibody tests, 
indicating that they share common antigens (McFerran et ^., 1980; 
Jackwood et ^., 1982) Statistically significant differences in
neutralization were detected among serotype I viruses, identifying 6 
subtypes among the 15 viruses tested, i.e. 8 commercial vaccines and 7 
field isolates. VN antibodies to IBDV serotype II were observed to 
occur naturally in chickens (Jackwood and Saif, 1983). Chickens with VN 
titres against serotype II were not protected against challenge with 
virulent serotype I and chickens vaccinated with serotype I did not 
produce VN titres to serotype II. No sign of disease and no lesion in 
the bursa of Fabricius were observed in chicks inoculated with IBDV 
serotype II (Jackwood et al., 1985).
1.6.1.2.1 Physico-chemical properties of IBDV
IBDV is a very stable virus. It does not contain an envelope 
and resists treatment with chloroform and ether, it is inactivated at 
pH 12 but not at pH 2 and resists 5 h at 56° C. An iodine complex was
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effective at reducing infectivity of IBDV but not a phenolic compound 
or a quaternary ammonium disinfectant (Benton et 1967). The virus 
persists for long periods, for up to 122 days, in the environment where 
infected chickens are accommodated (Benton et ^., 1967) even after 
thorough cleaning and disinfection (Lukert and Hitchner, 1984).
Dobos gt (1979) showed that the virion polypeptides of 
IBDV, VPl 90,000 Da, VP2 41,000 Da, VP3 35,000 Da and VP4 28,000 Da, 
corresponded respectively to 3, 51, 40 and 6 %, of the virion. The 
buoyant density of the virus in caesium chloride is 1.29 g/ml for 
incomplete particles and 1.33 g/ml for mature particles (Muller et al., 
1986).
1.6.1.3 Clinical signs and lesions
Clinical signs in chickens are observed mainly between 3 and 
6 weeks of age, and include severe depression, ruffled feathers, 
incoordination and diarrhoea varying from whitish or watery to 
yellowish and soiled cloacal region (Lukert and Hitchner, 1984). At 
necropsy haemorrhages are observed in the muscles of the thigh and 
breast. The bursa may be swollen and gelatinous if birds are observed 
4-5 days post-infection, and show congestion or haemorrhagic mucosa. 
Bursas may be atrophied, weighing one third of its original mass by the 
8th day of infection (Cheville, 1967).
The clinical disease is rapid in onset, often between 3-4 
days p.i. Mortality may vary from negligible to very high. Recent 
outbreaks of the highly virulent strains of IBDV were reported in
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Holland (Box, 1989). In the UK the disease was first reported in East 
Anglia and disseminated to other parts of the country, showing 
mortality as high as 70 % (Chettle at ^., 1989; Stuart, 1989). These 
outbreaks are believed to be caused by very virulent strains of the
same serotype as the classical strains. The majority of deaths in the
flock occur within a period of a few days ("spiked" mortality). 
Subclinical disease occurs naturally in susceptible chickens younger 
than 3-weeks-old, when the bursa is not fully grown, and virus 
multiplication in the bursa will not be sufficient to produce the 
generalized somatic changes seen in older chickens, but
immunosuppression often results as a manifestation of this infection.
Lesions in chickens which showed clinical signs of the 
disease include dehydration, darkened skeletal muscles, haemorrhages in 
the thigh and pectoral muscles, mucoid enteritis and enlarged kidneys 
due to oedema and hyperemia, with distended tubules and ureters. Gross 
bursal lesions vary with the stage of infection, being enlarged 2 to 4 
days p.i., reduced to normal at the 5th day p.i. and atrophied at the 
8th day p.i. (Cheville, 1967). Lesions in the kidneys (Ley et al.,
1979) are considered to result from immune complexes vdiich deposit in 
this organ. Skeeles et (1979-b) reported that IBDV-infected
8-week-old chickens had lowered complement titre, but normal 
2-week-old chickens had no measurable complement titre prior to 
or after IBDV inoculation, suggesting the involvement of 
complement in the lesions in the older chickens.
Histological lesions in the bursa are initially degeneration 
and necrosis of lymphocytes in the medular region of the follicles, 
which are replaced by heterophils and endothelial cells and pycnotic 
cell debris. Up to 100 % of bursa follicles may be affected by 3-4 days
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after infection and in the later stages of infection cystic cavities 
and fibroplasia of interfollicular connective tissue are detected 
(Lukert and Hitchner, 1984).
Simmons et (1977) detected bursal changes in turkey
poults which showed an acute respiratory disease. However, the 
significance of the IBD in turkeys remains to be determined (Cummings 
et al., 1986).
1.6.1.4 Pathogenesis and epizootiology
IBD occurs in the major areas of poultry production of the 
world. Chickens of all breeds are affected and usually show clinical 
disease between 3 and 6 weeks of age. Chickens younger than 3 weeks do 
not normally exhibit clinical signs but undergo a severe impairment of 
the bursa system which results in immunosuppression of the B cell 
response (Lukert and Hitchner, 1984). This inapparent form of the 
disease in chicks is of much economical importance due to the resulting 
permanent inability of the birds to produce an adequate immune response 
to vaccination and opportunist pathogens.
The target organ of the virus infection is the bursa of 
Fabricius, the organ responsible for the maturation of B lymphocytes. 
The greatest size of the bursa relative to body weight is between 3 to 
6 weeks of age, its physiological involution starts at 8-12 weeks and 
is complete by sexual maturity (Rose, 1981; Payne and Powell, 1984). 
Clinical disease is dependant on the stage of development of this 
organ, the maximum size of the bursa coinciding with the ages of
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occurrence of clinical IBD. These latter findings were experimentaly 
confirmed by the fact that different concentrations of bursal cells 
given to bursectomized chickens which were subsequently challenged with 
IBDV resulted in clinical disease only when chickens were inoculated 
with at least log^^ 7.0 cells (Ismail et 1987). Clinical disease
and lesions in chickens between 3 and 6 weeks of age is a consequence 
of the large titre of virus produced in the bursa and the immune 
response against it, resulting in tissue damage by the adhesion of 
immune complexes and complement to tissues and organs (Ivanyi and 
Morris, 1976; Ley and Yamamoto, 1978; Skeeles et ^ . , 1979-b; Skeeles 
et ^ . , 1980).
The severity of peripheral blood B cell depletion is 
age-dependent. Day-old chicks infected with virulent IBDV show a more 
severe B cell depletion, as compared to 3-week-old chicks, and a 
significant drop in circulating T cells (Sivanandan and Maheswaran, 
1981). IBDV is believed to affect B-cells which express surface IgM, 
cells which are precursors in the development of an antibody response 
(Hirai et ^., 1979; Hirai and Calnek, 1979; Hirai et ^., 1981; Boyd 
et ^., 1987). This was demonstrated by the dramatic reduction of all 
immunoglobulin classes after in ovo inoculation of IBDV (Hirai et al., 
1979 ). The gene rearrangement which enables the switch from IgM to IgG 
synthesis takes place in the bursa (Boyd et al., 1987). Using 
15-day-old chicks, Sharma et (1989) showed that bursal destruction 
was associated with a deficiency to switch from the synthesis of IgM to 
IgG. This is because chickens infected at that age undergo dramatic 
destruction of the bursa during the early migration of lymphocytes, 
which depart from the bursa to seed out to the secondary lymphoid 
tissues. B-cells migrate from the bursa of Fabricius to colonise the
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secondary lymphoid organs, principally around the time of hatching 
(Boyd and Ward, 1984). IBDV-infection at the time that B-cells seed out 
to populate the secondary lymphoid organs will drastically reduce the 
numbers of mature B lymphocytes and results in dramatic 
immunosuppression (Sivanandan and Maheswaran, 1981). The virus 
initially multiplies in the lymphocytes and mononuclear phagocyte 
system in the caecum, duodenum and jejunum and passes to the Kupffer 
cells in the liver. Viraemia from the liver distributes the virus to 
most organs, including the bursa, vdiere the virus multiplies to high 
titre as shown by IBDV-specific immunofluorescence, by only 11 hours 
p.i. (Muller et ^., 1979). IBD infection in the early life of birds 
produces increased susceptibility to other avian pathogens such as 
Newcastle disease (Allan et 1972; Giambrone et , 1976), Marek's 
disease (Giambrone et ^ . , 1976) and infectious bronchitis (Winterfield 
et 1978).
Turkeys have apparently a widespread infection with serotype 
II of IBDV. Bursal changes were observed in turkey poults
simultaneously to an acute respiratory disease (Simmons et ^., 1977). 
Experimental infection of 3 to 6 week-old turkeys using a chicken 
isolate (serotype I) was demonstrated (Giambrone et ^., 1978) and
although no morbidity, mortality or gross lesions were observed, a 
varying degree of histological changes and IBDV-specific
immunofluorescence was observed in the bursae, suggesting that chicken
isolates might become adapted to growth in turkeys which could act as 
reservoirs for IBDV infection of chickens (Giambrone et ^., 1978). 
Natural infection with serotype II in turkeys has been diagnosed in 
6-week-old poults with diarrhoea by virus isolation from faeces and 
serological evidence using SN and indirect immunofluorescence (McNulty
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et al., 1979). Turkey IBDV isolates may be infective to chickens 
(Cummings et ^., 1986). Isolates from serotype II of IBDV are
infectious and transmissible but do not produce an immunosupressive 
effect in turkeys (Jackwood et al., 1985).
1.6.1.5 Diagnosis
Sensitive hosts for virus isolation are 9 to 11-day-old SPF 
chicken embryos inoculated via the chorioallantoic membrane (CAM) with 
material from ground bursae. Embryonic death occurs at 3 to 5 days 
post-infection (Hitchner, 1970). Virus isolation using the allantoic 
or yolk sac routes usually requires virus adaptation through passage. 
Virus growth in chicken embryo fibroblasts (CEF) or chicken kidney (CK) 
cells also requires the adaptation to cell culture of previously 
embryo-adapted isolates through serial passage. Unadapted wild strains 
require inoculation into susceptible chickens.
Diagnosis of IBDV may be achieved by determining the presence 
of viral antigens in the bursa of Fabricius by using the agar gel 
precipitation test (AGP) with ground bursae tested against IBDV 
reference sera (Faragher, 1971; Wood et ^ ., 1979) or in bursal smears 
by immunoperoxidase staining (Cho et ^., 1986). AGP can be used to 
detect IBDV antibodies assayed against an IBDV antigen (Woernle, 1962).
SN for IBDV has been described in CEF or CK cells using the 
microtechnique (Skeeles et al., 1979-b; Weisman and Hitchner, 1978). SN
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has been considered more sensitive than AGP, since sera negative by AGP 
were found to be positive by SN (Weisman and Hitchner, 1978).
Marquardt et (1980) developed an ELISA for IBDV and
compared it to other serological methods. The SN test and an ELISA did 
not correlate, possibly due to the measurement of different antibody 
specificities. The ELISA test was found sensitive, specific, safe, 
reproducible and accurate for quantitating antibodies to IBDV and
20,000 to 25,000 times more sensitive than AGP. ELISA antibodies could 
be detected from the 4th day p.i. and high titres persisted for up to 
one year (Marquardt et ^ . , 1980).
Immunofluorescence and electron microscopy of the bursa of 
Fabricius have been found to be important means of early detection of 
virus growth (Lukert arid Hitchner, 1984).
Histological examination of the bursa is useful for the
diagnosis of the disease and to differentiate IBD from a Marek's
disease productive infection (Jakowski et al., 1969).
1.6.1.6 Prevention and control
IBDV is a very resistant virus and has defied methods of 
control based on disinfection and hygiene.
Vaccines have been developed and early ones were made of 
ground bursal tissue from chickens infected with virulent IBDV (Edgar 
and Cho, 1965) and these reduced the mortality rate from 5 % to 0.7 % 
but did produce bursal lesions, loss of weight gain and
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immunosuppressive effects similar to those of natural outbreaks of the 
disease (Snedeker et , 1967). These vaccines were restricted to use 
in IBD endemic areas or when the progeny chicks possessed passive 
antibodies. Attenuated strains of the virus were generated by passage 
in chicken embryonated eggs or chicken cell culture. Snedeker et 
(1967) described a chicken embryo adapted strain of vaccine obtained 
after 8 passages in the allantoic sac which still produced severe 
damage to the bursa of susceptible chicks. Further passage of the virus 
resulted in loss of virulence but retention of immunogenicity. 
Winterfield (1969) using vaccines derived from virus at the 27th to 
41st passage in chicken embryos, obtained effective protective immunity 
and no immunosuppressive effect in chicks free from maternal antibodies 
to IBD. Mild vaccine strains of IBDV were inactivated by maternally 
derived antibodies in chicks up to 21 days of age (Rinaldi et al.,
1974) and the immune response to attenuated vaccines was impaired in 
the presence of both low and high levels of maternal antibodies in 
chicks from 1 to 14 days but not with chicks over 28 days (Wood et al., 
1981). Maternal antibodies protected chicks against early infection 
with IBDV and from the immunosuppressive effects of the inapparent 
disease up to the third week post hatching (Hitchner, 1971; Baxendale, 
1976; T^eth and Cullen, 1976). Vaccination of parent stock with oil 
emulsion vaccines produced higher and longer levels of immunity in 
breeders with consequent protection of chicks over the most important 
phase of susceptibility with no detriment on the reproductive life of 
the chickens (Wyeth and Cullen, 1976; Lucio and Hitchner, 1979-a; V^eth 
and Chettle, 1982).
A killed virus oil-emulsion IBDV vaccine produced higher and
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less variable SN levels than a killed-virus IBDV suspension and the 
oil-vaccine induced SN titres which remained constant almost throughout 
a 50-week period of experimentation. The oil based vaccine produced 
anamnestic SN response against IBDV in breeders that have been primed 
with live vaccine at 2 weeks of age and revaccinated at 16 weeks of 
age. Antibody titres in dams related to protection of progeny (Lucio 
and Hitchner, 1979-a).
1.6.2 Infectious laryngotracheitis (ILT)
1.6.2.1 Definition
Infectious laryngotracheitis (ILT) is a viral disease of 
gallinaceous birds, especially chickens (Hanson, 1984). Pheasants, 
pheasant-chicken crosses (Hudson and Beaudette, 1932-b) and peafowl 
(Winterfield and So, 1968) have also been reported to be susceptible to 
experimental infection. The acute disease is characterized by 
respiratory signs including dyspnoea, gasping, coughing and nasal 
discharge with bloody exudate. A mild form of the disease may produce 
drops in egg production, conjunctivitis from watery eyes to haemorragic 
conjunctivitis, swelling of infraorbital sinuses and persistent nasal 
secretion (Hanson, 1984). ILTV induces a persistent infection
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(subclinical) with spontaneous episodes of virus shedding from carrier 
birds (Hughes et al., 1987).
1.6.2.2 Aetiology
ILT is caused by a virus (Beach, 1931) of the family 
Herpesviridae (Watrach et éd., 1963) subfamily alphaherpesvirinae, 
species Gallid Herpesvirus 1 (Roizman et ^ . , 1981). The structure of 
ILTV was studied in sections of infected chorioallantoic membranes of 
chicken embryos (Watrach et ^., 1959). Virus was most commonly 
observed in the cytoplasm of entodermal cells, with forms ranging from 
150 to 240 nm in diameter with an opaque core of 50 to 80 nm and an
outer capsule 25 to 50 nm thick. These structures were rarely seen in
the nuclei of cells, where particles were usually 80-100 nm in diameter
with a thin outer membrane and containing an inner core 30 to 40 nm in
diameter. Tubular structures were seen in the cytoplasm closely 
associated with the capsule of the virus (Watrach et ^., 1959). 
Studies on the structure of ILTV grown in CK cells (Watrach et al., 
1963) resulted in the observation of capsids displaying isometrical 
polyhedral structure, equilateral triangular facets and 5- and 
6-coordinated capsomeres (a 5:3:2 rotational symmetry) which was 
postulated to form an icosahedron of approximately 162 capsomeres.
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identical to that of herpes simplex, varicella-zoster and pseudorabies 
viruses (Cruickshank et 1963; Watrach et , 1963). The genome of 
herpesviruses is composed of DNA which is released in the cytoplasm of 
host cells (typically the epithelium of the trachea) and migrates to 
the nucleus during infection of cells (Hanson, 1984).
No clear serological differences among ILTV strains have been 
reported, although some variations were shown in neutralization tests 
(Burnet, 1936) using strains of different pathogenicity to chickens.
1.6.2.2.1 Physico-chemical properties of ILTV
The properties of herpesvirus particles according to Roizman 
et al. (1981) include a linear double stranded DNA 32-75 Guanine plus 
Cytosine moles %, 20 structural polypeptides with molecular weights 
from 12,000 to 220,000 Da, presence of lipid and covalently-linked 
carbohydrates in the envelope and buoyant density in caesium chloride 
1.20-1.29 g/ml.
ILTV was inactivated after 24-hour treatment with ethyl ether 
at 4° C (Fitzgerald and Hanson, 1963), resisted extended periods 
freeze-dried or maintainance at -20° C to -60° C (Goldhaft, 1961), and 
it was destroyed in 44 hours at 37° C in the trachea of chicken 
carcasses or after 5 hours at 25° C and 37° C in the chorioallantoic 
membrane of infected chicken embryos (Cover and Benton, 1958). A 3 % 
cresol or 1 % sodium hydroxide solution will inactivate ILTV in less 
than 1 minute (Hanson, 1984).
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1.6.2.3 Clinical signs and lesions
Only seldom do clinical cases resemble the typical peracute 
form of the disease, in which chickens show severe dyspnoea with 
expectoration of blood and haemorragic tracheitis with blood clots at 
necropsy (Van Roekel, 1955). The clinical signs are usually similar to 
other respiratory diseases of chickens, including reduction of growth 
rate, decrease in egg production, lacrimation, swelling of the 
infraorbital sinuses, haemorragic conjunctivitis and persistent nasal 
discharge (Hanson, 1984). Recent outbreaks in the UK were mild in 
nature and chickens showed depression, sneezing, tracheal rales and 
coughing (Hughes et ^., 1987). Jordan (1958) described that the 
infection was confined to the respiratory tract and eye and that almost 
100 % of birds showed congestion or inflammation of the trachea but 
rarely blood or blood clots in the trachea.
1.6.2.4 Pathogenesis and epizootiology
The disease can affect chickens of all ages (Hinshaw et al., 
1931). Virus multiplication is limited to respiratory tissues with 
little evidence of viraemia (Hitchner et ^., 1977). Transmission of 
the disease occurs more readily after contact with actively diseased 
birds than through contact with carrier birds which recovered from the 
disease (Hanson, 1984). ILTV was demonstrated in the conjunctival and
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respiratory secretions and tissues up to 6-8 weeks after infection.
The virus enters the host via the respiratory tract by 
inhalation or ocular introduction of aerosol discharges from coughing 
of diseased birds (Beaudette, 1937) and by ingestion (Hanson, 1984; 
Hughes et ^., 1987). Indirect spread may occur through fomites 
(Beaudette, 1937; Jordan, 1963) and the infection may persist in a farm 
from year to year, maintained by a carrier stock (Beaudette, 1937). 
Brandly (1935) demonstrated lack of vertical transmission as infected 
eggs failed to hatch and embryonic death occured between 2 and 12 days 
after inoculation (chorioallantoic membrane route). Jordan (1963) found 
no evidence of influence of age, breed, season or type of management on 
the incidence or severity of the disease. Morbidity from the disease 
was found to be approximately 100 % and mortality to range from 0 to 
49 %, with most of the mortality occurring within 22 days of infection 
with a maximum at the 11th day of disease (Hinshaw et ^., 1931). 
Incubation period for the clinical disease after natural exposure is 
between 6 and 12 days (Kernohan, 1931).
Carrier birds are an important source of recurrent infection 
on a farm (Jordan, 1958). Approximately 2 % of recovered birds may 
possess the virus in the trachea (Beaudette, 1949), however, 38 % of 
experimentally infected chickens developed latency (Bagust, 1986). In 
naturally infected birds ILTV was shown to persist in the trachea for 
long periods, from 72 days in 6 out of 8 birds and up to 16 months in 3 
of 25 birds (Komarov and Beaudette, 1932). Vaccination can result in 
birds becoming carriers which may spread the virus to susceptible birds 
introduced to the farm and infection may recur on a farm after contact 
of previously ILT vaccinated birds with susceptible pullets (Beaudette, 
1937). No difference was seen in shedding when birds were infected
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nasally/conjunctiva or intratracheally (Hughes et 1987). Virus
isolation was successful in intermittent episodes using chick embryo 
liver cell, which was found to be more sensitive for virus isolation 
than chicken kidney, lung or fibroblasts (Hughes and Jones, 1988). 
Recovered carrier birds did not show clinical signs during episodes of 
virus reactivation and cyclophosphamide treatment did not produce virus 
reactivation, possibly due to the previous high shedding rate (Hughes 
et al., 1987). There was no clear association between shedding and 
management stimuli. The trachea was implicated as a possible site of 
latency and the trigeminal ganglia has been incriminated (Bagust, 1987; 
Hughes et al., 1987).
1.6.2.5 Diagnosis
Because clinical signs and lesions of ILT are usually not 
characteristic, it is often necessary to undertake laboratory 
examination in search for the causal agent by direct detection of ILTV 
in the trachea, virus isolation in susceptible laboratory hosts or the 
detection of ILTV-specific antibody response.
For the laboratory diagnosis of ILT, the following approaches 
can be envisaged:
1. Virus isolation in susceptible hosts such as chicken 
embryo liver cells, chicken kidney cells, chicken 
embryonated eggs;
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2. Detection of virus in infected tracheas:
2.1 Using an ILTV-specific antibody in the fluorescent 
antibody tests (FAT), enzyme immunoassays, radio 
immunoassays etc.;
2.2 Electron microscopy (EM) to demonstrate ILTV in
tracheas;
3. Detection of antibody response against ILTV using for 
example SN or ELISA;
Virus isolation from lung and trachea of affected birds may 
be performed in susceptible 9 to 12 day-old chicken embryonating eggs 
inoculated via the CAM route (Jordan, 1964). Virus growth in the CAM 
produces small non-necrotic plaques or large plaques with necrotic 
centres which may be histologically examined for intranuclear inclusion 
bodies after 72 hours incubation (Hanson, 1984). CEK cells showed 
changes 24 hours p.i. consisting of giant cells, intranuclear 
inclusions and cell necrosis (Chang et ^ . , 1960).
Hughes and Jones (1988) studied different methods for the 
primary isolation of ILTV. It was concluded that the most sensitive 
system for ILTV growth was chick embryo liver cells followed by chick 
kidney cells. CEK, chick embryo lung and CAM were all less sensitive. 
CEF and Vero cells were considered of no value for the primary 
isolation of ILTV. It was concluded that ILTV could be detected by EM 
if samples had at least a concentration of log^^ 3.5 virus per 0.1 ml.
Intratracheal inoculation of ILT susceptible and immune birds
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with lung and tracheal exudate or suspension from diseased birds may be 
used for the reproduction of the disease (Hanson, 1984).
Histopathology of infected tissues stained by Giemsa, before 
necrosis and desquamation of the epithelium is observed, within 1 to 5 
days of infection, is valuable for the observation of inclusion bodies 
in the nuclei of the ciliated epithelium of the trachea or in the 
epithelium of conjunctiva (Cover and Benton, 1958).
FA may be used to identify the virus in infected tissues from 
2 to 14 days after infection (Wilks and Kogan, 1979).
Serological tests for ILT also include SN in chicken 
embryonated eggs using the CAM route of inoculation and evaluated by 
pock counting (Burnet, 1936). Woernle and Brunner (1961) described an 
AGP using CAM grown virus as antigen to detect ILTV-specific
antibodies. An AGP using tracheal scrapings as antigen may be used to
test sera, precipitation lines forming in 24-48 hours (Van Kammen and 
Spradbrow, 1976). An ELISA was described for ILT using virus grown in 
CK cells (Meulemans and Halen, 1982).
In studies by Adair et al.(1985), the ELISA had comparable
sensitivity to the FAT performed in multitest slides using infected
chicken embryo liver cell cultures. ELISA and FAT had slight superior 
sensitivity to SN. AGP was less sensitive than ELISA, FAT and SN but 
was considered useful to monitoring flocks. FAT was considered to have 
the disadvantage of subjectivity and the ELISA was found the ideal test 
for survey purposes (Adair et al., 1985).
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1.6.2.6 Prevention and control
ILTV vaccines induce a latent state of infection (Bagust, 
1986; Hughes et 1989-b), therefore vaccination should be
administered only to chickens which will enter an epizootic region and 
chickens should be at least 4 weeks of age at vaccination. Available 
vaccines include live attenuated or naturally low virulence strains of 
the virus which are administered via eye drop, via cloacal drop or 
brushing, feather follicle inoculation, wing web scarification or 
intranasally (Hanson, 1984). ILTV vaccines given via the cloaca have 
been reported to produce bursal destruction, resulting in failure to 
produce antibody to Brucella abortus (Robertson, 1976).
Infected, vaccinated, recovered or exposed birds should not 
be introduced in a susceptible flock. If the farm is already infected 
purchased susceptible flocks should be maintained in isolation to 
prevent the risk of infection acquired from carrier birds.
1.6.3 Infectious bronchitis (IB)
1.6.3.1 Definition
Infectious bronchitis is a viral disease which results in 
respiratory infection in chickens of all ages, a decline in egg 
production in layers including deformed, soft-shelled and rough shelled 
eggs (Hofstad, 1984) pale-shelled eggs (Cook, 1984), with loss of
43
internal quality (watery albumen) and also nephritic infection 
(Hofstad, 1984).
1.6.3.2 Aetiology
Infectious bronchitis virus (IBV) is a member of the family 
Coronaviridae , which has a single genus, the coronaviruses. Viral 
properties have been determined and compared to other coronaviruses 
(Almeida et al., 1968). IBV particles measured from 80 to 120 nm in 
diameter including the surface projections of approximately 20 nm in 
length.
The antigen plurality of IBV was first suggested by Jungherr 
et al. (1956) using an SN test in embryonated eggs and in chickens and 
cross-protection tests in chickens. The authors proposed a nomenclature 
of isolates based on place of isolation and first refered to 
Massachusetts and Connecticut serotypes. Connecticut was the first 
variant of IBV reported in the literature (Jungherr et ^ . , 1956). 
Derbyshire et (1979) used neutralization tests in tracheal organ 
cultures to study antigenic relationships between 24 strains of IBV and 
classified strains into 8 groups. During the 1980s, several outbreaks 
of IB were described in the UK and Europe reporting the appearance of 
variant IBV strains which were different from the Massachusetts strains 
commonly used to control the disease (Davelaar et ^., 1984; Cook,
1984). RNA oligonucleotide fingerprinting of 13 isolates of IBV could 
detect 11 distinct profiles and allowed a greater degree of
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differentiation (Clewley et al., 1981).
IBV replicates in the cytoplasm and buds into cytoplasmic 
vesicles (Almeida et al., 1968).
1.6.3.2.1 Physico-chemical properties of IBV
IBV is similar to other coronaviruses and contains three 
major protein structures, the nucleocapsid, the matrix and the peplomer 
(surface projection). The surface projection of IBV has been shown to 
consist to two glycopeptides Si (90,000 Da) and 52 (84,000 Da)
(Cavanagh, 1981, 1983). The matrix protein is a 23,000 Da glycopeptide 
(Stern et ^., 1982) and variations in its MW are due to different 
degrees of glycosylation. The nucleocapsid is a 50,000 to 54,000 Da 
polypeptide (Macnaughton et al., 1977).
IBV is ether labile (Almeida et ^ . , 1968) and most strains 
are inactivated after 15 minutes at 56° C. It is sensitive to most 
disinfectants but can spread airborne by sneezing or coughing chickens 
(Hofstad, 1984).
1.6.3.3 Clinical signs and lesions
Clinical signs appear as gasping coughing and tracheal rales 
after a short incubation period of usually around 24 hours. Young birds
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may show wet eyes, swollen sinuses and nasal discharge and congregate 
under the heat source. Growing chickens may undergo an unnoticed 
infection which may require observation of birds during quiet hours to 
allow listening to respiratory rales. Tracheal rales are sounds 
produced during breathing by the large amount of mucus deposited in the 
trachea. Decline in egg production varies from a slight drop to a sharp 
and long lasting loss. Eggs with watery albumen and misshappen eggs may 
be laid by infected hens (Hofstad, 1984).
At necropsy the trachea, nasal passages and sinuses show an 
exudate which varies from serous, catarrhal, mucous to caseous in 
texture. The tracheal mucosa may be congested. Air sacs may appear 
opaque or with caseous exudate. Kidneys may be swollen and pale with 
deposits of urate in the tubules and urethers (Hofstad, 1984).
1.6.3.4 Pathogenesis and epizootiology
All ages of chickens are susceptible to IB but young chicks 
are affected more severely. The trachea is the primary target organ. 
Morbidity from the disease is approximately 100 % and mortality 
although negligible by 6 weeks of age may reach 25 % in younger chicks 
(Hofstad, 1984) as a result of secondary bacterial infection. 
Susceptible flocks infected with IBV undergo a sharp decrease of egg 
production with delayed period of recovery frequently associated with 
poor egg quality (Hofstad, 1984). The incubation period of IB is 18-36 
hours varying with route and dose of infection (Hofstad, 1984). The 
infection is acquired by inhalation of aerosols spread from infected
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chickens with respiratory signs or from faeces from carrier birds. 
Chickens exposed to aerosols of undiluted IBV-infected allantoic fluid 
develop respiratory sigs within 24 hours but natural dissemination may 
require a longer incubation period of 36 hours or more (Hofstad, 1984). 
Exposure trials showed no transmission after 35 days p.i. from 
recovered chickens (Cunningham, 1970). IBV was recovered from chickens 
maintained under strict isolation up to 49 days p.i. and from chickens 
housed in less effective isolation for over 4 months (Cook, 1968). 
Alexander et (1978) reported the long term isolation of IBV strains 
H52 and H120 from caecal tonsils and kidneys, virus being shed in the 
faeces up to 224 days p.i.
Egg quality is affected by IBV infection. Egg abnormalities 
may persist in a recovered flock. Externally the eggs may show rough, 
uneven, irregular and thin shells. Internally, the albumen, specially 
the thick albumen, is watery and does not show the demarcation of thick 
and thin albumen of normal fresh eggs (Hofstad, 1984). Egg shell may 
appear pale in breeds which produce brown shelled eggs (Cook and 
Huggins, 1986). Recent IBV isolates in Britain caused more than 50 % of 
eggs laid by intranasally inoculated hens to be pale and produced some 
mortality and high morbidity in 11-day-old chicks when challenged 
together with a pool of pathogenic Escherichia coli (Cook and Huggins, 
1986).
After aerosol exposure IBV was at greatest concentration in 
the trachea, lung and air sacs and with a lower titre in other tissues, 
including the kidney, pancreas, spleen, liver and bursa of Fabricius. 
Distribution of IBV in the organs of infected chickens varied with the 
passage of the virus. A gradual loss of invasiveness for nonrespiratory
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tissues was observed after embryo passage (Hofstad and Yoder Jr., 
1966).
1.6.3.5 Diagnosis
Virus isolation may be performed in 10 to 11-day old chicken 
embryonating eggs inoculated via the allantoic sac route and virus 
growth produces dwarfing of the embryos within 7 days of incubation 
which increases in percentage and virulence for the embryo in 
subsequent passages (Hofstad, 1984). Tracheal ring cultures provide a 
more rapid and sensitive method of virus isolation (Cook et ^ . , 1976) 
and ciliostasis occurs within 3 days after infection. The virus may be 
adapted to growth in CK, in lung cells and liver cells of 15- to 18-day 
old chicken embryo (Hofstad, 1984), but this is not applicable to 
routine diagnosis.
Serological methods available for IB include the SN test in 
embryonating eggs which is labourious and time-consuming and the use of 
tracheal organ cultures is a rapid and sensitive alternative (Cook et 
al., 1976). A plaque reduction method performed in CK cells using 
CK-adapted IBV for detection of iBV-specific antibodies has been 
described to be comparable to SN tests using embryonated eggs and 
having the advantage that results can be obtained in 48 hours rather 
than the 5-7 days required for SN tests in eggs (Lukert, 1966).
Haemagglutination (HA) of chicken red blood cells was 
observed to occur after treatment with the enzyme phospholipase C type 
I which could be inhibited by IBV-specific sera (Bingham et al., 1975).
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A haemagglutination inhibition test (HI) for IB was developed by 
Alexander et (1976) and Alexander and Chettle (1977). Procedures 
from preparing the HA antigen for several IBV isolates were described 
(Lashgari and Newman, 1982). Because of difficulties in reproducibility 
and standardization of the test, a recommended procedure has been 
produced (Alexander et ^ ., 1983).
The HI was compared to the SN test in tracheal organ cultures 
for typing IBV isolates. Similar antigenic relationships were found by 
the two methods, but the HI test gave less clear results because of 
higher and variable cross reactivity among strains with that method. 
The HI test detected a group reaction and was confirmed of value for 
diagnosing IB and monitoring vaccination responses but could not be 
recommended for serotyping of IBV. The SN test in tracheal organ 
cultures gave clear cut results enabling definitive typing (Cook et 
^., 1987).
ELISA tests were described for IBV (Garcia and Bankovski, 
1981; Mockett and Darbyshire, 1981; Marquardt et ^., 1980). The
technique was more sensitive than SN or HI tests for antibody assay 
(Mockett and Darbyshire, 1981). Serotypes of IBV could not be 
differentiated using the ELISA test because of cross-reactivity 
(Marquardt et ^ ., 1980; Mockett and Darbyshire, 1981).
The FA test was used to differentiate IBV serotypes (Lukert,
1969) and results appeared to resembled those from cross-protection 
tests better than cross-neutralization tests. The Massachusetts 41 (M 
41) conjugate stained CK cells infected with M 41, Connecticut, Iowa 97 
and RPL serotypes but only the M 41 conjugate could stain M 41 infected 
chicken kidney cells (Lukert, 1969).
An AGP test has been used to identify virus isolates as IBV
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(Woernle, 1960). IBV can be grown in eggs for 72 hours and the 
allantoic fluid concentrated 10 times against polyethylene glycol at 4° 
C in dialysis tubing, to be used as antigen in the AGP test (Witter, 
1962). AGP was suggested as useful to indicate recent IBV infection 
(Witter, 1962) as antibody detected by AGP is transitory.
1.6.3.6 Prevention and control
Good hygiene although desirable is not sufficient to control 
IB. The virus is highly infectious and spreads airborne in aerosols 
produced by snicking infected flocks. The prevention of the disease has 
been achieved by vaccination.
IBV live attenuated and inactivated oil-based vaccines have 
been used to prevent IB. IBV live vaccine strains are available for 
many serotypes, e.g. Massachusetts, Connecticut, Arkansas 99, Florida 
and JMK (Hofstad, 1984). Live vaccines may produce undesirable effects 
in susceptible young chicks or laying hens, e.g., certain live vaccines 
strains may result in mortality and disease-like problems. Vaccinal 
reaction may be enhanced by concurrent infection with Mycoplasma and 
may be complicated by Escherichia coli or other bacteria. Severe 
infection has been reported after administration of certain less 
attenuated vaccine strains, e.g. the H52 strains (Hofstad, 1981). 
Vaccination of 1-day-old chicks with high levels of neutralizing 
antibodies (NA) via the ocular and nasal routes with H120 vaccine 
resulted in good immunity comparable to that of chicks with lower 
levels of NA vaccinated at 15 and 20 day of age. Vaccinal stimulation
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of the Harderian gland resulted in an increased number of 
immunoglobulin-bearing plasma cells and lymphocytes. Aerosol and 
drinking water routes produced smaller reactions and were found 
incapable of stimulating the Harderian gland. Vaccination at 6 to 10 
days of age resulted in a poor immune response (Davelaar, 1978).
Cell mediated (CMI) and humoral immunity are stimulated by 
live attenuated IBV vaccines. CMI as observed by a lymphocyte 
transformation test, appeared earlier than HI antibodies in birds 
responding to vaccination with the live vaccine strains H120 and H52 
or challenge with a virulent strain (M41). Although no direct 
correlation was observed between HI titres and CMI response, the latter 
appeared to be associated with development of resistance to IB 
infection and recovery from disease (Timms and Bracewell, 1981).
A long term immunity is needed for layers and breeders. This 
may be acquired by secondary vaccination using a less attenuated live 
strain of virus or by inactivated oil-emulsion vaccines injected 
intramuscularly. Oil-emulsion vaccines offered a good protection but 
can only be given to chickens already primed by live IBV vaccination. 
Primary or secondary responses to IBV oil-emulsion vaccines resulted in 
higher and more consistent HI antibodies titres but lower levels of CMI 
responses when compared to responses from live attenuated H120 or H52 
vaccines or challenge with virulent M41 virus. As a result of the
administration of live H120 vaccine at 3 weeks of age and 
intramuscular oil-emulsion vaccine at 16 weeks of age, higher egg
yields, higher HI antibodies and absence of the adverse effects which 
might result from the use of a more virulent strain (H52), also being 
used for secondary vaccination, have been observed. A good program was
found to be the vaccination of chicks at 3 weeks of age using a live
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attenuated strain of IBV and revaccination using an oil-emulsion 
vaccine at 15-19 weeks of age (Box and Ellis, 1985).
1.7 Aims of this Thesis
From the preceeding brief account of each virus infection, it 
became clear that there is a lack of detailed information on the 
antibody class response to these viruses and that, at least in the case 
of IB and ILT, there is need for better diagnostic tests.
In certain human viral diseases, such as rubella (Enders,
1985) and hepatitis A (Mortimer et ^., 1981-b), the detection of 
virus-specific IgM in serum could be associated to a recent infection. 
In such diseases the detection of specific IgM was shown to be useful 
for diagnosis and has been applied routinely.
The use of a diagnostic test based on the detection of 
specific IgM to viral infections of chickens is dependent on, first, 
the development of a technique which enables the rapid assay of IgM and 
second, knowledge of the profile of specific IgM generated by the 
infection. For the applicability of the technique for routine 
diagnosis, the IgM response needs to be shown as short lived and thus 
correlated to recent infection. Thus it will be necessary to determine 
the virus-specific IgM profiles of each virus infection to be studied.
Virus specific IgM in serum is difficult to detect in the 
presence of IgG, because the latter, present in greater amounts, 
competes with IgM and occupies antigenic epitopes, reducing their 
availability to IgM. Thus IgM present in lower concentration could
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remain undetectable if a technique such as indirect ELISA was used. In 
order to overcome this difficulty it is desirable to investigate 
methods for the separation of IgM from IgG.
Information is already available on the profile of specific 
IgM antibody after IBV infection (Mockett and Cook, 1986). This was 
determined using the well estabilished method of gel chromatography, in 
which serum components are separated according to their rate of flow 
through a column. The findings of that study form the basis for the 
series of experiments to be described in this thesis in which a study 
will be made of a technique for the rapid detection of virus specific 
IgM in chickens and its use for the diagnosis of recent IBV infection.
In the first stage of these studies affinity chromatography 
will be investigated as a method for the separation of IgM from serum 
to provide rapid separation. Investigation of such a technique is made 
possible by the availability of monoclonal antibodies (M.Ab. ) to 
chicken IgM. These will be used to prepare immunoadsorbents specific to 
chicken IgM by linking to gel. These highly specific reagents will be 
used in association with ELISAs which will be developed to detect virus 
specific IgM antibody.
The classical method to which the efficiency of the affinity 
chromatography technique will be coirç>ared will be gel chromatography, 
as this was the technique used by Mockett and Cook (1986) for IBV. This 
will provide further valuable information because gel chromatography 
fractionation of serum will also produce IgG fractions. These will be 
assayed by ELISA in a similar way to the IgM fractions, to detect virus 
specific IgG antibody, employing here M.Abs. anti-chicken IgG. 
Virus-specific IgG profiles will thus also be obtained, enabling a 
study to be made of both the IgM and IgG antibody responses to each of
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the viral infections.
The study of two other viral infections, caused by viruses 
distinct from IBV will be performed. These involve an infection causing 
latency (ILT) and one capable of producing immunosuppression (IBD). 
This will enable a study of the possibility that profiles of 
virus-specific IgM and IgG may vary according to the type of 
pathogenesis of the infecting virus and the results could provide some 
basis for a discussion of the various types of responses to be found in 
chickens infected with different viruses and their relationship to the 
mechanisms of pathogenesis.
The practical information obtained will be concerned with the 
method for and applicability of IgM detection for the diagnosis of 
viral diseases.
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Chapter 2
GENERAL MATERIALS AND METHODS
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Chapter 2 GENERAL MATERIALS AND METHODS
2.1 Chicken experiments
Specified pathogen free (SPF) chickens produced at Houghton 
Laboratory were used in all experiments. Five-week-old Rhode Island Red 
(RIR) birds were used in experiments with live virus. 14-week-old SPF 
Light Sussex (LSx) chickens were used for the experiment in chapter 8.
2.1.1 Accommodation
Chickens were kept in isolation rooms at Houghton Laboratory, 
Institute for Animal Health. On entering the isolation unit, a 
disposable paper boiler suit and rubber boots were put on. Each of the 
isolation rooms had an independent showering system where rubber boots 
were changed and a rubber suit put on for showering. A shower was taken 
in the anteroom both on entering and on leaving the isolation room. Air 
supply to the rooms was provided by an individual control unit for each 
room which controlled pressure, filtration by high efficiency 
particulate air (HEPA) or high efficiency sub-micron particulate air 
(HESPA) filters and the temperature. The extracted air was also passed 
through high efficiency filters and isolation rooms were maintained at 
a negative pressure. Extract air also passed through HEPA filters. 
Light was controlled by a timer to provide a length of artificial 
daylight according to the age of the chickens, for example continuous
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from day-old to the third week of age, 15 hours for young chickens and 
17 hours for layers. Colony cages measuring approximately 1.3 m^  of 
floor area and 100 cm in height were used. These cages accommodated a 
maximum of 10 chickens up to the age of approximately 8 weeks or 5 
older birds. The cages had galvanized wire net floor, walls and roof 
(openable to obtain access to chickens).
2.1.2 Food and water
Chick starter or layer food mixture, provided ^  libitum in 
large capacity feeders extending through the total length of one side 
of the cage, was free from animal protein and available in pellets 
(Labsure, UK.). Water was also available M  libitum via nipple 
drinkers.
2.1.3 Inoculation procedures
Live virus was typically administered by eye drop in volumes 
of 0.1 ml and birds were held steadily until the inoculum was installed 
in the pocket of skin formed by the conjunctiva and a movement of 
swallowing was observed. Virus was maintained on ice during the 
procedure of inoculation. In one experiment (chapter 8) live virus or 
an oil-emulsioned vaccine were injected intramuscularly (0.5 ml) into 
the breast muscle.
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2.1.4 Blood sampling
Blood samples were taken from the brachial (wing) vein to 
provide serum, using a 5 or 10 ml syringe fitted with 21-gauge needle. 
The needle was first introduced into the subcutaneous space and 
subsequently into the vein. A slight compression was produced in the 
axilar region when necessary to swell the vein. The point of 
introduction of the needle was gently compressed for one minute after 
needle withdrawal to avoid haemorrhage and haematoma formation. An 
average of 2.5 ml of blood was collected from 5-week-old chickens and 4 
ml from older chickens. Intervals between collections varied from daily 
to weekly, according to the experiment and period after infection. 
Blood was allowed to clot in plastic disposable bijoux either overnight 
at room temperature or for approximately 3 hours at 37° C. Serum was 
separated from the blood clot and centrifuged at 2,000 g for 10 minutes 
to remove blood cells. Sera pools, containing equal volumes of all 
individual sera, were prepared for each group and all sera were stored 
frozen at -20° C.
2.2 Viruses
2.2.1 Infectious bronchitis virus (IBV)
The M41 strain of the Massachusetts serotype was used to 
produce antigen for ELISA. The VF69-149 strain of the Massachusetts 
serotype (Darbyshire et ^ ., 1979) was used in the experiment described
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in chapter 4. Lyophilized, live attenuated H120 Massachusetts serotype 
vaccine (Intervet UK., Science Park, Milton, Cambridge.) and an 
oil-based inactivated Massachusetts vaccine (IBLIN, Pitman-Moore, 
Harefield, Middlesex.) were used in the experiment described in 
chapter 8.
2.2.1.1 Titration of IBV in tracheal organ cultures
IBV used to infect chickens was titrated in TOC according to 
the method described by Cook et (1976). Briefly, tracheal rings 
(0.5-1.0 mm thickness) prepared from the tracheas of nineteen-day-old 
embryos, placed in individual tubes were inoculated (5 tubes per 
dilution) with 0.5 log^^ dilutions of virus in Eagle's MEM and 
incubated at 37° C with rolling for 3-4 days. Cultures were read for 
ciliary activity under low power magnification. IBV-infected cultures 
showed cessation of ciliary activity (ciliostasis). Healthy tracheal 
rings maintain ciliary activity, easily detectable under low power 
magnification. The endpoint was calculated according to the method of 
Reed and Muench (1938). The titration of the H120 vaccine is shown as 
an example (Table 2.1).
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Table 2.1
Titration of the H120 vaccine in TOC
Virus Number of tubes additive
dilution ciliostatic beating scores ratio %
(lo9io) static beat static/beat
-3.5 5/5* 0/5+ 15 0 15/15 100
-4.0 4/5 1/5 10 1 10/11 91
-4.5 3/5 2/5 6 3 6/9 67
—5.0 3/5 2/5 3 5 3/8 38
* Number ciliostatic/number inoculated 
+ Number beating/number inoculated
formula. % next above 50 % -_______50 %______   ^ 67 - 50
% next above 50 % - next below % 67 - 38
17/29 = 0.58 X 0.5 (half log^^ dilutions) = 0.29 + 4.5 (last dilution 
with reading above 50 %) = 4.79
Titre: log^^ 4.8 CD^q per 0.1 ml.
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2.2.1.2 Preparation of IBV ELISA, antigen
IBV ELISA antigen was prepared according to the method 
described by Mockett and Cook (1986). 240 eleven-day-old SPF chicken 
embryonated eggs were inoculated with log^ Q 3 to 4 CD^^ of the M41 
strain and incubated at 37° C for 24 hours. The embryos were chilled 
and the allantoic fluids collected and pooled, and subsequently 
clarified by centrifugation at 4,500 g for 30 minutes at 4° C in a 
Sorvall RC5B superspeed refrigerated centrifuge. The virus in the 
supernatant was pelleted by centrifugation at 27,000 g for 1.5 hours 
(Sorvall RC5B) and the pellet resuspended in 5 ml of TNE buffer (lOmM 
Tris-HCl pH 7.4, 100 mM NaCl, 1 mM EDTA). The pellet was resuspended in 
5 ml of TNE buffer and homoger^zed using a dounce homogen_j.zer, then 
placed on top of a 25 to 55 % (weight/weight) sucrose gradient and 
centrifuged at 50,000 g for 18 hours at 4° C (Sorvall OTD 55B). 
Fractions were collected and the absorbance at 280 nm was measured 
using a Pye Unicam SP 1800 spectrophotometer. The material from the 
protein peak (O.D. greater than 1.0) was collected and pooled. This 
provided the antigen for coating ELISA plates.
If the procedure was not to be completed immediately, the 
virus pellet was mixed with an equal volume of glycerol and stored at 
-70° C. The viral concentrate was subsequently thawed and resuspended 
in approximately 90 ml of TNE buffer to dilute the glycerol, then 
centrifuged at 35,000 g for 1 hour at 4° C (Sorvall RC5B). The pellet 
was re suspended in 5 ml TNE and dounce homogenised prior to 
purification on the sucrose gradient as described above.
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For use in the ELISA, the antigen was titrated as described 
in section 2.3.1.
2.2.2 Infectious laryngotracheitis virus (ILTV)
A commercial lyophilized live attenuated vaccine against ILT 
(Salsbury Laboratories, Charles City, Iowa, USA) was used to inoculate 
the chickens. The Thorn V882 strain of ILTV (Dr. Griffin, Houghton 
Laboratory) was used to prepare ELISA antigen.
2.2.2.1 Titration of ILTV in CK cells
Ten-fold dilutions of virus were made in sterile PBS and 
adsorbed (0.5 ml) onto CK monolayers in Petri dishes for 1.5 hours at 
37° C (CO2 incubator) with constant rocking. Two replicates were used 
per dilution. The inoculum was removed and cells were overlayed with 4
ml of Eagle's MEM containing 1 % agar and 4 % calf serum. Petri dishes
were incubated for 24 h at 37° C and a second agar overlay containing 1
% neutral red was added. Plaques were counted 96 hours after
infection. The titre was calculated by the quantitative lesion counting 
method. The number of PFU counted (mean of replicates) was multiplied 
by the dilution factor and converted to PFU per ml, as shown in Table 
2 .2 .
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Table 2.2
Titration of ILTV in CK cells
dilution PFU of replicate 
Petri dishes 
1 2
mean PFU
confluent 
confluent 
67 90
7 4
0 0
confluent
confluent
78.5
5.5
0
The figure obtained at the dilution log^^ 4.0 (78.5 PFU) was 
multiplied by the dilution factor (xl0,000 = 785,000) and corrected to 
a value in ml (multiplied by 2, as the inoculum was 0.5 ml = 1,570,000 
PFU). The same procedure was applied to the count of the log^^ 5.0 
dilution (xl00,000 and x2 = 1,100,000). The results obtained were 
averaged (mean = 1,335,000). The result was expressed as follows:
Infectiviiytitre: log^Q 6.1 pfu per ml.
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2.2.2.2 Preparation of ILTV ELISA antigen
The Thorn V882 strain of ILTV was grown in CK monolayers in 
ten 75 cm^  tissue culture flasks. Cells were infected (0.5 ml) with 
log^ Q^ 5.3 PFU and incubated for 48-72 hours, until complete CPE was 
observed. Flasks were frozen and thawed twice and the supernatant 
clarified by centrifugation at 7,000 g for 30 minutes at 4° C (Sorvall 
RC5B). The supernatant was then centrifuged at 47,800 g (Sorvall RC5B) 
for 3 hours to pellet the virus. The virus pellet was resuspended in 
TNE to give 2 % of the initial volume. The virus concentrate was then 
aliquoted and stored at -70° C. For use in the ELISA the antigen was 
titrated as described in section 2.3.1.
2.2.3 Infectious bursal disease virus (IBDV)
A vaccinal strain (PBG 98) obtained from Mr. W. Baxendale, 
Intervet UK., The Elms, Houghton, England was used to prepare the 
antigen for ELISA. The 52/70 strain of IBDV (Bygrave and Faragher,
1970) was used to infect the chickens. The virus was supplied by Mr. P. 
Wyeth of The Central Veterinary Laboratory, Weybridge, UK.
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2.2.3.1 Preparation of IBDV ELISA antigen
The vaccine strain, PBG 98, (approximately log^^ 8.0 
TCIDgg/ïnl) was inoculated (0.5 ml) onto CEF monolayers in 75 cm^  flasks 
and adsorbed for 45 minutes at 37° C with frequent rotation to spread 
the inoculum evenly. Infected cells were maintained in serum free 
Earle's 199 medium (20 ml per 75 cm^  flask) and incubated for 72-96 
hours at 37° C. Monolayers, showing complete CPE, were frozen and 
thawed twice and centrifuged for 30 minutes at 7,000 g in a Sorvall 
RC5B at 4° C to clarify from cell debris. Virus in the supernatant was 
pelleted by centrifugation at 47,800 g for 3 hours at 4° C (Sorvall 
RC5B). The pellet was resuspended in TNE to give 1 % of the initial 
volume, aliquoted and stored at -70° C. For use in the ELISA the 
antigen was titrated as described in section 2.3.1.
2.2.3.2 Growth of the 52/70 strain
The 52/70 strain was grown in the bursa of Fabricius of chicks 
and prepared from homogenized bursae collected 3 days after the 
inoculation. Serial log^^ dilutions of the virus were given by
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eye-drop (0.1 ml) to SPF chicks for the titration of the virus. Five 
chicks were used per dilution, kept in separated isolators. Presence of 
virus in the bursa of each chick was identified by an agar gel 
precipitation test (Faragher, 1971) 72 hours after the inoculation. 
Titre was approximately log^Q 3.3 CID^^ (information by Mr. N. Chettle, 
CVL, Weybridge, England).
2.3 ELISA
The enzyme-linked immunosorbent assay (ELISA), as described 
by Engvall and Perlmann (1971) was used with modifications. Assays were 
performed in flexible polyvinyl chloride microELISA plates (Dynatech). 
All volumes of reagents added per well were 50 ul. Washing plates 
between each step was performed by three cycles of aspiration/dispens­
ing using phosphate buffered saline with 0.05 % Tween 20 (Sigma 
Chemical Co.) (PBST) in an ELISA washer (Microwash 2, Skatron A/S, 
Norway). The ELISAs used were designed to detect virus specific 
antibody and its class (IgM or IgG) using M.Ab. or to detect the 
production of M.Ab. by hybridoma cell lines grown in tissue culture 
(supernatants) or in ascitic fluids. ELISAs are described in detail 
below.
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2.3.1 Antigen titration
The concentration of each antigen to be used was determined 
by coating plates with doubling dilutions of the antigen in carbonate 
buffer (3 mM Na^CO^, 7 mM NaHCO^, NaN^ 0.02 %, pH 9.6) for 2 hours at 
37° C. All volumes used were 50 ul per well. Doubling dilutions of a 
known positive serum for each virus or normal uninoculated serum 
(negative control) in PBST were added next and incubated for 20 
minutes at 37° C. Bound IgG antibody was detected by using an anti-igG 
M.Ab. pool (Gl, G3 and G5; section 2.4) at approximately 30 ug per ml 
in PBST (calculated using a conversion factor for IgG (Hudson and Hay, 
1980), incubated for 1 hour at 37° C. Bound M.Ab. was detected by goat 
anti-mouse IgG (whole molecule) alkaline phosphatase conjugate diluted 
at 1:1000 in PBST and incubated for 20 min at 37° C. Bound conjugate 
was detected by substrate p-NPP at 1 mg per ml in diethanolamine buffer 
(diethanolamine 97 ml, Mg^Clg-OHaO lOOmg, NaN^ 200 mg and distilled 
water to 800 ml), incubated for 20 minutes at 37° C. Colour was stopped 
by adding 3 M NaOH. Plates were read in a microELISA Auto Reader MR 580 
(Dynatech) at 405 nm wavelength. The dilution of antigen to be used was 
chosen as that which produced the greatest ratio of difference between 
the values with positive and negative sera.
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2.3.2 ELISA, for virus-specific antibodies
ELISAs were used to detect virus specific antibody, and to 
identify the immunoglobulin classes IgM or IgG (figure 2.1). Plates 
were coated with the appropriate antigen, IBV, ILTV or IBDV at a 
predetermined dilution (section 2.3.1). All volumes used were 50 ul per 
well. The tests shared a similar procedure, indicated as follows:
1. MicroELISA plates coated with the appropriate virus (in 
carbonate buffer) for 2 hours at 37° C or overnight at 4° C;
2. Wash;
3. Immunoaffinity or gel chromatography purified fractions of 
sera added and incubated for 1 hour at 37° C (humid chamber);
4. Wash;
5. Detection of bound chicken antibody:
(a) Assay for chicken IgM: M.Ab. anti-chicken IgM pool at 
approximately 30 ug/ml incubated for 1 h at 37° C;
or
(b) Assay for chicken IgG: M.Ab. anti-chicken IgG pool at 
approximately 30 ug/ml incubated for 1 h at 37° C;
6. Wash;
7. Detection of bound M.Ab. by goat anti-mouse IgG alkaline 
phosphatase conjugate (1:1000) incubated for 30 minutes at 
37° C;
8. Wash;
9. Detection of bound conjugate with alkaline phosphatase 
substrate p-NPP incubated for 1 hour at 37° C;
10. Reaction stopped by adding 3M NaOH;
11. Plates read in the microELISA reader;
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Figure 2.1 ELISA for virus specific antibodies
The figure represents a diagram of two wells in an 
ELISA microplate to show the ELISAs used to detect virus 
specific antibodies and their immunoglobulin class.
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Figure 2.1 
ELISA FOR VIRUS SPECIFIC ANTIBODIES
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Figure 2.2 Picture of a virus-specific ELISA
The photograph shows an ELISA microplate used to detect IgM and 
IgG antibodies to ILTV. The plate was coated with ILTV antigen 
and the assay performed as described in section 2.3. Only the 
inner wells of the plate were used, from B2 to Gll. Gel 
chromatography fractions of serum collected 29 days after the 
inoculation of chickens with ILTV were assayed. The microplate 
was subdivided into two sections. 40 wells were used to detect 
IgG in serum fractions number 44 to 83, and 20 wells used to 
detect IgM in serum fractions number 44 to 63. The IgM 
antibodies appeared earlier during the fractionation (fractions 
number 45 to 53), as the IgM molecule is heavier than IgG. The 
IgG antibodies were detected from fraction number 58 to 73.
Diagram of the microplate picture shown 
2 3 4 5 6 7 8 9 10 11 12
A
B 44* 45 46 47 48 49 50 51 52 53
C IgG 54 55 56 57 58 59 60 61 62 63
D 64 65 66 67 68 69 70 71 72 73
E 74 75 76 77 78 79 80 81 82 83
F 44 45 46 47 48 49 50 51 52 53
G IgM 54 55 56 57 58 59 60 61 62 63
H
Notes:
Fraction number (*) is shown on the corresponding well 
assayed on the microplate. On the upper half of the plate 
antibodies of the IgG class are assayed (40 fractions of 
serum). On the lower half of the plate the IgM antibodies are 
assayed. Bold type figures are the positive wells for 
ILTV-specific antibodies.
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2.3.3 ELISA, to monitor M.Ab. production
The production of M.Ab. specific to chicken
immunoglobulin was monitored with an ELISA employing microELISA 
plates coated with chicken IgM or IgG. A flow-chart of the 
procedure is shown in figure 2.3. All volumes used were 50 ul per 
well. Details of the procedure were as described in previous 
sections. The assay was as follows:
1. MicroELISA plates coated for 2 hours at 37° C with 
either:
(a) chicken IgM obtained by gel chromatography, at
approximately 10 ug per ml in carbonate buffer;
or
(b) chicken IgG obtained by gel chromatography, at
approximately 10 ug per ml in carbonate buffer;
2. Wash;
3. Hybridoma cells supernatant medium or ascitic fluids 
added, diluted 1:5 in PBST, for 20 minutes at 37° C;
4. Wash;
5. Goat anti-mouse conjugate (1:1000) for 20 minutes at 
37° C;
6. Wash;
7. Substrate p-NPP for 20 minutes at 37° C;
8. Stop (3 M NaOH);
9. Read;
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Figure 2.3 ELISA for monitoring M.Ab. production.
The figure shows two wells of an ELISA microplates: one 
is coated with chicken IgM and the other is coated with 
chicken IgG.
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Figure  2.3  
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2.4 Monoclonal antiboc^
Hybridoma cells synthesizing M.Abs. specific to chicken IgM u 
chain (designated Ml, MlO and Mil), IgG gamma chain (designated Gl, G3 
and G5) and IgA (designated P9 and P25) (Mockett, 1986-a) were obtained 
from the cell stock at Houghton Laboratory, I AH, Houghton, Cambs., UK., 
where they were stored in liquid nitrogen.
2.4.1 Mice
The Balb/c strain of mice obtained from a commercial supplier 
(Harlan-Olac Ltd., Bicester, Oxon, UK.) was used to grow hybridoma 
cells. Mice were females and 7 weeks of age when used.
2.4.1.1 Accommodation
Mice were kept in colony cages in controlled environment 
accommodation in an isolation unit with filtered air. The cages 
consisted of a plastic container with a wire grid lid with receptacle 
for food and water and a bed of wood shavings. Each cage accommodated a
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maximum of ten mice.
2.4.1.2 Food and water
Mice were provided with pelleted balanced food (Labsure, UK.) 
ad libitum. Drinking water was available ^  libitum in bottles fitted 
with a nipple.
2.4.2 Production of M.Ab.
Figure 2.4 summarizes the procedures for the production of
M.Ab..
2.4.2.1 In vitro growth of hybridoma cell lines
2.4.2.1.1 Preparation of macrophage cell monolayers
Macrophages function as feeder cells for the initiation of 
growth of hybridoma cells by producing interleukin 1, lymphocyte
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stimulating factor. Balb/C mice were used as donors of macrophages 
because hybridomas are derived from a fusion of a Balb/C myeloma cell 
line (NSI-Ag4-l) with spleen cells of an immunized Balb/C mouse 
(Kohler and Milstein, 1975); using the same strain of mice avoided 
rejection of the hybridomas by the peritoneal macrophages. Mice were 
killed by cervical dislocation and the skin doused with 70 % alcohol. 
The abdominal skin was then opened to expose the muscular wall and 
approximately 5 ml of serum free RPMI (Roswell Park Memorial Institute) 
1640 medium (containing 100 International Units penicillin, 0.1 ug 
streptonycin and 0.1 ug fungizone per ml) was inoculated into the linea 
media over the liver to reduce the risk of puncturing the intestine. 
The fluid was gently aspirated and injected three times to wash off 
cells from the cavity and then withdrawn. The peritoneal washing was 
resuspended to contain approximately log^ ^^  5.3 cells per ml in RPMI 
containing 10 % foetal calf serum (Gibco Ltd., Scotland) and 
cultivated in 24 well cell culture plates (Limbro, Flow Lab.) in a €0% 
incubator (Raven water jacket incubator. Forma Scientific, Ohio, USA). 
Macrophages were not necessarily confluent at the time of seeding 
hybridoma cells, which was carried out within 24 to 48 hours of 
incubation of the macrophages.
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Figure 2.4 Flow chart of the procedures for the 
production of M.Ab.
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2.4.2.1.2 Growth of h^ridoma cells
The ampoule containing the hybridoma cells was removed from 
liquid nitrogen and rapidly thawed in a water bath at 37° C. The cells 
were re suspended in 20 ml of serum free RPMI medium and washed to 
remove freezing medium (defined in section 2.4.2.5). After two 
washings, cells were resuspended in 16 ml RPMI containing 10% foetal 
calf serum and distributed 2 ml per internal well (8 wells) of a 24 
well plate (Limbro). At the logarithmic stage of growth, hybridoma 
cells were transferred to 25 cm^  and subsequently to 75 cm^  flasks. The 
supernatant fluid from these flasks was tested for M.Ab. activity by 
ELISA (section 2.3.3) and is refered to as M.Ab. produced m  vitro.
2.4.2.1.3 Preparation of hybridoma cells to inoculate 
mice
Hybridoma cell lines were grown iu vitro to a stage of fast 
growing cells (logarithmic phase) in 75 cm^  flasks, those shown by 
ELISA to be producing M.Ab. were then pelleted by low speed 
centrifugation, 1,300 rpm in a Centaur 2 MSE centrifuge, and washed in 
serum free RPMI medium. Washed cells from one bottle were resuspended 
in 1 ml serum free RPMI medium ready for inoculation into one mouse.
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2.4.2.2 Inoculation procedures
The mice were primed by the inoculation of 0.5 ml of Pristane
(2, 4, 10, 14 Tetramethylpentadecane) into the peritoneal cavity at
least one week prior to the administration of hybridoma cells. Pristane 
reduces the risk of rejection of hybridoma cells by producing 
immunosuppression in mice. Packed hybridoma cells, resuspended in 1 ml 
serum free RPMI were inoculated into the peritoneal cavity of the mouse 
at the left side of the medial line (linea alba) and in the upper half
of the abdomen, using a needle introduced to half of its length and
close to the internal face of the abdominal wall. The skin at the site 
of injection was wiped clean with 70% alcohol prior to inoculation. 1 
ml plastic disposable syringes fitted with 23 gauge needles were used.
2.4.2.3 Ascitic fluid collection
Hybridoma cells growing in the abdominal cavity of mice 
induced a large accumulation of ascitic fluid, therefore, mice were 
monitored daily for swelling of the abdominal region. When swelling was 
observed, the fluid was collected with a sterile 19-gauge needle into a 
plastic disposable Universal container. Use of aseptic technique 
allowed repeated collections to be made from the same mouse. An average 
of 5 ml of fluid was collected from each mouse. On the occasions when 
solid tumours grew, mice were humanely killed (dislocation of cervical 
vertebrae atlas and axis) as soon as distress was observed.
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2.4.2.4 Preparation of ascitic fluids for storage
Ascitic fluids were centrifuged to remove peritoneal cells, 
0.02 % NaNj was added and they were stored at 4° C. Fluids were tested 
by ELISA (section 2.3.3) and those showing a positive reaction against 
their respective immunoglobulin were precipitated overnight at room 
temperature using sodium sulphate sodium sulphate at a final 
concentration of 18 % (v/v). Insoluble immunoglobulin was pelleted by 
centrifugation for 3 minutes in an Eppendorf Microspin, resuspended 
and dialyzed in the appropriate buffer, either PBS for ELISA or 
coupling buffer to prepare the immunoadsorbents (described in chapter 
4). The protein concentration was estimated by measuring the O.D. (280 
nm) and applying a conversion factor for IgG (0.7, Hudson and Hay, 
1980). Hybridoma cell lines prepared by Mockett (1986-a) all 
synthesized the IgG isotype.
2.4.2.5 Freezing h^ridcana cells lines
Rapidly growing (logarithmic phase) cells from 75 cm^  flasks 
were centrifuged at 1,300 rpm (Centaur 2, MSE) and resuspended in 
freezing medium (filtered sterile 85 % foetal calf serum with 15 % 
DMSO). The pelleted cells from one flask were resuspended in 1 ml of 
freezing medium and frozen by decreasing the temperature slowly and 
gradually by approximately 1 degree per minute. This was achieved by 
immersing the ampoule, sealed by heat, in a flexible tubing (Cryoflex, 
Nunc) in industrial alcohol and placing it in a - 70° C freezer for 24
83
hours. Subsequently, ampoules were rapidly transferred to liquid 
nitrogen for long term storage of cells.
2.5 Gel chromatogratdiy of chicken sera
90 X 2.2 cm glass columns (Wright) were packed with 
Sephacryl S-300 gel according to the instructions of the manufacturer 
(Pharmacia). A flow rate of buffer of approximately 30 ml per hour was 
maintained by a peristaltic pump (LKB model 2132). The buffer was 1 M 
NaCl, 0.1 M Tris-HCl, 1 mM EDTA, 0.02 % NaN^. The buffer at the top of 
the gel was carefully removed and one ml of serum, which had been 
clarified by centrifugation in a microcentrifuge (Eppendorf) and 
filtered through a 450 nm porosity filter (Sarstedt), was loaded 
without disturbing the gel surface. The serum was allowed to diffuse 
into the gel and the buffer was gently replaced on the top to initiate 
the flow controlled by the pump. Fractions were collected using an 
automatic fraction collector (LKB Redirac Fraction Collector) and read 
at ultraviolet (uv) light (280 nm) in a spectrophotometer (Pye Unicam 
SP 1800) and a graphic profile was obtained. Typically this consisted 
of three absorbance peaks (figure 2.5). The heaviest molecules, which 
were eluted first, included IgM, and appeared in the first peak (a), as 
large molecules did not enter the gel beads. The second peak (b) 
contained IgG, which was delayed by the gel beads. The third peak (c) 
contained serum albumin. IgM (peak a) or IgG (peak b) serum extracts 
obtained by gel chromatography were used to coat ELISA plates to 
monitor the M.Ab. production (2.3.3).
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Figure 2.5
Chromatographic profile of chicken serum. Chicken serum was 
fractionated by gel chromatography in a 90X2.2 column packed 
with Sephacryl S-300 with eluant 1 M NaCl, 0.1 M Tris-HCl, 1 
mM EDTA at a flow rate of 30 ml per hour. O.D. of fractions 
was read at 280 nm and values plotted graphically. The curve 
presents three distinct peaks; IgM immunoglobulin is found in 
the first peak (a) of absorbance, as high molecular weight 
molecules do not enter the beads of Sephacryl and flow 
through the inter-bead space, being eluted first (fractions 
55 to 64 ) ; IgG immunoglobulin will flow immediately next 
(fractions 65 to 85) in the second peak (b), being delayed as 
it enters the gel beads. The third peak (c) contains serum 
albumin.
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Chapter 3
COMPARISON OF MGNOCLCmL AND POLYCLONAL ANTIBODIES SPECIFIC 
TO CHICKEN IMMUNOGLOBULINS AS REAGENTS IN ELISA
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3. Comparison of monoclonal and polyclonal antibodies 
specific to chicken immunoglobulins as reagents in ELISA
3.1 Introduction
A comparison of monoclonal (M.Ab.) and polyclonal (P.Ab.) 
antibodies was performed in order to decide which of these would be the 
most suitable to use in these experiments. Specific antibodies to 
chicken immunoglobulins, IgM and IgG, were the essential prerequisite 
to the work described in this thesis, both for detecting chicken 
immunoglobulins (IgM or IgG) by ELISA and to prepare IgM 
immunoadsorbents.
The immune response designated as specific is performed by T 
(Thymus) and B (Bursa) lymphocytes. T cells are responsible for the 
cellular response and B cells are responsible for the humoral response. 
These cells undergo transformations after contact with a foreign 
substance (antigen), which enables the correct identification of this 
given substance among others. The antigen serves as an instruction to 
reassort the order in the gene of T and B cells, which thereafter 
become compromized to a single specificity and give rise to generations 
of identical (clones) cells. Some of these clones are memory in the 
preparation for a secondary contact. The immune system is responsible 
for the identification of substances self or non-self to an individual. 
This recognition is essential for the elimination of invading 
organisms. On a complex antigen many sites are available for the immune 
system to recognize and to develop a response against. The immune
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system will identify as many antigenic determinants (epitopes) as 
possible in order to adequately succeed with the elimination of an
antigen. Many clones of lymphocytes will be formed, each of which is
derived from a single parent cell which firstly commited itself to a 
particular epitope. The pooled response of all B cell clones is 
detectable in the serum of the host and these antibodies are known as 
P.Ab. This antibody diversity may produce drawbacks in serological 
assays as the broad range of reactivity means lack of selectivity which 
may not enable their use for the detection of a determined epitope. For 
assays which required a higher specificity to differentiate minor
epitopes, a purer reagent with controlled reactivity is desirable, and 
this should be achieved using M.Abs.
The continuous growth of cells secreting antibody to a
predefined specificity was described by Kohler and Milstein (1975). 
Spleen cells from a mouse immunised with the antigen of interest were 
fused with cells from a myeloma cell line. This resulted in hybrids 
carrying the character for immortality (continuous growth) and ability 
to produce antibody to the selected specificity. Fused cells were grown 
and screened for the required specificity and cloned. This powerful 
tool of continuously growing hybrid cells which synthesize antibody of 
a single and predefined specificity has revolutionized many fields of 
medico-biological sciences.
M.Abs. specific to chicken IgM and IgG were compared to P.Ab. 
anti-chicken IgG (heavy chain), produced in a rabbit, for their 
specificity and sensitivity to detect chicken IgG by ELISA. This 
experiment was carried out in order to choose the reagents to be used 
to identify and purify chicken immunoglobulins. M.Abs. were prepared as
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described in chapter 2. M.Abs. produced in cell supernatants ( m  vitro) 
and in the ascitic fluids (in vivo) were also compared.
3.2 Materials and Methods
3.2.1 Rabbit
3.2.1.1 Accommodation
A New Zealand white rabbit was accommodated in an individual 
cage located in a room with filtered air. Temperature and illumination 
were automatically controlled.
3.2.1.2 Food and water
Pelleted balanced food and water (via nipple drinker) were 
provided ad libitum.
3.2.1.3 Inoculation procedure
The rabbit was inoculated intramuscularly (by Dr. Mockett)
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with 200 ug of chicken heavy chain in 50 % Freund's complete adjuvant. 
This material (Mockett, 1986-a) consisted of IgG partially reduced and 
alkylated (dithiothreitol and iodo acetic acid) to break inter-chain 
disulphide bonds, and subsequently fractionated by gel chromatography 
(Sephadex G-lOO) to separate heavy and light chains. A second 
inoculation with 200 ug of the same IgG preparation was given four 
weeks later.
3.2.1.4 Blood sampling
Blood was collected from the ear vein into a Universal 
container four weeks after the second inoculation. Blood was allowed to 
clot overnight at room temperature. The serum was separated by 
centrifugation at 2,000 g and stored at -20° C.
3.3. Conparison of monoclonal and polyclonal antibodies
3.3.1 ELISA to identic chicken IgG enploying rabbit 
anti-chicken IgG serum
Basically, the ELISA was performed as described in chapter
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2.3 but with the following modifications. MicroELISA plates were coated 
with either 10 ug/ml, 1 ug/ml or 200 ng/ml of chicken IgG or IgM 
obtained by gel chromatography of chicken serum (described in section 
2.5). Doubling dilutions of the rabbit serum in PBST were added onto 
plates coated with the different concentrations of chicken IgM or IgG. 
Bound rabbit IgG was detected by using goat anti-rabbit IgG alkaline 
phosphatase conjugate at 1:1000 in PBST incubated for 20 minutes at 37° 
C. Bound conjugate was detected by p-NPP substrate and the plates were 
read as described in ELISA section 2.3.
3.3.2 ELISA to identify chicken immunoglobulin using 
anti-chicken M.Ab.
M.Abs. anti-chicken IgM (Ml) and IgG (G3) produced m  vitro 
(cell culture) or m  vivo (ascitic fluid) as described in chapter 2, 
were tested for antibody activity by ELISA. ELISA plates were coated 
with chicken IgM or IgG as described above. Dilutions in PBST of 
hybridoma supernatants or ascitic fluids were added next and incubated 
for 20 minutes. Subsequent steps were as in section 2.3.
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3.4 Results
Figure 3.1 shows the results of testing the rabbit
anti-chicken IgG P.Ab. by ELISA against different concentrations of
chicken IgM and IgG. The rabbit serum produced high non-specific
reaction on the plates coated with chicken IgM. At the highest 
concentration of coating immunoglobulin (10 ug/ml), high cross 
reactions were observed and the rabbit serum did not distinguish 
between IgM and IgG. When used at low dilutions against 1 ug/ml of 
immunoglobulin, there was an unacceptable lack of specificity, for 
example, at logg 4.6 dilution (1:25) against 1 ug/ml of IgG the O.D. 
was 1.43 and against 1 ug/ml of IgM was 1.17. With this coating
concentration, an adequate specificity was observed only with a logg
8.6 (1: 400) serum dilution (IgG O.D. 1.28; IgM O.D. 0.10). Against 
plates coated with a concentration of 200 ng/ml, acceptable specificity 
was observed with serum diluted at log^  7.6 (1:200) (IgG O.D. 1.45; IgM 
O.D. 0.18).
In contrast, M.Ab. anti-chicken immunoglobulins were shown to 
be highly specific, as shown in figures 3.2 (a), (b), (c) and (d).
The G3 M.Ab. (anti-IgG) produced by the hybridoma cell lines 
grown in tissue culture flasks, when tested on IgG-coated plates (10 
ug/ml), figure 3.2(a), showed high O.D.s, for example 1.02 when tested 
at 1:2 dilution. Specificity was shown to be excellent when testing the 
same dilution on IgM coated plates (10 ug/ml), figure 3.2(b), O.D. 
0.10. The readings obtained with the G3 M.Ab. on the IgM coated plates 
included as controls were always inferior to 0.1. The lower
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concentrations of M.Ab. produced m  vitro as compared to the production 
in the ascitic fluids of mice was evident when comparing results of 
figures 3.2(a) and 3.2(c). The G3 M.Ab. when produced by cells grown in 
the peritoneal cavity of mice showed the same high specificity for 
chicken IgG, figure 3.2(c), but antibody titres were higher than those 
produced in tissue culture, for example at the dilution of logg 5.6 
(1:50) the O.D. was 1.04, whereas the same dilution for tissue culture 
supernatants gave an O.D. of 0.52. This result is consistent with the 
general view that a higher concentration of M.Ab. is produced in 
ascitic fluids than m  vitro.
Similar results were observed with the Ml M.Ab. (anti-IgM) 
concerning the high specificity to chicken IgM, absence of 
cross-reaction with chicken IgG and higher concentrations produced in 
the ascitic fluids, shown in figure 3.2(d), than in tissue culture 
supernatants, figure 3.2(b). For example, the O.D. of Ml diluted at 
log  ^ 5.6 (1:50) on the IgM coated plates was 0.40 from vitro culture 
of cells and 0.82 from the ascitic fluid. The Ml M.Ab. was tested 
against IgG coated plates, giving reading always lower than 0.1,
An anti-IgA M.Ab. (P25) was tested on both IgM and IgG coated 
plates to control non-specific adsorption of M.Ab. onto plates and to 
confirm the absence of IgA as a contaminant in fractions used to coat 
plates. These results confirm that this was the case.
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Figure 3.1
ELISA for the assessment of optimal concentration of 
rabbit anti-chicken IgG (Fc) P.Ab. MicroELISA plates 
were coated with chicken IgM or IgG (obtained by gel 
chromatography of chicken serum) at concentrations of 
200 ng, 1 ug and 10 ug per ml in carbonate buffer pH 
9.6, for 1 h at 37° C. Subsequently, doubling rabbit 
serum dilutions from 1:25 to 1:51200 (represented in 
graph as log base 2) in PBST were added. Goat 
anti-rabbit conjugate at 1:1000 in PBST was added next 
to detect any bound rabbit antibody. Subsequent steps 
were as described in section 2.3.
95
Figure 3*1
plates coated with:
IgG 10 u g /m l  
i ^ I g G  1 u g /m l  
•>  IgG 300 n g /m l 
IgM 10 u g /m l 
^ I g M  1 u g /m l  
"#"IgM  300 n g /m l
o 0.4
lo g  b a se  3 d ilu t io n s  o f r a b b it  a n t i - c h ic k e n  IgG se r u m
96
Figure 3.2(a) N.Abs. produced m  vitro tested on IgG 
coated plates
M.Abs. anti-chicken immunoglobulins Ml (anti-IgM), G3 
(anti-IgG) and P25 (anti-IgA), were produced in tissue 
culture flasks (in vitro). Cell supernatants were tested 
by ELISA on plates coated with 10 ug/ml of chicken IgG.
Figure 3.2(b) M.Abs. produced vitro tested on Ig^ 
coated plates
The M.Abs. poduced as described in 3.2(a) were tested on 
plates coated with chicken IgM.
Figure 3.2(c) M.Abs. produced m  vivo tested on IgG 
coated plates
M.Abs. anti-chicken immunoglobulins Ml (anti-IgM), G3 
(anti-IgG) and P25 (anti-IgA) were produced in the 
peritoneal cavity of mice. Ascitic fluids were tested by 
ELISA on plates coated with 10 ug/ml of chicken IgG.
Figure 3.2(d) M.Abs. produced m  vivo tested on IgM 
coated plates
The M.Æs. produced as described in 3.2(c) were tested 
on plates coated with chicken IgM.
97
1,2
1,0 
' r a  0 . 8
s
0.6
'o
O
0.4
fto
0.2
0.0
Figure 3.3(a)
□  P25 M.Ab, 
ra Ml M.Ab. 
■  G3 M.Ab.
1:2 C ell s u p e r n a ta n t ,  d i lu t io n
Figure 3.2(b)
1,0 - r -
□  P35 M.Ab, m  Ml M.Ab. 
mm G3 M.Ab.
*w
g 0.6
«3
Ü 0.4
0.2
0.0
^’^ ^ C ell s u p e r n a t a n t  d i lu t io n
1,2
1.0
to 0.8
g
0.6
Id
o
0.4
ft
O
0.2
0,0
Figure 3.2(c) Figure 3.2(d)
□  P35 M.Ab. 
a  Ml M.Ab. 
■  G3 M.Ab.
1:10 1:50
A s c it ic  f lu id  d i lu t io n
1:100
1.0 -T-
CZ] P25 M.Ab. 
a s  Ml M.Ab. 
mm G3 M.Ab.
I 0.6
I 0 . 4 ------
0.2
1:1000.0 1^0
Ascitic fluid d ilu tion
1:10
98
3.5 Discussion
The method for the identification of the classes of chicken 
immunoglobulin had to be very specific and results reliable, and no 
degree of cross-reactivity of the reagents would be accepted. 
Consequently, as complete differentiation between IgG and IgM was 
necessary, P.Ab. (rabbit) to chicken IgG was shown to be of poor 
specificity and not adequate for the purposes required in the proposed 
studies.
M.Abs. were therefore chosen to assay chicken immunoglobulins 
in the ELISA and for use in affinity chromatography to purify IgM from 
serum after the demonstration of their advantages in terms of 
specificity and sensitivity over P.Ab.. This is because M.Ab. is 
produced by a single clone of cells, producing antibody of a single 
specificity. Another advantage is ^ inexhaustible supply of M.Ab. of 
standard avidity and binding properties, as hybridoma cells can be 
grown whenever required.
The comparison of methods of growing hybridoma cells to 
produce M.Ab. showed that the system which provided the highest 
concentration of M.Ab. was the growth of hybridoma cell lines in the 
peritoneal cavity of mice (ascitic fluid). Nonetheless, cells growing 
in vitro produced concentrations of M.Ab. useful for assays such as 
ELISA.
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The conclusion from this experiment is that M.Abs. have many 
advantages over P.Abs. for the purposes of studies of chicken 
immunoglobulins. M.Abs. precipitated from the ascitic fluids (as 
described in chapter 2.4) will be used in all subsequent studies.
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Chapter 4
TEIE RAPID PÜRIFICATICW OF SERUM I #  FOR TEE DIAGNOSIS OF 
RECENT INFECTIONS OF CHICKENS
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4. The rapid purification of serum IgM for the diagnosis of 
recent infections of chickens
4.1 Introduction
IgM is the first class of antibody to be synthesized both 
during the ontogeny of the immune system and in the development of an 
immune response. During differentiation, clones of plasma cells switch 
from the expression of u chains to gamma chains (constant region), 
thereby changing the class of antibody synthesized without altering the 
variable region, as individual antibody-producing cells are committed 
to a single specificity (Wang et ^., 1970). In chickens, cells which 
initially synthesize IgM switch to the production of IgG. These changes 
are hosted primarily by the bursa of Fabricius (Kincade and Cooper, 
1971; Kincade et ^., 1970; Subba Rao et ^., 1978), where cells 
producing IgG develop from cells that initially synthesized IgM. Thus, 
the synthesis of IgM is a short-lived event on the development of an 
immune response. Determination of specific IgM in human serum has been 
used for the diagnosis of recent infections. Acute rubella (Enders and 
Knotek, 1986; Mortimer et ^., 1981-a) and hepatitis A (Mortimer et 
al., 1981-b) infections have been rapidly diagnosed by the
demonstration of IgM specific antibody by using an antibody-capture 
ELISA and an antibody-capture radioimmunoassay, respectively. In 
chickens, an iBV-specific IgM response has been demonstrated to be
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short-lived after infection. This finding was considered useful for 
routine diagnosis of the disease, where speed is a key factor for 
adequate measures of control to be taken (Mockett and Cook, 1986). In 
that work, separation of chicken IgM from IgG by gel chromatography was 
found necessary before IgM could be assayed in an ELISA, because of the 
higher avidity of IgG over IgM for antigen epitopes and also because of 
the rapid switch from specific IgM to IgG synthesis (Mockett and Cook, 
1986).
Affinity chromatography is a method of selective separation 
according to unique properties of groups of substances, which make one 
substance avid for another. Natural examples of substances which 
combine non-covalently (reversibly) to chemical partners are enzyme and 
its substrate, antibody and its specific antigen (immunoaffinity 
chromatography), lectins and sugar residues of polysaccharides or 
glycoproteins and the glycoprotein avidin from egg-white which binds to 
the vitamin biotin. For achieving selective capture, one of the 
partners, the first, is insolubilized, cross-linked by glutaraldehyde 
or immobilized onto a matrix such as Sepharose. When mixed with a 
solution of the respective partner it results in the adsorption of that 
from solution. Affinity chromatography has been used to purify IgM from 
avian sera and chicken bile (Mockett, 1986-b). The immunoadsorbents 
were made with monoclonal antibody to chicken u chain (IgM) linked to 
cyanogen bromide activated Sepharose. Mockett (1986-a) has used 
affinity chromatography also to purify the envelope proteins of IBV 
(spike and membrane proteins) by linking anti-IBV M.Ab. to gels. The
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purity of eluants was controlled by electrophoresis in polyacrylamide 
gels. The materials and methods employed here for the affinity 
chromatography purification of IgM were essentially similar to those 
described previously (Mockett, 1986-a, b).Chemical binding of antigens 
or antibodies to a carrier polymer has long been described in the 
literature (Axen et ^., 1967; Becker, 1976; Cuatrecasas et al., 1968; 
Dandliker et ^., 1968; Dean et ^., 1985; Klein, 1972; Kristiansen, 
1974, 1976;). Agarose based matrix is cross-linked to stabilize beads 
to the harsh conditions of dissociation especially with chaottopic 
eluting agents, for example ammonium thiocyanate (NH^SCN) and sodium 
thiocyanate (NaSCN) (Kristiansen, 1974). Ig ligands to be associated to 
the gel are coupled at an optimal concentration. High density of 
coupled Ig ligand will diminish or impair spacial mobility of the 
molecule, and reduce the chances of best steric fit of antigen-antibody 
(Kristiansen, 1976). Protein nucleophiles (carbon phenolic rings, 
oxygen, nitrogen or sulphur) of electron rich aminoacid side chains are 
functional groups involved in coupling. Imidocarbonate groups of 
cyanogen-bromide activated Sepharose 4B react with protein nucleophiles 
forming covalent isourea linkages (Becker, 1976).
The aim of these experiments was to attempt to develop a 
method for rapid purification of chicken IgM using IgM-immunoadsorbents 
which, in association with an ELISA, could be used both as a research 
tool and in routine laboratory diagnosis of recent infection.
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4.2 Materials and Methods
4.2.1 M.Abs. to chicken immunoglobulins
M.Abs. to chicken immunoglobulins were produced by growing 
the appropriate hybridoma cell lines Ml, MlO and Mil (anti-IgM) Gl, G3 
and G5 (anti-IgG) and P9 and P25 (anti-IgA) (Mockett, 1986-a) available 
at Houghton Laboratory. Detailed description of the growth of the 
hybridoma cells and the production of M.Abs. is given in the chapter 
2.4.2.
4.2.2 Chicken sera
4.2.2.1 Sera used to compare the efficiency of different 
eluting agents
Large volumes of serum from a common source was required to 
perform all the standardization steps during studies with the 
IgM-immunosadsorbents. For this purpose, ten 18-week-old chickens were 
bled and individual sera were pooled. These birds had received an oil 
emulsion vaccine against IBV, following priming with H120 live 
attenuated virus at 3 weeks of age. The sera collected on the 10th day 
after the administration of oil emulsion vaccine was used for all the 
studies.
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4.2.2.2 Sera used to conpare affinity and gel
chromatography for the purification of serum IgM
Twenty 5-week-old RIR SPF chickens bred at Houghton 
Laboratory and housed in isolation units were used. Approximately 
log^o 5.8 CDgQ of the VF69-149 strain of IBV was administered 
intranasally (0.1 ml) to each chicken. Infected birds were bled daily 
between 6 and 9 days and at 24 days p.i.. Serum was separated and 
stored at -20° C. Pooled sera were both treated with the IgM 
immunoadsorbents and fractionated by gel chromatography. Uninoculated 
SPF chickens were used to provide control negative serum.
4.2.3 Preparation of Ig^immunoadsorbents
Anti-chicken IgM M.Abs. (Ml, MlO and Mil) were coupled to 
cyanogen bromide-activated (CNBr) Sepharose 4B according to 
instructions of the manufacturer (Pharmacia). Dried gel was swollen and 
washed in 1 mM HCl, subsequently washed in coupling buffer (0.1 M 
NaHCO^, 0.5 M NaCl, NaN^ 0.02 %, pH 8.3) and immediately mixed with the 
M.Ab. solution prepared as described in chapter 2.4.2.4. The protein 
content of the M.Ab. solution (1 ml) was estimated prior to mixing with 
1 ml of swollen CNBr-Sepharose 4B using the absorbance value (280 nm) 
multiplied by a conversion factor for IgM (0.8, Hudson and Hay, 1980). 
The M.Ab. (Ig fraction of ascitic fluids) was diluted as required and 
the mixture was incubated overnight at 4° C or for 2 hours at 37° C in
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an end-over-end mixer. After the linking process, the extent of 
coupling was estimated by subtracting the concentration of protein 
present in the supernatant from the concentration value observed in the 
initial solution. Residual active groups on the gel were blocked by 
mixing with 1 M ethanolamine pH 9.8 for 2 hours at room temperature. 
Alternate high and low pH buffers (acetate buffer pH 4.5 and coupling 
buffer pH 8.3) were used to remove unbound protein, washing the gel six 
times (20 ml each time) alternately in each buffer. Prior to use, 
immunoadsorbent gels (1 ml) were washed 3 times with NH^SCN, pH 4.7 
(approximately 30 ml) followed by 3 washes in PBS (approximately 30 
ml), as traces of NH^SCN would impair immunoadsorption, and stored at 
4° C in PBS containing 0.02 % NaN^.
4.2.4 IgM-affinity chromatography purification
One ml of the immunoadsorbent was mixed with 1 ml of the 
filtered pooled serum and incubated under agitation for 2 hours at 37° 
C. Excess serum was washed off with PBS until the O.D. of washings 
reached zero. Bound IgM was dissociated using one of five different 
dissociating agents:
3 M NH^SCN pH 4.7;
2 M NaCl, 0.15 M Tris-HCl, 2 mM EDTA, pH 7.4 (NTE Buffer);
3 M NaSCN pH 6.7;
3 M Nal pH 9.2;
2 M NaCl pH 7.4;
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These eluting agents were compared and evaluated according to 
simplicity of use and efficiency. IgM yield in eluants was estimated by 
reading the O.D. at 280 nm and multiplying by a conversion factor (0.8) 
for IgM (Hudson and Hay, 1980). Eluants were assayed in an ELISA 
described in chapter 2.3.2.
4.2.5 Dialysis
Eluants obtained using NH^SCN, NaSCN and Nal required 
dialysis in PBS before testing. Dialysis was performed in 9 mm diameter 
dialysis tubing (Medicell International Ltd., London, UK.). Fractions 
of eluant (2 ml) were transferred to the tubing which was immersed in 1 
litre of PBS and allowed to diffuse for 24/48 hours at room 
temperature.
4.2.6 Gel Chromatography
Pooled chicken sera were fractionated by gel chromatography 
in a 90x2.2 cm glass column packed with Sephacryl S-300 (Pharmacia) as 
described in chapter 2.5. The O.D. of fractions (280 nm) was determined 
and a profile was plotted graphically. All fractions were assayed by 
ELISA for antibodies to IBV and to identify the immunoglobulin class 
(chapter 2.3.2). The results were compared to those obtained using the
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IgM affinity chromatography.
4.2.7 ELISA
ELISAs to identify immunoglobulin classes and their 
specificity to IBV were used as described in chapter 2.3.2, based on 
the method described by Mockett (1986-b). Serum from uninoculated SPF 
chickens fractionated by gel or affinity chromatography served as 
control negative in all assays. Plates were blanked on the appropriate 
immunoglobulin negative control for reading IgM or IgG results.
4.2.8 Reproducibility of results
ELISAs were repeated three times to demonstrate that results 
were reproducible. The figures shown represent one set of assays. All 
assays of each set were performed at the same time in order to enable 
comparison of the results of different collections.
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4.3 Results
4.3.1 Coupling M.Ab. to Sepharose
The efficiency of coupling M.Ab. to CNBr-Sepharose in an 
end-over-end mixer overnight at 4° C was compared to coupling at 37° C 
for two hours. The results (table 4.1) show that coupling overnight at 
4° C produced a linking ranging from 87 to 92 % of the available 
protein concentration and that it was more effective than coupling for 
2 hours at 37° C (70-78 % linking). Similar linking was achieved with 
both low (2.6 mg/ml, 87 %, Ml-b) and high (13.5 mg/ml, 89 %, Mil) 
concentrations of M.Ab..
4.3.2 Efficiency of the IgM-immunoadsorbents following 
repeated use
The IgM-immunoadsorbents were used repeatedly over a period 
of 14 months and the record of the uses provided information regarding
the durability of the gels. Table 4.2 shows the results of three sets
of tests made on different dates, each of which consisted of three
repetitions. The total IgM (means of three repetitions) recovered by
the immunoadsorbent was 0.38 mg in October 1988, 0.15 mg in June 89,
110
0.09 mg in August 1989 and 0.05 mg in December 1989. Chemical binding 
was stable and immunoadsorbents could be used with good performance for 
approximately 8 months. However, a significant (0.1>p>0.05) loss of 
function was observed after 8 months of repeated use. After 
approximately 20 uses, throughout the period investigated, the 
reduction in performance was approximately 87 %. It is therefore 
recommended that the immunoadsorbent be used as soon as possible and 
its efficiency of trapping IgM be checked each time it is used, by 
monitoring the O.D. of eluants at 280 nm.
4.3.3 Effect of the concentration of coupled M.Ab. on the 
efficiency of the immunoadsorbents
A comparison was made of the effect different concentrations 
of M.Ab. coupled to 1 ml of CNBr-Sepharose 4B gel on the ability of the 
immunoadsorbents to bind IgM. It was shown (Table 4.3) that immuno­
adsorbent gels containing large amounts of M.Ab. 10.5 mg/ml (MIC) or 
12.0 mg/ml (Mll-b) did not produce a proportionally higher adsorption 
of IgM than did gels containing 3.9 mg, 2.3 mg and 3.6 mg M.Ab./ml gel. 
The total IgM recovered by gel MlO (1.3 mg) and gel Mll-b (0.9 mg) was 
not superior to that yielded by gel Ml-a (2.1 mg), Ml-b (1.1 mg) and 
Mll-a (2.7 mg). In fact, the worst results were obtained using the 
lowest (Ml-b) and highest (Mll-b) concentrations of M.Ab. and the 
results suggest that the linking of M.Ab. to the gel concentrations 
between 2 and 4 mg/ml was the most efficient.
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Table 4.1 Efficiency of coupling M.Ab. to CNBr-Sepharose 
overnight ^  4 C or for 2 hours ^  37 C
Immuno­
adsorbent
condition 
of coupling
initial
protein
mg
protein
bound
mg
% coupling
Ml—a 4° C overnight 3.9 3.5 89
Ml-b I 2.6 2.3 87
MlO I 11.4 10.5 92
Mil I 13.5 12.0 89
Mll-a 37° C / 2 h 5.7 3.9 70
Mll-b I 5.0 3.6 72
Mll-c I 5.2 4.0 78
Ml+MlO+Mll I 4.6 3.3 71
The protein concentration was estimated in sodium sulphate 
precipitated and PBS dialysed ascitic fluids by measuring the O.D. 
at 280 nm and multiplying by a conversion factor for IgG (0.7), 
which results in a value of mg per ml. M.Ab. Preparations at a 
known protein concentration were mixed with CNBr-Sepharose and the 
extent of linking (protein bound mg) was estimated by calculating 
the protein content in the supernatant after coupling 
(% coupling), subtracted from the initial protein content.
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Table 4.2
Total Ig^ recovery (mg) after repeated 
use of the IgM-immunoadsorbents
dates: Oct 88 Jun 89 Aug 89 Dec 89
repeated 
assays:
0.49
0.46
0.18
0.20
0.16
0.10
0.11
0.10
0.06
0.07
0.05
0.03
mean; 0.38 0.15 0.09 0.05
% of value 
Oct 88: 100 40 24 13
standard
deviation
0.17 0.05 0.03 0.02
113
Table 4.3 Comparison of the effect of 
of M.Ab. linked to 1 ml of gel on 
immunoadsorbents to recover IgM from 1 ml
Immuno­
adsorbent
M.Ab. mg 
per ml gel
total IgM 
yield (mg)
Ml—a 3.9 2.1
Ml-b 2.3 1.1
Mll-a 3.6 2.7
Mll-b 12.0 0.9
MlO 10.5 1.3
The eluting agent was NH^SCN and fractions collected (3 ml) 
were read at 280 nm. The total IgM recovered was calculated 
based on the absorbance and volume of fractions.
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4.3.4 Ccm^rison of eluting agents to dissociate Ig^ from the
immunoadsorbents
Table 4.4 shows a comparison of five eluting agents, 3M 
NH^SCN, 3M NaSCN, 3M Nal, 2M NaCl and NTE buffer, which were tested for 
their ability to dissociate bound IgM from the immunoadsorbents. The 
protein concentration of the eluants was estimated by measuring the 
O.D. of fractions and multiplying by the conversion factor for IgM 
(Hudson and Hay, 1980). 3 M NH^SCN was the most efficient dissociating 
agent and it was used for regenerating gels for subsequent use, but 
dialysis in PBS was required prior to the assay of eluants by ELISA, 
therefore it was not suitable for routine use.The most convenient 
eluting agent was NTE buffer, as eluant fractions obtained with this 
buffer could be directly assayed in the ELISA, without the need for 
dialysis against PBS. It was also a moderately efficient eluting agent, 
being capable of eluting 38 % of the concentration of IgM recovered by 
NH^SCN. This dissociating agent was considered particularly useful for 
the rapid assay of IgM in routine diagnosis. NTE buffer was therefore 
used as eluting agent in the tests to compare the profile of 
IBV-specific IgM obtained by affinity chromatography with that obtained 
by gel chromatography. 3 M NaSCN was a less efficient dissociating 
agent, showing a mean recovery of IgM of 0.2 mg (16 % of the yield with 
NH^SCN eluant). It was found that this dissociating agent must be 
freshly prepared to give adequate results. The other eluting agents Nal 
and NaCl were less efficient, yielding the equivalent of 7 and 14 % 
recovery, respectively, compared to that recovered by NH^SCN.
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Table 4.4 Con^rison of different eluting agents used to
dissociate IgM from 10%-immunoadsorbent Mil
Total
eluting pH optical density of fractions at 280 nm IgM (mg) 
agent
3M NH^SCN 4.7
3M NaSCN 6.7
3M Nal 9.2
2M NaCl 7.4
NTE buffer 7.4
1 2 3 4 5 6 7 8 recovers
.46 .26 .10 .03 .00 .00 .00 .00 1.36
.10 .20 .14 .07 .03 .10 .04 .00 1.09
.17 .20 .19 .12 .07 .05 .02 .00 1.31
.10 .04 .02 .01 .00 .00 .00 .00 0.27
.05 .03 .01 .07 .02 .00 .00 .00 0.29
.03 .00 .00 .00 .00 .00 .00 .00 0.05
.02 .04 .01 .00 .00 .00 .00 .00 0.11
.02 .01 .01 .00 .00 .00 .00 .00 0.06
.02 .02 .01 .01 .00 .00 .00 .00 0.10
.04 .03 .02 .01 .01 .00 .00 .00 0.17
.01 .02 .02 .02 .02 .00 .00 .00 0.14
.07 .05 .03 .00 .00 .00 .00 .00 0.24
.06 .05 .05 .04 .03 .02 .02 .02 0.62
.03 .03 .04 .06 .06 .04 .04 .00 0.48
.05 .05 .04 .02 .02 .03 .02 .00 0.37
Comparison of different eluting agents to dissociate IgM from the 
immunoadsorbent Mil (3.6 mg M.Ab. per ml of gel). Five 1 ml 
aliquots of the immunoadsorbent were each mixed with 1 ml aliquots 
of the same chicken serum sample and each treated with one of the 
dissociating agents. Three repetitions of each of five dissocia­
ting agents are shown. Fractions of eluants are presented in the 
order of appearance during the dissociation. O.D. readings of 
fractions at 280 nm wavelength are shown. Total protein harvested 
from gels was calculated using a conversion factor for IgM (Hudson 
and Hay, 1980).
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4.3.5 Purification of chicken IgM by gel or affinity 
chromatograpAiy
Serum fractions from IBV infected chickens obtained by both 
IgM-immunoaffinity chromatography using NTE buffer and by gel 
chromatography (section 4.2.6) were assayed in an ELISA and the 
results were used to compare the two methods for the purification of 
serum IgM. The results were plotted graphically and are shown in 
figures 4.1 to 4.10. Figures 4.1, 4.3, 4.5, 4.7 and 4.9 show the 
affinity chromatography results obtained on pooled sera collected 6, 7, 
8, 9 and 24 days p.i., respectively. Figures 4.2, 4.4, 4.6, 4.8 and 
4.10 show the results obtained by gel chromatography fractionation of 
sera collected at the same times. For the assay of the affinity 
chromatography fractions, all aliquots including PBS washings and 
dissociated eluants were tested. The PBS washing contained a high 
concentration of IgG, which had not been bound to the immunoadsorbent. 
Once the O.D. readings reached zero, as the PBS had washed off excess 
serum, NTE buffer was applied and the fractions of eluant dissociated 
from the immunoadsorbent were found to contain only IgM, as detected by 
the IBV-specific ELISA. The sequence of events is shown in graphs of 
affinity chromatography and demonstrated the change from high IgG 
levels in PBS washings of serum to exclusively IgM levels in the 
eluant, as a result of the treatment with the IgM-immunoadsorbents.
In contrast, gel chromatography fractionation separated IgM 
from IgG according to the differences in molecular weight and the two
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immunoglobulins were localized in different peaks (figures 4.2, 4.4, 
4.6, 4.8 and 4.10).
A summary of the findings obtained at each time p.i. is shown 
in figure 4.11. The comparison of the concentrations of IBV-specific 
IgM and IgG at different times p.i. was made by measuring the weight of 
the areas under the curves of the ELISA results and plotting the 
weights graphically. The evolution of the IBV-specific IgM was shown to 
be following the same trend by the two methods of separation of 
immunoglobulins.
4.3.6 Reproducibility of ELISA results
The ELISAs were repeated 3 times to demonstrate the 
reproducibility of results and one set of assays is shown, plotted 
graphically in each the figures included below. As an example, table
4.5 shows the ELISA results of IgM eluates of pooled sera collected at 
day 8 p.i.
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Table 4.5
Demonstration of reproducibility of results obtained by ELISA 
for the determination of IBV-specific IgM in eluants from 
iq^jSiinoadsorbents
eluant
fraction
Replicate ELISAs 
2
number IgM/IgG IgM/IgG IgM/IgG
1 0.100/0.040+ 0.211/0.056 0.155/0.080
2 0.195/0.080 0.332/0.094 0.274/0.100
3 0.220/0.090 0.372/0.104 0.267/0.095
4 0.160/0.030 0.317/0.121 0.248/0.075
5 0.160/0.030 0.317/0.064 0.235/0.062
6 0.160/0.030 0.300/0.061 0.167/0.066
* results plotted graphically in figure 4.5;
+ figures indicate optical density at 405 nm;
Each eluant fraction was both assayed to detect IBV-specific 
IgM and IgG antibodies;
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Figure 4.1
IgM affinity chromatography of chicken serum collected 6 days
p.i. The ELISA for IBV-specific IgM and IgG are shown,
together with the O.D. values of the fractions.
Figure 4.2
Gel chromatography of chicken serum collected 6 days p.i. 
The ELISA results for IBV-specific IgM and IgG are shown, 
together with the O.D. values of the fractions.
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Figure 4.3
IgM affinity chromatography of chicken serum collected 7
days p.i. The ELISA results for IBV-specific IgM and IgG are
shown, together with the O.D. values of the fractions.
Figure 4.4
Gel chromatography of chicken serum collected 7 days p.i. 
The ELISA results for IBV-specific IgM and IgG are shown, 
together with the O.D. values of the fractions.
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0 .7
0.6 O.D, 380 nm
0.5
ü) 0 .4  — —
0.3 — —
P h 0 . 3 -----
•©• O  0 ® 0
0.0
PBS washing fractions NTE eluant
Figure 4.4
1.0
O.D. 380 nm
0.8
0.6
0 .4
0.2
0.0
1101009080706050
fractions
123
Figure 4.5
IgM affinity chromatography of chicken serum collected 8
days p.i. The ELISA results for IBV-specific IgM and IgG are
shown, together with the O.D. values of the fractions.
Figure 4.6
Gel chromatography of chicken serum collected 8 days p.i.
The ELISA results for IBV-specific IgM and IgG are shown, 
together with the O.D. values of the fractions.
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Figure 4.7
Ig^ affinity chromatography of chicken serum collected 9
days p.i. The ELISA results for IBV-specific IgM and IgG
are shown, together with the O.D. values of the fractions.
Figure 4.8
Gel chromatography of chicken serum collected 9 days p.i.
The ELISA results for IBV-specific IgM and IgG are shown, 
together with the O.D. values of the fractions.
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Figure 4.9
Ig^ affinity chromatography of chicken serum collected 24
days p.i. The ELISA results for IBV-specific IgM and IgG
are shown, together with the O.D. values of the fractions.
Figure 4.10
Gel chromatography of chicken serum collected 24 days p.i.
The ELISA results for IBV-specific IgM and IgG are shown, 
together with the O.D. values of the fractions.
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Figure 4.11
IBV-specific ign antibodies purified affinity or gel 
chromatography. The fractions of IBV sera submitted to IgM 
affinity purification and gel chromatography were assayed by 
ELISA. The areas under the curves corresponding to 
IBV-specific IgM and IgG were cut out and weighed and the 
results (mg) plotted graphically. The sequential evolution of 
IBV-specific IgM antibodies separated by the two methods can 
be compared.
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4.4 Discussion
The immunoadsorbents prepared with different concentrations 
of M.Abs. were tested and compared to evaluate performance. It was 
found that above a certain density of ligand, higher M.Ab. 
concentrations did not increase proportionally the ability to bind IgM. 
This result agrees with the findings of Kristiansen (1976) who 
described the deleterious effect of high concentration of ligand on the 
spatial mobility of the molecule for an adequate fit of epitopes and 
idiotypes. This does occur in high density coupling of ligand due to 
static multipoint linkage. It follows that the concentration between 2 
and 4 mg M.Ab. per ml of gel is recommended for an optimal performance 
of the immunoadsorbents.
The ELISA results obtained with eluants from the
IgM-immunoadsorbents compared well to those obtained when testing 
fractions from gel chromatography and showed that the IgM-
immunoadsorbents could separate IgM specifically. The relative amounts 
of specific-IgM present on each of the days examined after IBV
inoculation was found to be similar by both methods. With both
fractionation methods increasing IBV-IgM titres were observed from the 
6th to the 8th day p.i. and IgM was absent on the 24th day. The 
IBV-specific IgM response was shown to be transient after infection,
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agreeing with the result of Mockett and Cook (1986).
Purification of IgM by affinity chromatography showed 
advantages over gel chromatography. The time necessary for the former 
procedure is much shorter, i.e., approximately 3 hours compared to 
approximately 12 hours required to process each serum sample by gel 
chromatography. In addition, several sera may be purified 
simultaneously by affinity chromatography. A large number of 
immunoadsorbents can be readily prepared because M.Abs. are available 
in large quantities and only 1 ml of gel is sufficient to harvest the 
majority of IgM from 1 ml of serum. Analysis of several samples 
simultaneously is not easily possible using gel chromatography due to 
the complexity of the equipment required and the inherent time 
consuming methodology.
For the elution of bound IgM, NTE buffer was shown to be 
reasonably effective and to have the added advantage that dialysis was 
not required. It is, therefore, recommended as a suitable eluting 
agent, enabling rapid screening of eluants by ELISA. 3M NH^SCN was the 
most efficient eluting agent and the amounts of IgM recovered using it 
were similar to the values for IgM in serum reported previously (Lebacq 
-Verheyden ^  1974), showing 1 ml immunoadsorbent to be effective
at removing most of the IgM from 1 ml serum. It was therefore the most 
appropriate eluting agent to use to recover the total bound IgM. This 
buffer was used regularly to regenerate the immunoadsorbents between 
uses and was shown to be useful when speed was not crucial.
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These experiments were planned to devise a method for the 
rapid purification of IgM from serum suitable for diagnostic use. For 
this purpose, immunoaffinity chromatography purification of IgM from 
chicken serum was shown to be a reliable and rapid method and one which 
could be applied to the diagnosis of recent IBV infection, in 
association with a sensitive assay such as ELISA. The possibility of 
its use to purify IgM produced as a result of infection with other 
viruses will be considered in later chapters.
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Chapter 5
STUDY OT IggM M ©  IgG ANTIBODY RESPONSES OF QIICKENS TO 
INFECTIOUS BURSAL DISEASE (IBD) VIRUS
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5. Stucty of the IgM and IgG antibody responses of chickens to 
Infectious Bursal Disease (IBD) virus
5.1 Introduction
Infectious bursal disease (IBD) or Gumboro disease is a 
highly contagious viral disease occuring principally in chickens 
between 3 and 6 weeks of age (Lukert and Hitchner, 1984). IBD has 
occurred in the intensive poultry farming areas throughout the world 
since 1962, when it was first described in Gumboro, Delaware, USA 
(Cosgrove, 1962). IBD is caused by a virus classified in the 
Bimaviridae family (Dobos et ^., 1979). The disease results in very 
important economic losses during the rearing period. Losses in young 
chickens result from mortality, the retarded growth and the subsequent 
failure of surviving chickens to develop an adequate humoral response 
to vaccination and to environmental pathogens.
This study examined IBDV-specific IgM and IgG antibody 
responses to infection with IBDV strain 52/70 in chickens free from 
maternal antibodies to IBDV to enable the full manifestation of the 
infection. In the field, breeders are given a booster oil-emulsion 
vaccine against IBDV and long-lasting high titres of antibodies are 
produced, which are passively transferred to the progeny. Chicks with 
maternally derived antibodies are protected against challenge during 
the period of growth when the subclinal disease could occur, up to 
approximately 21 days of age.
In this experiment, five week-old chickens were used since
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these had been used in similar work with IBV and ILTV, so direct 
comparison would be possible. At this age the bursa is at its greatest 
size and infection results in clinical disease. Younger chicks might 
have undergone a too severe depletion of B-cells. This would be 
undesirable for this study, since it was hoped to obtain a measurable 
serological response that could be compared to that produced by the 
other two viral infections.
5-2 Materials and Methods
5-2.1 Chickens
Thirty-two five-week-old Houghton Laboratory SPF RIR chickens 
were used. Chickens were known to be free from antibodies to IBDV and 
were maintained in isolation (as described in chapter 2).
5.2.2 Virus inoculation
The 52/70 strain (Bygrave and Faragher, 1970) of IBDV was 
given (0.1 ml) ocularly to the chickens using a 1:10 dilution of virus 
prepared from bursal extract, and containing approximately log^Q 3.3 
median chick infectious doses (Mr. P. Wyeth and Mr. N. Chettle, CVL,
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Weybridge, personal communication). A second inoculation was done 
forty-two days after the primary inoculation, using the same route of 
inoculation and batch of virus. The 52/70 strain of IBDV is grown and 
titrated in chickens, as described in chapter 2.2.3.2.
5.2.3 Sampling procedures
Blood was taken from the brachial (wing) vein, immediately 
prior to inoculation (preinoculation) and at two-day intervals up to 
the 8^  ^day p.i.. Subsequent collections were taken at the 12^^, 16^^, 
24^^, 27^^, 33f^ and 39^  ^day p.i.. At the 42nd day p.i., chickens were 
bled and given a second virus inoculation. Blood samples were taken up 
to the 43^^ day after the second inoculation as indicated in figure 
5.3.
5.2.4 Gel chromatography of serum
IgM and IgG were separated from chicken sera as described in 
chapter 2.5.
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5.2.5 Affinity chromatography of IgM from serum
The purification of IgM from chicken serum was as described 
in chapter 3.2.4, using NTE buffer as eluting agent.
5.2.6 ELISA
IBDV-specific antibodies in fractions containing IgM or IgG 
obtained from gel or affinity chromatography of sera were assayed by 
ELISA as described in chapter 2.3.2. IBDV antigen was used at 1:200 
diluted in carbonate buffer to coat plates. Serum fractions or 
immunoadsorbent eluants were added undiluted onto the virus coated 
plates. ELISA results were plotted and the areas under the curves 
corresponding to IgM or IgG were cut out and weighed. The weights for 
both antibody classes were plotted against day p.i..
Pooled sera were assayed for IBDV-specific IgG by an indirect 
ELISA essentially as described in section 2.3.2. In the second step 
(test sample) doubling dilutions of serum samples in PBST were added. 
All other details of the ELISA were as described in chapter 2.3.2.
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5.3 Results
5.3.1 Acute disease following infection with IBDV 52/70
The experiment was conducted with chickens free from 
maternally-derived IBDV antibody and hence the full effect of disease 
was obtained. Chickens were visibly ill from the 2nd day p.i.. 
Prostration, ruffled feathers in approximately 40% of chickens (13 
chickens) and a foul-smelling yellowish diarrhoea, in virtually all 
chickens was observed up to day 6 p.i.. A total of 37.5% mortality (12 
chickens) was recorded. Mortality was observed principally between 48 
hours (5 chickens) and 96 hours (4 chickens) p.i.. Deaths continued up 
to day 10, although no other obvious clinical sign was observed beyond 
day 6 p.i.. Chickens which showed signs of prostration and ruffled 
feathers usually died of the infection. These were distinguishable from 
the others by being stunted in size. Post-mortem examination revealed 
darkening of skeletal muscles with haemorrhages especially in the 
thigh, and mucosal petechiae in the junction of the proventriculus and 
the gizzard. The mucosa of the bursa of Fabricius was haemorrhagic and 
externally, at the serosa the organ had gelatinous oedema. Following 
the secondary inoculation no clinical disease or mortality was 
observed.
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Haematoxylin-eosin (HE) stained cross-sections of the bursa 
of Fabricius of chickens which died of the disease on the 4^  ^ day p.i. 
were examined histologically and showed extensive necrosis of the 
lymphocytes and follicular vacuolation (figure 5.2). For comparison, 
figure 5.1 shows a cross-section of a normal bursa of Fabricius from an 
uninoculated chicken.
5.3.2 Profile of IBDV-specific serum antibodies in response 
to infection by IBDV strain 52/70
5.3.2.1 Serum IgM and IgG fractionated gel chromatography
Relative quantities of IBDV-specific antibodies detected by 
ELISA in gel chromatography fractions of sera are shown in figure 5.3. 
The results obtained from serum samples collected at day 6 and 16 are 
also shown in figure 5.4 to illustrate high and low concentration of 
IBDV-specific IgM, respectively, and the increased amounts of IgG at 16 
days. IBDV-specific IgM antibody was first detected 4 days p.i. and its 
greatest concentration was shown on day 6 p.i., thereafter declining 
rapidly to low levels by the 16^^ day. An increase in IBDV-specific IgM 
was detected on days 39 and 42 p.i.. A second dose of the virus 42 days 
p.i. resulted in a secondary IBDV-specific IgM response, with a peak at 
day 30 after secondary inoculation, thereafter declining. Although in 
the secondary IgM response peak amounts reached similar
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Figure 5.1
Cross-section of normal bursa of Fabricius.
The normal features of the bursa of Fabricius shown in 
the picture include the plicae (P) with epithelium (E) 
and the folliculi (F) with medullar (me) and cortical 
(co) regions. Bursa was fixed with BFS (buffered formal 
saline, 10 % formalin phosphate buffered saline),
sections stained by hematoxylin-eosin (HE) and viewed at 
40 times magnification.
Figure 5.2
Cross-section of IBDV infected bursa of Fabricius. The 
picture shows a cross-section of the bursa processed as 
above. The bursa was fixed and section viewed as in 
figure 5.1. Most of the folliculi (F) observed showed 
alterations, especially reduction in follicular size, 
the organization into medullar and cortical regions and 
follicular vacuolation (V).
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concentrations to those following primary inoculation, titres were 
detectable for much longer, for more than 37 days, from the 6th to at 
least the 43^^ day p.i,, when the experiment was terminated. However, 
decreased titres were detected at the last sampling time.
IBDV-specific IgG was first detected at 6 days p.i. and its 
concentration increased continuously up to day 16 p.i.. A slight 
decline was detected at day 24 p.i., but IgG concentration gradually 
increased up to day 42 p.i., the time of the second inoculation. The 
second inoculation resulted in an anamnestic IBDV-IgG response which 
increased from day 10 p.i.. Secondary IgG levels fluctuated, as they 
did in the primary response, concentrations increasing from day 10 to 
18 p.i., declining on days 20 and 25 but increasing again from day 30 
to 43 p.i. after the second inoculation.
5.3.2.2 Serum IgM purified ^  affinity chromatography
Pooled sera collected after the IBDV primary inoculation were 
used to demonstrate the use of affinity chromatography to purify IgM 
from serum of IBDV infected chickens. The eluants recovered from the 
immunoadsorbents were assayed by ELISA and the results were plotted 
graphically. The areas under the curves were cut out and weighed and 
the weights obtained for each day p.i. were plotted graphically and are 
shown in figure 5.5. The profile of IBDV-specific IgM obtained was 
similar to that obtained by gel chromatography. IBDV-specific IgM was 
detected from days 4 to 12 p.i. and its highest concentration was at
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Figure 5.3
Evolution of and IgG antibodies specific to IBDV 
after inoculation with the strain 52/70
The IBDV-specific IgM and IgG response was examined 
after primary and secondary inoculations with strain 
52/70. Gel chromatography fractions were assayed for 
IBDV-specific antibodies and to identify their antibody 
class by ELISA. The ELISA results were plotted and the 
areas under the curves corresponding to IgM or IgG were 
cut and weighed. The weights plotted against day p.i. 
are shown in this graph.
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day 6 p.i.. However, no IgM could be detected after day 12 p.i. and no 
increase was observed at day 39, as had been seen previously by gel 
chromatography.
5.3.2.3 Indirect ELISA
An indirect ELISA was performed in an attempt to detect 
IBDV-specific IgM and IgG antibodies in whole pooled serum samples 
collected after the primary inoculation with IBDV 52/70. The results 
are shown in figure 5.6. The profile obtained with the indirect ELISA 
was compared to those obtained by gel and affinity chromatography. The 
IBDV-specific IgM antibody was present at the highest levels in all 
tests at the 6^  ^ day p.i. and declined rapidly by day 12 p.i.. 
Similarly to the results with the gel chromatrography fractions, an 
increase in IgM titre was observed from day 33 to day 39 p.i.. 
IBDV-specific IgG was detected from day 6 and rapidly increased to 
high amounts at day 8, declined to a lower titres at day 24 which 
resumed to high titres by day 39 p.i..
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Figure 5.4
Gel chromatography of chicken serum
(a) 6 days p.i. IBDV 52/70
Sample of pooled sera was fractionated and 
fractions were assayed by ELISA for IBDV-specific 
antibodies and to identify the antibody class. This 
figure is included to demonstrate the presence of high 
levels of IBDV-specific IgM at 6 days p.i. with the 
52/70 strain. Also to support the data from figure 5.5, 
on the immunoadsorption of IgM and the presence of 
IBDV-specific IgM antibodies at this day after 
inoculation.
(b) days p.i. IBDV 52/70.
The pooled serum sample was fractionated and 
assayed as described above and illustrates the low 
levels of IBDV-specific IgM and high levels of IgG 
present at that time after inoculation.
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Figure 5-5
Purification of Ig^ from serum of chickens 
infected with IBDV strain 52/70 by affinity 
chromatography
Sera (pools) collected after primary 
inoculation were used to extract the IgM fraction by 
affinity chromatography using IgM-immunoadsorbent. The 
eluting agent used was NTE. The eluants were tested by 
ELISA for IBDV specific antibodies and for the 
identification of the immunoglobulin class (IgM or IgG). 
The results were plotted and the areas under the
curves were cut out and weighed. The graph shows the 
weight in milligrams obtained for each day p.i..
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Figure 5.6
IBDV specific Iq^ and IgG determined by an 
indirect ELISA.
Serum pools collected after the primary 
inoculation with IBDV 52/70 were assayed for IgM and IgG 
antibody specific to IBDV by ELISA, using M.Ab. to 
identify the immunoglobulin class. The ELISA was 
essentially as described in chapter 2.3.2, with steps, 
in brief, as follows:
(1) IBDV coated plates (1:200); (2) serum
dilutions in PBST; (3) M.Ab. anti-IgM or IgG (30 ug/ml); 
(4) conjugate goat anti-mouse alkaline phosphatase 
(1:1000 in PBST); (5) substrate p-NPP; (6) reaction 
stopped with 3 M NaOH; (7) plates read at 405 nm.
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5.4 Discussion
The profiles of IBDV-specific IgM and IgG antibodies have 
been demonstrated after primary and secondary inoculations with the 
virulent 52/70 strain and this is the first report on the detection of 
IBDV-specific IgM. In addition, this is the first sequential 
determination of IBDV-specific IgG after infection with IBDV strain 
52/70.
Three approaches were used for the detection of IgM and IgG. 
Gel chromatography or affinity chromatography were used to separate 
both immunoglobulins, followed by ELISA for the assay of IBDV-specific 
antibody and its class. An indirect ELISA, which did not require 
previous purification of IgM and IgG from serum, was also used for the 
detection of IBDV-specific IgM or IgG. Considering its advantages, the 
indirect ELISA is the most practical approach to rapidly detect the IgM 
class of specific antibody, although preliminary results (j^ ot shown) 
suggest that the test may fail for not obvious reasons with other 
viruses studied here, IBV and ILTV. In addition, for an indirect ELISA 
a characterised set of M.Abs. may be required for the specific 
identification of the immunoglobulin class, based on the results of 
poor specificity of polyclonal antibodies in chapter 3 of this thesis. 
Such reagents are not available for most laboratories engaged in 
diagnosis. Nevertheless, it becomes apparent that M.Abs. are highly 
valuable tools in serology. Gel chromatography and affinity 
chromatography purification of IgM are alternatives to facilitate the 
assay of the antibody class, and affinity chromatography, described in
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chapter 4, offers the advantages of rapidity and simplicity to separate 
serum IgM over gel chromatography, a feature which is most important in 
diagnosis.
The results obtained by affinity chromatography and ELISA 
have shown that the classic profile of anti-viral IgM antibodies have 
been produced (Roitt, 1984) in response to the IBDV-52/70 infection. It 
was interesting to observe that the specific antibody response to IBDV 
was comparable to that demonstrated following the IBV infection 
(chapter 4). It follows that IBDV affecting chickens outside the age 
range when immunosupression occurs, that is up to approximately 3 weeks 
of age, generates a rapid response comparable to other viral infections 
which do not cause impairment of the immune system.
The IgM profile obtained by affinity chromatography was 
compared to that obtained by gel chromatography and indirect ELISA. The 
highest concentration of IBDV-specific IgM was detected at day 6 p.i. 
by all the three methods. The rapid decline of IgM was detected 
similarly by the three methods, however, both gel chromatography and 
indirect ELISA showed continued detection of levels of specific IgM. 
Gel chromatography results maintained a reaction up to the end of the 
primary response, especially high at days 39 and 42 p.i.. Indirect 
ELISA results also showed an enhanced rection at the end of the primary 
response, at days 33 and 39 p.i.. The reason for these findings is not 
known. However, the results with the IgM extracts by affinity 
chromatography are considered reliable due to the higher purity of the 
reagent (pure IgM) added to the ELISA and chances for non specific 
reaction are virtually absent.
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The bursa of Fabricius was obviously affected in this 
experiment, as can be seen by the examination of the histological 
sections. The destruction of the bursa of Fabricius by the IBDV 
infection did not affect noticeably the specific response to IBDV. This 
was probably because the secondary lymphoid tissues were already 
populated and these lymphocytes were capable of responding and 
maintaining the antibody response against the infection. However, it 
is known that the IBDV infection results in impaired immune response to 
various immunogens and infections in young chickens. One interesting 
subject of future study would be the exact stage of development of the 
B-lymphocyte most susceptible to IBDV and the IBDV receptor on these 
lymphocytes. This study could explain the reason for a "normal" 
response to IBDV despite the destruction of B-lymphocytes.
IBDV-specific IgM antibody was first detected at day 4 p.i. 
and rapidly reached its highest levels by day 6 p.i., thereafter 
declining rapidly by day 16. IBDV-specific IgG antibodies were detected 
from day 6 and reached high levels by day 16, results which demonstrate 
the rapid switch from IgM to IgG. In the literature IBDV VN antibody 
was detected at day 5 p.i. in 8-week-old chickens given virulent IBDV 
(Skeeles et ^., 1979-b). Rapidly produced VN antibody was also
detected by Cursiefen et ^ . , (1978), from day 4 p.i., using chickens 3 
to 5 week-old infected with an attenuated strain of IBDV. No directly 
comparable results were available in the literature to analyse the 
findings obtained, however, the cited references help to illustrate 
that virulent IBDV generated a rapid specific antibody response of both
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classes in chickens infected after the age of maximum susceptibility of 
the immune system. Marquardt et (1980) developed the indirect
ELISA to detect IBDV antibodies and used an anti-chicken IgG conjugate 
to demonstrate antibodies in the serum of 8-week-old experimentally 
vaccinated chickens. The IBDV-specific IgG antibody response was shown 
to reach its highest concentration 4 and 5 weeks p.i. and to decline 
gradually from 6 to 52 weeks p.i.. When ELISA was compared to AGP, it 
detected antibody titres at least 1 week earlier and was 20,000 to 
25,000 times more sensitive than AGP. The ELISA results were compared 
to VN to which divergences were shown, probably reflecting different 
specificities of antibodies (Marquardt et al., 1980).
Previous reports have demonstrated the effect of IBDV 
infection on total serum (not IBDV-specific) IgM or IgG. Hirai et al., 
(1979) showed that the immunoglobulin concentration was reduced for the 
IgM class after infections at 1, 4 and 6-week-old but IgG, however, was 
shown to be reduced only after early infection (iu ovo, and 1 day-old) 
but increased in chickens infected at 1, 4 and 6 weeks of age. Total 
immunoglobulin synthesis could have been affected here in this 
experiment, but it was shown that the synthesis of specific antibodies 
was not affected as far as the sequence of development and switches is 
concerned. Chickens infected at the age used in this experiment did not 
undergo a suppression of the humoral response but presented clinical 
signs, lesions and mortality caused by the high titres of virus 
produced during the infection (Ismail et ^ . , 1987).
Considering the variations in the picture of the pathogenesis 
of IBDV with regard to different ages of chickens being used, it
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follows that the study of the effects of the IBDV infection on the 
immune system can only be compared when the same age of chickens are 
used.
In the future it is planned to study the effect of IBDV on 
the synthesis of specific antibody classes in younger chickens with the 
aid of immunohistochemistry using M.Ab. to study the target cell.
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Chapter 6
STUDIES OT ^  Iggï IgG SPECIFIC ANTIBODY RESPONSES OF
CHICKENS INFECTED WITH INFECTIOUS lARYNGOTRACHEITIS (ILT) VIRUS
159
6. Studies of the IgM and IgG specific antibody responses of 
chickens infected with infectious laryngotracheitis (ILT) virus
6.1 Introduction
The specific antibody response to ILTV infection is to be 
determined and compared to that following IBV and IBDV infection. It 
would be interesting to know what specific IgM antibody response would 
result from an infection characterized by latency following the acute 
form of the disease, e.g. ILT, particularly in the context of using the 
detection of ILTV-specific IgM in the diagnosis of ILT. ILTV is a 
member of the Herpesviridae family, subfamily alphaherpesvirinae 
(Roizman et al^, 1981), species Gallid herpesvirus 1, and is known to 
induce a carrier state in an infected flock (Komarov and Beaudette, 
1932; Beaudette, 1949). ILT infection is characterized by an acute 
disease, which may vary from mucoid to haemorrhagic laryngotracheitis. 
A milder form of ILT has been described in outbreaks in England with 
only a few chickens with typical respiratory signs and low mortality 
(Curtis and Wallis, 1981). Latent virus has been demonstrated in CK 
after inoculation with supernatant medium from TOCs prepared from 
chickens infected with a wild strain of ILTV and in chickens infected 
with a vaccine strain, in 38 and 44 % of samples, respectively (Bagust, 
1986). Recent studies.in live birds have demonstrated the reactivation 
of ILTV in chickens recovered from the acute disease, this was 
characterized by intermittent episodes of virus shedding, and by virus
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re-isolation from swabs of the trachea and less frequently oropharynx 
in chicken embryo liver cells. Virus reactivation was apparently 
spontaneous and without recurrence of clinical signs (Hughes et al., 
1989-a). Essentially similar findings have been observed in birds 
vaccinated with a live ILTV vaccine strain (Hughes ^  ^ . , 1989-b). 
Clinical signs of ILT were observed in vaccinated chickens which 
resembled the milder form of the natural disease (Hughes et ^., 1987) 
and reactivation of ILTV occurred spontaneously in 25 % of the 
cockerels from the 8th week post vaccination, without producing 
clinical signs.
Adair et (1985) have detected the antibody response to 
ILTV from day 7 p.i. by SN, fluorescent antibody (FA) test and ELISA, 
using an anti-chicken IgG conjugate. They detected highest IgG titres 
at day 17 p.i.. Testing convalescent sera 2 weeks after an ILT 
outbreak, SN, FA and ELISA techniques detected anti-ILTV antibody 
titres in 20 of 29 chickens and agar gel precipitation (AGP) detected 
antibody in 12 of 20 chickens tested. York et (1989) detected
anti-ILTV serum titres from day 7 by ELISA (anti-chicken IgG heavy and 
light chains conjugate) and from day 10 by SN. Using the same 
conjugate as when testing sera, tracheal anti-ILTV antibody was 
detected by ELISA from day 5 and the IgA class was detected from day 7, 
but no attempt was made to detect IgM.
This present study aims to examine the primary and secondary 
IgM and IgG responses of chickens infected with ILTV, and to consider 
the applicability of the determination of specific IgM in the diagnosis 
of recent ILTV infection.
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6.2 Materials and Methods
6.2.1 Chickens
Ten five-week-old Houghton Laboratory RIR SPF chickens were 
accommodated in isolation and fed as described in chapter 2.1.
6.2.2 Virus inoculation
An ILT vaccine strain (Salsbury Laboratories) containing 
log^o 6.1 PFU in 0.1 ml was titrated as described in chapter 2.2.2.1 
and inoculated via eye-drop as described in chapter 2.1.3. A second 
vaccination was given on the 42"^ day after the primary vaccination, 
using the same strain, batch and dose of virus.
6.2.3 Sampling procedures
Blood samples were taken from the brachial vein prior to the 
primary vaccination on day 0 and subsequently on 3, 5, 6, 8, 12 16, 20, 
23, 26, 29, 32, 37 and 42 days after primary and 3, 6, 8, 12, 21 and 32 
days after secondary vaccination. Bleeding and the separation of serum
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was described in chapter 2.1.4.
6.2.4 Gel chromatography of serum
IgM and IgG were separated from pooled serum samples by gel 
chromatography as described in chapter 2.5. In order to examine the 
individual variation of responses and the reproducibility of the 
results obtained with the pools, as compared to individual samples, 
four individual sera were also fractionated separately at each of 3 
different sampling times (6, 16 and 26 days post primary inoculation).
6.2.5 Affinity chromatography of IgM from serum
Purification of serum IgM by affinity chromatography was 
performed as described in chapter 4 on sera collected after the primary 
vaccination.
6.2.6 ELISA
An ELISA was used to detect ILTV-specific antibody in
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fractions of sera obtained by gel and affinity chromatography. The ILTV 
antigen was used diluted at 1:100 in carbonate buffer to coat plates. 
Fractions of sera were added undiluted. Details of the procedure are 
described in chapter 2.3.2.
6.3 Results
6.3.1 Clinical signs
The clinical observation of the chickens revealed that 
clinical signs were very mild. A very careful observation with 
attention to respiratory sounds was necessary. Apart from the 
occasional rale no other sign was observed.
6.3.2 Profile of ILTV-specific Ig^ and IgG response in sera 
separated by gel chromatography and assayed by ELISA
Figure 6.1 shows the ELISA results obtained by testing all 
serum pools fractionated by gel chromatography to identify IgM and IgG 
antibody specific to ILTV. The IgM profile fluctuated. ILTV-specific 
IgM was not detectable before 5 days p.i. and titres rose sharply to 
their highest levels at 6 days, less detected between the 8th and the
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14th day, whilst at the 16th day IgM reached its lowest concentration. 
Increased titres of ILTV-specific IgM were detected from the 20th day, 
and increased gradually to a second peak at the 26th day after primary 
inoculation. IgM levels then declined again, up until the 30th day but 
thereafter increased until the 42nd day, when the secondary inoculation 
of ILTV was performed. The response to the secondary inoculation was 
followed for 32 days, and titres formed a plateau, which was maintained 
after a drop in antibody titre immediately post secondary inoculation.
Examination of serum samples from four individual 
chickens,collected at 6, 16 and 26 days after primary inoculation 
(figure 6.2), resulted in the demonstration of the same pattern of IgM 
production in individual as with serum pools, in that titres declined 
between day 6 and 16 and increased again on day 26. The individual 
results on day 6 were generally the highest and those at day 16 the 
lowest, both with less individual variation than at day 26. These 
results indicate that it was valid to examine pools of serum rather 
than individuals.
The ILT specific IgG profile is included in figure 6.1. The 
titres of IgG rose continuously up to day 26. The period from day 26 to 
day 42 was characterised by a fluctuating IgG profile. The secondary 
ILTV-specific IgG response was initially delayed during the first 3 
days after the second inoculation. ILTV-specific IgG increased from day 
6 to 22 after the second virus inoculation and by the end of sampling 
on day 32 showed a decline.
The assays were repeated three times and the SEM was 
calculated. The SEM is indicated as range bars for the values of each 
collection in figure 6.1.
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Figure 6.1 Profile of serum ILTV specific IgM and 
IgG antibodies separated by gel chromatography and 
assayed ELISA
The ILTV specific antibody response was examined 
after primary and secondary viral inoculations. 
Gel chromatography fractions of pooled sera were 
assayed for ILTV-specific antibodies and to 
identify their antibody class. The ELISA results 
were plotted and the areas under the curves 
corresponding to IgM or IgG were cut out and 
weighed. The graph shows for each antibody class, 
the weight of the ELISA areas in mg obtained for 
all serum collections examined.
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Figure 6.2
Gel chromatography and ELISA of individual serum 
samples
Four individual serum samples collected at the 
sampling days 6, 16 and 26 after primary ILTV
inoculation, were fractionated by gel 
chromatography and subsequently assayed by ELISA. 
Samples were chosen at random among the 10 
individuals at each collection. ELISA results for 
ILTV-specificity are expressed as indicated 
previously. The weight for each observation is 
indicated on the top of each bar (in mg). The black 
bars next to each cluster represent the mean for 
that cluster, including a representation of the 
standard error of the mean (SEM).
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6.3.3 Profile of ILTV-specific serum IgM purified by affinity 
chromatography and assayed by ELISA
Samples of sera collected after the primary vaccination were 
also submitted to treatment with the IgM immunoadsorbents for the 
purification of serum IgM. Eluants were assayed by ELISA for ILTV 
antibodies and to identify the antibody class. The areas under the 
curves corresponding to IgM were cut out and weighed and results 
plotted graphically. Eluants were also assayed for IgG antibodies by 
ELISA, in order to check the purity of eluted IgM fractions and all 
were negative (results not shown). The results of the IgM assays are 
shown in figure 6.3. The gel chromatography results are included again 
for comparison. A similar fluctuating profile to that obtained by gel 
chromatography was observed for ILTV-specific IgM purified from serum 
by affinity chromatography. Again 2 peaks of IgM were observed, at the 
6th and 23-26th days after inoculation. These results are in an 
agreement with the findings obtained with gel chromatography and 
confirm both the fluctuating nature of the IgM response and the value 
of affinity chromatography in separating serum IgM.
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Figure 6.3 Profile of ILTV-specific IgM purified by 
affinity and gel chromatography of chicken serum 
and assayed by ELISA
The purification of serum IgM by IgM 
immunoadsorbent is described in chapter 3. One ml 
of chicken serum was mixed with 1 ml IgM 
immunoadsorbent gel for approximately 2 hours at 
37° C and the trapped IgM was eluted with NTE 
buffer. Eluants were assayed for ILTV-specific 
antibodies by ELISA. ELISA results were plotted, 
the areas under the curves were cut out and weighed 
and the results plotted graphically. The figure 
shows ILTV-specific IgM at different days post ILTV 
primary inoculation, expressed as weight of areas 
in mg. The results obtained using gel 
chromatography are included again for comparison.
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6.4 Discussion
This is the first report on the detection of ILTV-specific 
IgM. The profile of ILTV specific IgM antibody obtained was different 
from that following either IBV or IBDV infection in the sense that 
specific IgM persisted for the entire experiment and was cyclic. The 
classical pattern of specific-IgM response, characterized by a 
short-lived production after contact with the antigen, as observed 
following inoculation with IBV or IBDV, chapters 4 and 5, respectively, 
was observed after the inoculation of the birds with ILTV but two 
further episodes of IgM production were also observed. The fluctuating 
ILTV-specific IgM concentrations are possibly associated with cycles of 
virus excretion. Re-excretion of ILTV has been described previously 
after vaccination or challenge with ILTV strains (Bagust, 1986; Hughes 
et ^ ., 1987; Hughes et ^ ., 1989-a and b).
In the series of events which lead to the synthesis of 
antibodies, IgM is always the first class of antibody to be produced. 
Cells committed to the synthesis of IgM antibody to a certain 
specificity, i.e. the synthesis of a certain idiotype, switch to the 
synthesis of IgG heavy chains without changing the synthesis of the 
variable region (the Fab region is maintained) (Wang et ^ . , 1970). The 
capability of switching depends on the bursa microenvironment (Kincade 
et ^., 1970; Subba Rao et ^., 1978). Chicken B-lymphocytes mature in 
the bursa where they acquire the ability to rearrange the sequence of 
the gene responsible for the synthesis of heavy chains (Weill et al.,
1986). The actual mechanism for the switch to the synthesis of IgG or
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IgA is poorly understood. Similarly, how the above correlates with the 
finding of a persistent, fluctuating or cyclic ILTV-specific IgM is not 
clear. Possibly the pattern of the IgM response following the ILTV 
infection arises due to characteristics of the disease. ILT infection 
is restricted to the trachea in the acute disease (Hughes et , 1987) 
and no virus is isolated from peripheral blood leukocytes, bursa, 
spleen or thymus. If it is considered that a different presentation of 
an antigen may induce a different pattern of synthesis of antibody 
classes, the mode of presentation of ILTV to the immune system 
(persistent or recurrent) may account for the profile of specific IgM. 
As an example, the IBV infection induces the classical profile of 
short-lived IgM. However, the production of IBV-specific IgM has been 
studied in response to an oil-emulsion vaccine (chapter 8 of this 
thesis) and shown to develop through a longer period of time than the 
response to live virus infection and at much lower concentration.
One interesting finding in relation to the pathogenesis of 
ILTV was that virus given via the cloaca could induce changes in bursa 
of Fabricius, with degeneration of follicles and subsequent impaired 
antibody response to Brucella abortus (Robertson, 1976). Virus was 
detected in cloacal swabs of chickens given ILTV intratracheally or 
via combined intranasal/conjunctival routes (Hughes et ^., 1987), 
suggested to be ingested virus expelled from the trachea within mucus.
In order to explain the profile of IgM it would be necessary 
to design an experiment in which individual birds are examined for 
presence of virus as well as for antibody, as individuals may show 
different rates of virus reactivation. Such a study could include the 
examination of the trachea in an attempt to identify alternative target
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cells to epithelial cells, such as B-lymphocytes.
Persisting IgM responses have been reported previously 
against antigens which are poorly degraded, such as the pneumococcal 
polysaccharide (Paul et ^., 1967). IgM clones were selectively
stimulated by the administration of lower doses of antigen (Pasanen, 
1971). It is not known if any of these factors could be involved in 
ILTV infection.
Latent infections resulting from inoculation of vaccine 
strains of ILTV have been reported (Bagust, 1986; Hughes et al., 
1989-a), and sites of latency have been shown to be highly localised in 
restricted areas scattered throughout the trachea, probably in the 
sites of initial viral replication (Bagust, 1986) or trigeminal 
ganglion (Bagust et ^., 1986). Latency is another aspect of the ILTV 
infection which may account for the different profile of specific IgM. 
The isolation of latent vaccinal ILTV was observed to be delayed 
following inoculation with a lower dose of virus, i.e. administration 
of 450 PFU, resulted within 2 months in a recurrent neutralizing titre 
(1:40) but not virus re-isolation. However, a higher dose (4,000 PFU) 
resulted in re-isolation of ILTV within 2 months and with neutralizing 
antibody titres of 1:60 (Bagust, 1986). Virus reactivation may be 
dependant on the initial dose or volume of virus. In this study the 
dose of vaccinal virus administered was very high, i.e. log^ ^^  6.1 PFU. 
Based on the findings reported by Bagust (1986), the higher inoculum 
might have resulted in the earlier reactivation of virus, probably due 
to more sites of latency being formed and this could then explain the 
secondary cycle of IgM by the 26th day p.i..
Some comments will be made on other herpesviruses.
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Herpes Simplex Virus (HSV) is classified in the same 
subfamily as ILTV (alphaherpesvirinae) and both viruses induce latent 
infections (Roizman et al., 1981). HSV induces latency in which the 
viral genome is maintained in a non-infectious state associated to the 
neuronal genome (Cook et ^., 1974). Persistent IgM titres have been 
reported in some HSV infections, although most studies refer to HSV 
specific IgM present only following primary inoculations (Norrild, 
1985). Following a primary skin infection, HSV penetrates the 
peripheral nerve and travels to the local sensory ganglia (Hill et al., 
1983). Reactivation of HSV did not induce specific IgM levels after 
localized recurrent disease (herpes labialis, fever blisters or cold 
sores) (Doerr ot ^., 1976). Two other pieces of information help to 
illustrate the point of great variability of response based on 
different type of stimulus: HSV type 2, the genital herpes virus, has 
been reported to induce a suppression of humoral IgM and IgG 
HSV-specific antibody for a period of 50 days following both primary 
and secondary infections (Nick et ^., 1987). In contrast HSV-1
elicited typical HSV-specific IgM and IgG responses (Nick et al., 
1987).
A human gammaherpesvirus (Epstein- Barr virus-EBV) produces a 
prolong ed active infection and 60 % of seropositive individuals may be 
shedding EBV during their whole lives (Yao et ^., 1985). In addition 
EBV was shown to evade acyclovir treatment in persistently infected 
B-cells (Yao et al., 1989).
Returning to comments on ILTV, the examination of individual 
serum samples after the separation of IgM showed two important points: 
Firstly the ILTV-specific IgM antibody results obtained with individual
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sera correlated with those obtained with pooled sera (p<0.02). 
Secondly, the variation in amounts detected in individuals on day 26 
p.i., the time of the spontaneous second IgM peak, suggests that 
individual birds may have had different rates of replication or 
reactivation of the virus.
ILTV-specific IgG was demonstrated to increase from the 5th 
day p.i. throughout the primary infection, indicating that a switch 
from IgM to IgG was occurring. The secondary IgG response was 
anamnestic, as it reached higher titres and more rapidly than those in 
the primary response.
This study showed that there was a persistent IgM response 
after a primary ILTV infection, apparently intermittently re-started in 
a cyclic fashion, and which maybe associated with virus reactivation. 
The latter was not investigated but would be an important part of 
future studies. The results indicated that the determination of ILTV 
specific IgM for the routine diagnosis of ILT is not applicable.
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Chapter 7
FURTHER STUDIES OF TEE ANTIBODY RESPOJSES OF CHICKENS TO ILTV 
INFECTIOJ; DETERMINATim OF SPECIFIC IgA, IgM AND IgG IN THE TRACHEA 
AND CŒIFIRMATIW OF THE PAITERN OF SERUM Ig^ AND IgG RESPONSES
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7. Further studies of the antibody responses of chickens to 
ILTV infection: determination of specific IgA, igM and IgG in the 
trachea and confirmation of the pattern of serum IgM and IgG responses
7-1 Introduction
The previous ILTV study (chapter 6) demonstrated, for the 
first time the profile of ILTV-specific serum IgM produced after 
infection, which was shown to be fluctuating or cyclical. This was 
somewhat surprising and was suggested to be associated to latency of 
the virus. It was decided to carry out a similar experiment to confirm 
and extend these findings. In addition, the opportunity was taken to 
investigate the production of antibody in the trachea.
Neutralizing antibodies to ILTV have been demonstrated in the 
trachea at the 7th and 8th day p.i. (Bagust et ^., 1986). IgA and IgG 
antibodies specific to ILTV in tracheal washings and IgA and IgG- 
bearing cells in the trachea were determined for a period of 28 days 
after vaccination and for 10 days after challenge (York et ^., 1989). 
ILTV specific antibody was also determined using an enzyme-conjugated 
anti-chicken IgG heavy and light chains in an ELISA. Results were 
described as "total" antibody, and could be biased to IgG detection, 
because of the possible greater reaction of the conjugate with chicken 
IgG heavy chain. "Total" antibody was detected in tracheal washings 
from day 5 post vaccination and from day 0 post challenge, IgA antibody 
was detected from day 7 post vaccination and from day 0 post challenge. 
These authors did not look for the presence of IgM in the trachea. The
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highest titres of "total" Ig were detected at day 10, declined up to 
day 21 and re-detected on day 28 after vaccination, both in tracheal 
washings and serum. However the titre did not vary after challenge. IgA 
was detected at highest concentrations at day 7 and seemed to persist 
at variable levels up to day 28 in tracheal washings after vaccination 
and did not vary after challenge, but was not detected in serum. 
Analysing their results following the primary infection, it was noted 
tiiat both with total and with IgA antibodies, the titres seemed to 
increase at the 28^^ day p.i., and was associated with increased 
numbers of IgG and IgA bearing lymphocytes, possibly suggesting 
reexcretion. However, these observations were not discussed by the 
authors.
This study aims to investigate the production of IgM, IgA and 
IgG ILTV-specific antibodies in the trachea of chickens after a primary 
inoculation of ILTV and to repeat the findings - obtained with serum 
antibodies in the previous chapter of this thesis.
7.2 Materials and methods
7.2.1 Chickens
Thirty 5-week-old RIR SPF chickens were accommodated and fed 
as described in chapter 2.1.
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7.2.2 Virus inoculation
A vaccine strain of ILTV (Salsbury Laboratories) of the same 
batch as the sample used in chapter 6, containing log^^ 6.1 PFU/0.1 ml 
was used to vaccinate the chickens ocularly, as described in chapter 
2 .
7.2.3 Sampling procedures
Blood samples were taken from the brachial vein from a group 
of 5 birds at 5-day intervals up to 55 days p.i. and then at the end of 
the experiment (78 days p.i.). Tracheal washings were collected every 5 
days up to 40 days and then at 78 days p.i. using three birds per 
collection. Serum and tracheal washings taken from uninoculated 
chickens were used as negative controls. Sera were separated from the 
blood clot, centrifuged and stored at -20° C, as described in chapter 
2.1.4.
7.2.3.1 Collection of tracheal washings
The three birds sampled at each of the 5-day intervals were 
bled and killed by intravenous injection of pentobarbitone 200 mg/ml
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(Expirai, Ceva Ltd., Watford, Herts.). The trachea was exposed by 
opening the cervical skin longitudinally and clipped using Diffenbach's 
bulldog clips at the proximal end immediately posterior to the larynx 
and at the distal end by the entrance into the thoracic cavity. The 
trachea was freed from connective tissue m  situ using fingers, to 
minimise the risk of haemorrhages and avoid contamination of the 
tracheal lumen with serum components. The clipped and externally clean 
trachea was removed by cutting outside the clips. One clip at one end 
of the trachea was opened slightly to allow the introduction of a 
23-gauge needle so that 0.5 ml of PBS could be gently introduced. The 
needle was withdrawn, the clip closed and the trachea gently massaged. 
The washing fluid was collected using a 23-gauge needle fitted on a 1 
ml syringe. All the liquid available in the trachea was collected. 
Tracheal washings were frozen individually at -20° C until assayed by 
ELISA.
7.2.4 Gel chromatography of serum
Pooled sera was fractionated by gel chromatography as 
described in chapter 2.5.
7.2.5 M.Abs. to chicken immunoglobulins
M.Abs. were prepared as described in chapter 2.4. For the
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assay of chicken IgA, in addition to the previously mentioned P9 and 
p25 M.Abs. anti-IgA, the 41SC M.Ab. specific to chicken IgA (Mockett, 
unpublished data) was also added. Approximately equal amounts of M.Ab. 
P9, p25 and 41SC were used to give a final concentration of 30 ug of 
protein per ml in PBST. M.Abs. Ml, MlO and Mil were used to detect IgM 
and Gl, G3 and G5 to detect IgG as described in chapter 2.3.2.
7.2.6 ELISA
The ELISA for ILTV-specific antibodies in gel chromatography 
fractions was as described in chapter 2.3.2.
Tracheal washings were assayed by ELISA basically as 
described in chapter 2.3.2 but with the following modifications:
1. MicroELISA plates were coated with ILTV antigen at 1:50;
2. Plates washed;
3. Tracheal washings diluted at 1:10 in PBST were added and 
incubated for 2 hours at 37° C;
4. Plates washed;
5. Addition of M.Ab anti-chicken immunoglobulin:
Ml+MlO+Mll, G1+G3+G5 or P9+P25+41SC at 30 ug/ml, added for 2 
hours at 37° C;
6. Plates washed;
7. Addition of conjugate goat anti-mouse alkaline phosphatase 
at 1:1000 in PBST added for 30 min at 37° C;
8. Plates washed;
9. Addition of substrate p-NPP at 1 mg per ml in 
diethanolamine buffer pH 9.8 for 1 hour at 37° C;
10. Reaction stopped with 3 M NaOH;
11. Plates read at 405 nm in an Auto Reader MR 580;
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7.3 Results
7.3.1 Clinical signs and gross lesions in the tracheas
Clinical signs were very mild, detected only as off-tone
voice sounds. Tracheas were congested until the end of the experiment 
on day 78 and contained thick mucus which frequently blocked the needle 
used to withdraw the tracheal washing. The thick mucus was especially 
confined to the upper third of the trachea and tended to be less
abundant in the distal region. Tracheal washings did not have any
evidence of contamination by blood. Normal tracheas did not show
congestion or excess mucus.
7.3.2 Detection of ILTV-specific IgA, IgM and IgG ^  tracheal 
washings by ELISA.
No previous report of the detection of ILTV-specific IgM was 
found in the literature. ILTV-specific IgM was detected in tracheal 
washings from day 5 p.i. (figure 7.1), which decreased between days 10 
and 20, increasing again after day 20 up to day 30, when it reached its 
highest concentration. IgM levels decreased by days 35 and 40, but were 
still present at the final testing on day 78 p.i.
ILTV-specific IgG was detected from the 5th day and its 
concentration increased up to day 10, but decreased on days 15 and 20,
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to its lowest levels. IgG levels rose again on day 25 to its highest 
concentration, but decreased on days 30, 35 and 40. It was still 
detected on day 78 p.i.
ILTV-specific IgA was already present on day 5 p.i. and 
reached its maximum level on day 10. It decreased on day 15, to its 
lowest concentration and then showed a slight increase between day 20 
and 30. Subsequently, IgA decreased sharply on days 35 and 40 but was 
still detected on day 78 p.i.
The ELISAS were repeated 3 times and the reproducibility of 
the assays is indicated by the inclusion of SEMs in figure 7.1.
7.3.3 ELISA of gel chromatography fractions of sera
The profile obtained for ILTV-specific IgM in serum 
fractionated by gel chromatography (figure 7.2) resembled that obtained 
with the tracheal washings (figure 7.1) and the results obtained in the 
previous chapter (figure 6.1). ILTV-IgM was observed at its highest 
amounts at day 10 and after a decline reached a high concentration 
again at day 45 after the inoculation. IgM was high in serum but low in 
the trachea at day 10, indicating no or little contamination from 
blood.
ILTV-specific IgG showed a continuous increase in titre from 
the 5th day up to the end of the experiment, again similar to the 
results obtained previously.
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Figure 7.1
Profile of Ig^ (a), IgG (b) and IgA (c) antibodies 
specific to ILTV in tracheal washings
Tracheal washings collected at a 5-day interval after 
the administration of the I LTV vaccine were assayed by 
ELISA. Three individual birds were sampled at each given 
period after the inoculation. The mean result of the 3 
tests is presented in this graph and the SEM is included 
for each collection. O. Ds. 4-05 nm.
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Figure 7.2
Profile of ILTV-specific Ig^ and IgG obtained by gel 
chromatography of serum and tested by ELISA.
Serum was fractionated by gel chromatography and 
fractions assayed by ELISA as described previously. The 
results from the ELISA were plotted and the areas cut out 
and weighed. The graph shows the areas of ILTV-specific 
IgM and ILTV-specific IgG at intervals after inoculation.
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7.4 Discussion
This experiment has provided two important findings. First,
the
similar results to those of/experiment described in chapter 6 were 
obtained, indicating that the techniques used in this thesis are 
reliable and reproducible. Second, it has shown the presence of 
ILTV-specific IgA, IgM and IgG antibodies in the trachea of chickens 
inoculated with a live ILTV strain. This is the first demonstration of 
ILTV-specific IgM in tracheal washings of birds infected with ILTV. The 
three classes of antibody IgM, IgA and IgG seemed to be produced at 
similar times and to fluctuate.
The pattern of the local antibody response to ILTV in the 
trachea might be associated to the latency of the virus, as ILTV is 
known to induce a carrier state in which the virus may be excreted from 
time to time (Bagust et al., 1986; Hughes et ^ ., 1987; Hughes et al., 
1989-a; Hughes et ^ ., 1989-b).
In this study, ILTV-infected birds showed tracheal congestion 
and mucus for a prolonged time, still present at day 78 p.i.. Two 
mechanisms may explain these observations: antibody dependent
enhancement and masking of virus antigens. With regards to the former, 
the increased infectivity of certain viral infections by 
subneutralizing concentrations of specific antibody has been reported 
(Hawkes and Lafferty, 1967; Peiris and Porterfield, 1979; Gould et al.,
1987), i.e. binding of virus-antibody complexes to cellular Fc and
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complement receptors, resulting in pinocytosis. Antibody-dependant 
enhancement of infectivity is a widespread phenomenon with members of 
Flaviviridae, Togaviridae and Bunyaviridae but has been reported also 
in Rhabdovi ridae, Reoviridae, Herpesviridae and Coronaviridae 
(Porterfield and Cardosa, 1984). Not related to the aspect of immune 
complex enhancement of infectivity, but appropriate to mention, is the 
finding that some viruses may mask their antigenic sites using host 
proteins, for example, a host beta-microglobulin was found to coat 
human cytomegalovirus -a member of the Herpesviridae, which thus evaded 
neutralization (McKeating et ^., 1987). igG-antibody enhancement of 
viral infectivity was detected with rabbitpox virus and Murray Valley 
encephalitis virus grown in cell culture. These mechanisms are reviewed 
due to the persistence of the lesions observed in the tracheas of the 
vaccinated chickens to provide alternative explanations for the 
findings. However, these explanations are very speculative.
The IgA response demonstrated in the tracheal washings
supported the results obtained by York et (1989). These workers 
also found IgA specific to ILTV in a peak concentration around 7-10 
days p.i. Although York et (1989), did not comment on it, it seems 
that they may have, like in this study (Figure 6.1), also obtained a 
"spontaneous" (although slight) rise of ILTV-IgA at the 28 /p.i., by 
both assaying the tracheal washings and counting the igA-bearing
B-cells in tracheal sections.
The pattern of the local tracheal antibody response for each
class of antibody resembled that found for the serum IgM, with a
primary inoculation eliciting two peaks of antibody response. The 
highest concentration of IgM in serum was found at day 6 p.i. in the
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previous experiment (Chapter 6, Figure 6.1), while in this experiment 
it was at day 10 p.i. This could be due to the different and less 
frequent sampling interval used in this experiment. It is possible that 
the highest concentration of ILTV-specific IgM may have occurred 
between the 5th and 10th days p.i. in this experiment, but was not 
detected due to not sampling at that time. However, all antibody 
classes responses seemed to occur relatively later in time when 
compared to the previous experiment. Both studies agreed on the period 
of the decrease of specific IgM concentrations around the 15th and the 
20th day. Both experiments also showed the reappearance of 
ILTV-specific IgM at 25-30 days p.i. This reinforces the probability 
that the cyclic pattern of the IgM response is a true feature of ILTV 
infections.
IgM was detected earlier in the trachea than in serum, 
indicating the local synthesis of IgM, which is, at least initially, 
not transudated from the serum.
It would be interesting to examine tracheal washings from 
ILTV infected chickens for the presence of virus neutralizing 
antibodies. The question is posed as to what is the role of the 
ILTV-specific IgA, IgM and IgG detected antibodies in the elimination 
of the virus. It could be speculated that these antibodies are 
efficient in preventing an aerogenous uptake of virus, but may be not 
as important in evading a persistent infection, possibly due to cell to 
cell spread of this avian herpesvirus.
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Chapter 8
STUDIES OF THE IBV-SPECIFIC IgM AND IgG ANTIBODY RESPONSES IN 
THE SERUM OF CHICKENS GIVEN LIVE-ATTENUATED IBV VACCINE VIA THE OCULAR 
OR INTRAMUSCULAR ROUTES OR OIL-EMULSIW IBV VACCINE INTRAMUSCULARLY AND 
THE EFFECTS OF CHALLENGE
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8. Studies of the IB7-specific IgM and IgG antibocty responses 
in the serum of chickens given live-attenuated IBV vaccine via the 
ocular or intramuscular routes or oil-emulsion IBV vaccine 
intramuscularly and the effects of challenge
8.1 Introduction
IBV is a coronavirus of chickens which causes economically 
important diseases. The diseases vary from respiratory, usually 
complicated by secondary bacterial infection, to reproductive, causing 
important losses in egg production and quality, and renal.
The humoral antibody responses to IBV infections have been 
well studied. Gillette (1974) described the profiles of 
IBV-neutralizing IgM and IgG antibodies in serum separated by sucrose 
density-gradient centrifugation and found that most of the neutralizing 
activity in the first week was performed by a mercaptoethanol (ME) 
sensitive antibody (IgM) and in the subsequent weeks mostly by a ME 
resistant antibody (IgG). Mockett and Cook (1986) have demonstrated the 
IgM and IgG antibody responses to primary and secondary intranasal IBV 
infections using an ELISA and gel chromatography fractionated sera and 
concluded that the detection of IBV-specific IgM could be used in the 
diagnosis of a recent IBV infection.
In the previous chapters of this thesis, the antibody
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responses to viral infections have been studied following viral entry 
into the host tissues via a natural route.
Inoculation of live vaccine-primed breeders and layers with 
oil emulsion vaccines via the intramuscular route in intensive chicken 
production is an increasingly common procedure to induce circulating 
specific antibodies, which persist for longer than otherwise.
These experiments were designed to study the IgM and IgG 
antibody responses to IBV of chickens vaccinated ocularly or 
intramuscularly with a live-attenuated vaccine strain of IBV or 
intramuscularly with a water-in-oil emulsion inactivated IBV vaccine. 
Since inactivated vaccines are usually given i.m. and live vaccines via 
the upper respiratory tract,it was felt to be interesting to examine 
the profiles of the production of the two immunoglobulins resulting 
from the different methods of presentation of the virus to the immune 
system and its possible role in the protection of the respiratory 
tract. In addition, the antibody classes which are produced in response 
to an oil emulsion vaccine are not known. This knowledge will be 
particularly useful for the differentiation of the long lasting immune 
response to an oil vaccine from the response to a recent IBV infection, 
especially in the light of using the detection of IBV-specific IgM in 
the diagnosis of IBV.
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8.2 Materials and Methods
8.2.1 Chickens
Four groups of Houghton Laboratory Light Sussex SPF chickens, 
each consisting of 6 birds, were kept in separate isolation rooms, 
with food and water as described in chapter 2.1. Group 1 was the 
control uninoculated chickens, group 2 received an IBV water-in-oil 
emulsion vaccine (Iblin, Pitman-Moore, UK.) intramuscularly (i.m.), 
group 3 was injected i.m. with a live attenuated vaccine strain of IBV 
(H120, Intervet UK.) and group 4 was given ocularly the same strain of 
IBV as group 3.
8.2.2 Virus inoculation
Group 2 was inoculated i.m. into the breast muscle with the 
recommended dose, i.e., 0.5 ml of the water-in-oil emulsion vaccine. 
Group 3 was inoculated i.m. into the breast muscle with 0.5 ml of the 
live attenuated vaccine strain. Group 4 was given ocularly 0.1 ml of 
the live attenuated vaccine strain. The vaccine used in groups 3 and 4 
contained approximately log^^ 4.8 of IBV per ml. All groups were
challenged i.n. 24 days later using the IBV M41 strain of the 
Massachusetts serotype containing log^^ 5.1 in 0.1 ml.
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8.2.3 Sampling procedures
Blood sairples were taken from the wing vein on day 0, prior 
to inoculation, then, during the period of the previously observed IgM 
peak (chapter 3; Mockett and Cook, 1986) on days 6, 7, 8 and 9 p.i. 
then on the 24^^ day, prior to the challenge and finally on the 6^  ^day 
post challenge. Individual serum samples from each group and at each 
collection time were separately pooled and stored at -20° C. A more 
detailed account of the bleeding and serum separation procedure is 
given in chapter 2.1.4.
8.2.4 Gel chromatography of serum
The fractionation of pooled chicken serum samples by gel 
chromatography to separate IgM and IgG was described in chapter 2.5.
8.2.5 ELISA
The ELISA to detect IBV-specific IgM and IgG antibodies in 
gel chromatography fractions was described in chapter 2.3.2.
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8.2.6 Ciliostasis test
The protection of the respiratory tract was assessed by 
examining the tracheas for the effects of the challenge on the 
ciliated epithelial cells lining the trachea. The normal columnar cells 
of the respiratory tract exhibit ciliary movement (beating), in the 
mechanism of expelling the mucous secretions with the routinely 
captured dust (and invading organisms) towards the upper parts of the 
tract. The method for the assessment of protection of the respiratory 
tract using tracheal ring explants was described by Derbyshire (1980). 
On days 4 and 6 post challenge chickens were sacrificed by intravenous 
injection of Expirai (Pentobarbitone 200 mg/ml, CEVA Ltd., Watford, 
Herts). Tracheas were carefully removed and kept in MEM until 
sectioning. Tracheal rings of approximately 1-2 mm in thickness were 
cut using a scalpel, distributed onto a glass slide permanently bathed 
in MEM and read for ciliary activity at a low power magnification of 
the microscope (lOx). Ten rings were prepared from each individual 
trachea, three from the upper, four from the middle and three from the 
lower part. Uninoculated control birds (SPF) were used to prepare 
tracheal explants with normal ciliary activity. Each ring was scored on 
a scale from 0 (100% ciliary activity) to 4 (complete ciliostasis). 
This test was performed under the direct supervision of Dr. Jane K.A 
Cook, Houghton Laboratory.
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8.2.7 Haemagglutination inhibition test
The haemagglutination inhibition (HI) test was performed as 
described by Alexander et (1983). The haemagglutinating (HA)
Massachusetts M41 antigen was prepared and used as described by 
Lashgari and Newman (1982). Antigen was available from the lyophilized 
aliquots prepared previously (Martins, 1987). The antigen was 
reconstituted, titrated and diluted to contain 4 HA units in PBS. HI 
tests were performed with 4 HA units of antigen in V-bottom shaped 
microplates, with back titrations of the antigen used to control the 
antigen titre. 50 ul volumes were used throughout the test. Red blood 
cells (RBCs) were prepared from a 5-chicken pooled blood sample 
collected in Alsever's solution. RBCs were washed three times in PBS 
and resuspended to a 1 % v/v concentration.
The HI test was performed on fractions of sera and whole sera 
from all groups collected at the 9^  ^ and 24^^ day p.i. and when the 
chicks were killed at the 6^  ^ day post challenge. Gel chromatography 
serum fractions to be assayed in the HI test were selected (ten of each 
class) from those which produced the highest O.D. values for IBV 
specific IgM or IgG antibodies in the ELISA. Serum fractions or the 
corresponding whole sera were diluted in PBS in microplates and mixed 
with the diluted antigen for 30 minutes at 4° C. RBCs at 1 % (v/v) 
were then added and incubated for 45 minutes at 4° C. The plates were 
read by tilting the plate enough to allow the control button of RBCs 
(PBS plus RBCs) to run. A free running button of RBCs indicated HA 
inhibition by the serum in that well (Alexander et , 1983). Negative 
sera allowed HA to occur, when only a very small button formed, which
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did not run on tilting the plate,
8.2.8 IBV-Neutralization test in tracheal organ cultures 
(TOC)
Serum fractions and the whole sera were also tested for 
neutralizing antibodies. This test was performed based on the technique 
described for IBV by Cook et (1976) and Derbyshire et sd. (1979). 
In brief, tracheal explants were prepared as follows : 19-day old
chicken embryos were used. Shells were wiped clean with 70 % alcohol, 
especially the air chamber at the top, the shell was cut around the
limits of the air chamber and embryos were removed aseptically. The
skin was opened and the trachea exposed. The trachea was removed, free 
from connective and fat tissues, and immersed in a universal containing 
serum free Eagle's MEM. Rings approximately 0.5-1 mm thick were cut 
using a tissue chopper (Mcllwain tissue chopper. Mickle Engineering 
Co., Gomshall, Surrey, England). A minimum of twenty rings were 
prepared from each trachea. Using a large bore Pasteur pipette, one 
ring was placed in each tube containing 0.5 ml Eagle's MEM. Tubes were 
sealed with a silicone bung and placed on rollers turning at 8 
revolutions per hour at 37° C. Cultures were used, after checking for 
the viability of ciliary movement, usually within 24 to 48 hours.
The IBV-virus neutralization test was performed using 100
CDgQ of the IBV M41 stfain. The virus was back-titrated (four
replicates per dilution) to re-assess the titre used and positive and
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negative serum controls (4 replicates) were included in each test. 
Pooled sera or gel chromatography derived IgM or IgG fractions of sera 
were assayed. Sera were diluted in serial doubling dilutions and gel 
chromatography fractions were assayed at a dilution of 1:8, due to 
their already high dilution in the process of fractionation. An equal 
volume of the dilutions of sera or fractions and the virus (100 )
were mixed and incubated for 30 minutes at room temperature. The tubes 
containing TOCs which had been drained were inoculated (4 tubes per 
sample) with 0.2 ml of the mixture and incubated for 60 minutes at 37° 
C. Subsequently, 0.5 ml of Eagle's MEM containing 20 ml IM HEPES and 50 
ml 30% alpha-methyl D-glucoside per litre was added and tubes were 
returned to incubation with rolling at 37° C for 3 days. Reading was at 
low power magnification and titres were calculated by the method of 
Reed and Muench (1938), based on presence or absence of ciliary 
activity in the TOCs.
8.3 Results
8.3.1 Clinical observation of the chickens
Chickens given the live vaccine (those in groups 3 and 4) 
showed similar respiratory rales. Clinical signs up to 6 days after 
vaccination were at varying degrees such as audible at a distance or 
only observed on close examination, i.e. when holding the chickens 
during sampling. Table 8.1 shows the incidence of clinical signs within
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the groups as observed after vaccination or challenge (6 days p.i.). No 
sign was observed in the control uninoculated group and in the group 
given oil-emulsion vaccine, however, after challenge these were the 
only groups to develop clinical signs, indicating that they were not 
protected. Hence, the groups given live vaccine (ocularly or i.m.) did 
not show clinical signs after challenge, indicating that they were 
protected.
8.3.2 Profile of the IBV—sped fie IgM and IgG antibody 
responses by gel chromatography and ELISA.
The ELISA results of gel chromatography fractions are shown 
in figure 8.1. IBV-specific IgM titres were first observed on day 6 
post vaccination in the group which received the live vaccine ocularly 
(group 4), whereas in all the other groups IBV-specific IgM was 
undetectable at this time. IgM titres rose rapidly in groups 3 and 4 
(live vaccine groups) by day 7 and in both groups the production of IgM 
continued in parallel up to day 8. By the 24^^ day post vaccination 
both groups 3 and 4 had presented a major decline of the IgM levels, 
although antibody was still detectable. The IBV-specific IgG response 
was first detected on day 7 in the two groups given live vaccine. Both 
groups presented a rapid production of IgG antibodies from days 8 and 9 
which continued to rise up to day 24.
The primary response to the IBV-oil emulsion vaccine was 
first detected as IBV-specific IgM antibody on day 7 p.i. and at the
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subsequent collection times IgM levels increased only very slightly and 
continued to be detectable, but at a low level on days 9 and 24. This 
is the first report on the IBV-specific IgM produced as a response to 
an IBV oil-emulsion vaccine. IBV-specific IgG after the oil emulsion 
vaccine was not detected on day 9 but was detected on day 24 p.i. The 
IgM and IgG responses to the oil-emulsion vaccine were much lower than 
those induced by the live vaccines given by either route.
Response to the challenge given at day 24 resulted in a sharp 
rise of both IgM and IgG titres by day 6 in the oil-emulsion vaccinated 
group: the group which also presented the highest IgM response to 
challenge. Both groups given live vaccine had shown only a slight 
increase in IgM and IgG response to the challenge by day 6 p.i.
8.3.3 Ciliostasis test
Protection of the chickens against challenge with virulent 
IBV was assessed by examining the effect of challenge on tracheal 
epithelium ciliary activity. The results are shown in table 8.2. Both 
groups 3 (live vaccine i.m.) and group 4 (live vaccine ocularly) did 
not show ciliostasis, similarly to uninoculated chickens (not shown). 
On the other hand, birds which received the oil-emulsioned vaccine 
showed ciliostasis similar to that presented by the challenge control 
group, indicating that they had not been protected against challenge.
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Table 8.1
Clinical observation of chickens after vaccination and 
challenge with IBV
Incidence of clinical signs 
6 days after
group vaccination challenge
1 control none 100
2 oil-emulsion 
vaccine
none 100
3 live vaccine 
i.m.
100 none
4 live vaccine 
ocularly
100 % none
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Figure 8.1
Profile of the IBV-specific IgM and IgG antibody 
responses
IgM and IgG were separated from chicken serum pools by 
gel chromatography at the given times after 
inoculation and subsequently assayed by ELISA for 
IBV-specific antibodies and their class. ELISA results 
were plotted in graphs and areas corresponding to IgM 
and IgG were cut out and weighed. The weight areas (in 
mg) of IgM and IgG relating to the days after 
infection were plotted graphically.
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Table 8.2
Ciliostasis test after challenge with IBV M41
Time (days) after challenge 
4 6
tracheal region^ tracheal region
Group* scores
upper middle lower
scores
upper middle lower
1 control 25 ^3-3-2 2—3—3—2 2-2-3 40 4-4-4 4—4—4—4 4-4-4
40 4-4-4 4-4_4_4 4—4—4 40 4—4—4 4—4—4—4 4—4—4
total score
40
105
4-4-4 4—4—4—4 4-4-4 40
120
4-4-4 4_4_4_4 4—4—4
2 oil- 37 3—4—4 3—3—4—4 4-4-4 40 4—4—4 4—4—4—4 4—4—4
emulsion
vaccine 40 4-4-4 4—4—4—4 4—4—4 40 4—4—4 4_4_4_4 4—4—4
total score
40
117
4-4-4 4—4—4—4 4-4-4 40
120
4—4—4 4—4—4—4 4-4-4
3 live 2 0—Q-1 1—0—0-0 0-0-0 10 1-1-1 l-l-l-l 1—1—1
vaccine
i.m. 2 0-0-0 0—0—0-0 0—1—1 10 1-1-1 1—1—1—1 1—1—1
total score
1
5
0-0-0 0—0—0-0 0-0-1 0
20
0-0-0 0—0—0-0 0-0-0
4 live 10 1-1-2 1—1—1—2 0-1-0 4 0-0-0 1—1—2-0 0-0-0
vaccine
ocularly 14 0—1—2 2—1—2—1 2-1-2 0 0-0-0 0-0-0—0 0-0-0
total score
0
24
0-0-0 0—0—0-0 0-0-0 0
4
0-0-0 0—0-0-0 0-0-0
* Three individuals were tested at each sampling day;
+ Ten rings were examined from each trachea;
£ Scores: 0 = fully beating; 1 = 25 % ciliostasis; 2 = 50 % 
ciliostasis; 3 = 75 % ciliostasis; 4 = complete ciliostasis;
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8.3.4 Haemagglutination inhibition test
Some of the IgM and IgG fractions obtained by gel 
chromatography of sera were assayed separately in the HI test. The 
fractions of pooled sera containing the highest IBV-specific antibody 
titres detected by ELISA were selected. Ten fractions corresponding to 
IgM and ten fractions to IgG were assayed. An example of ELISA and HI 
results obtained with IgM and IgG fractions collected day 24 p.i is 
shown graphically in figure 8.2, to illustrate the relationship between 
presence of IgM or IgG (detected by ELISA) and presence of HI activity.
The complete results are shown in table 8.3. IBV-specific HI 
activity was detected in both IgM or IgG fractions of sera collected 
from chickens \diich received the live vaccine given ocularly at 9 and 
24 days post vaccination (group 4). HI activity in IgM fractions was 
detected only in sera collected from that group. HI activity in the IgG 
but not IgM fractions was also detected 6 days post challenge in group 
4. The other groups showed HI activity only in IgG fractions of sera. 
HI activity was detected in the IgG fractions only of sera collected 24 
days post vaccination in the group which received live vaccine i.m. and 
only 6 days post challenge in the group which received oil-emulsion 
vaccine.
Whole individual sera were also tested for HI activity at the 
24^^ day post vaccination and at 4 and 6 days post challenge (Table 
8.4). The highest titres were observed in groups 3 and 4 at the 24^^ 
day post vaccination and at the 4^  ^ and 6^  ^ days post challenge
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(> 1:640). In group 2 (inactivated vaccine) half of the individuals had 
high titres (>1:640) and 1 individual was negative at 24 days p.i. but 
only 1 had a high titre (> 1:640) post challenge at day 6. The control 
group was negative (< 1:20) at the 24^^ day p.i. and continued still 
negative at the 4^  ^day post challenge, but a low HI titre was observed 
in one individual (1:40) at the 6th day post challenge.
8.3.5 IBV-neutralization test m  TOC
Neutralization tests were done on the whole pooled sera. 
IBV-neutralizing antibodies were detected in group 4 (given the live 
vaccine ocularly) at 24 days p.i. (1:46) and 6 days post challenge 
(1:50) and in group 3 (given live vaccine intramuscularly), at 24 days 
p.i. (1:46) and 6 days post challenge (1:40). Group 2, which received 
the inactivated oil-emulsion vaccine, showed titres of less than 1:8 at 
24 days p.i. and 1:11 at 6 days post challenge. No neutralizing 
antibodies were detected in serum from the control group. Results are
shown in table 8.5.
Only very low IBV-neutralizing antibody titres, approximately 
1:8, could be detected in gel chromatography fractions of serum 
(results not shown), presumably because the fractions were too dilute.
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Table 8.3
Haemagglutination inhibition test on gel chromatography fractions 
of sera
9 days post 
vaccination
24 days post 
vaccination
6 days post 
challenge
Group
IgM 
frac­
tion HI
IgG 
frac­
tion HI
IgM 
frac­
tion HI
IgG
frac­
tion HI
IgM
frac­
tion HI
IgG 
frac­
tion HI
38* -@ 52 38 52 38 52
39 — 53 — 39 — 53 — 39 - 53 -
2 40 — 54 — 40 — 54 — 40 - 54 20*
oil-emulsion 41 — 55 — 41 - 55 - 41 - 55 40
vaccine 42 — 56 — 42 - 56 - 42 - 56 40
43 — 57 — 43 — 57 — 43 - 57 20
44 — 58 — 44 — 58 — 44 - 58 20
45 — 59 — 45 — 59 — 45 - 59 -
46 — 60 — 46 — 60 — 46 - 60 -
47 - 61 - 47 - 61 — 47 — 61 —
38 52 38 52 38 — 52 —
39 — 53 — 39 53 — 39 - 53 -
3 40 — 54 — 40 — 54 20 40 - 54 -
live 41 — 55 — 41 — 55 20 41 — 55 -
vaccine 42 — 56 — 42 - 56 40 42 - 56 -
i.m. 43 — 57 — 43 — 57 80 43 - 57 -
44 — 58 — 44 — 58 80 44 - 58 -
45 — 59 — 45 — 59 80 45 - 59 -
46 — 60 — 46 — 60 80 46 - 60 -
47 - 61 - 47 - 61 80 47 — 61 —
38 52 38 20 52 20 38 _ 52 20
39 — 53 — 39 20 53 40 39 - 53 20
4 40 20 54 20 40 40 54 80 40 - 54 40
live 41 40 55 40 41 80 55 80 41 - 55 80
vaccine 42 40 56 40 42 80 56 80 42 - 56 80
ocularly 43 40 57 40 43 80 57 80 43 - 57 80
44 40 58 40 44 80 58 80 44 - 58 40
45 40 59 40 45 80 59 80 45 - 59 40
46 40 60 40 46 40 60 80 46 - 60 40
47 40 61 40 47 40 61 80 47 — 61 40
+ fraction number by gel chromatography;
@ titre of 1:10 or lower; a not detectable titre;
* HI titre expressed as the reciprocal of dilution;
Note: The control group, results not included in this table, did 
not show detectable HI titres in either IgM and IgG fractions of 
sera;
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Table 8.4
Examination of individual sera for IBV haemagglutination 
inhibition antibodies
Group 24 days 4 days 6 days
post-vaccination post-challenge
1
control
20*
20
20
+ 20
40
2 160 40
oil emulsion 80 160 40
40
>640
>640
>640
160 >6400
3 >640 >640 >640
live vaccine >640 >640 >640
i.m. >640
>640
>640
>640
>640 >640
4 >640 >640 >640
live vaccine >640 >640 >640
ocularly >640
>640
>640
>640
>640 >640
* HI titres are expressed as the reciprocal of the dilution; 
+ titre equal or lower than 1:10, undetectable;
@ >640 : titre equal or greater than 1:640;
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Table 8.5
Results of tests in tracheal organ cultures (TCX:) for 
IBV-neutralizing antibodies in serum pools *
Group
Neutralizing antibody titre in serum pool 
collected at 
24 d.p.i 6 d.p. challenge
1 (control) < 1:5 < 1:8
2 (inactivated
vaccine)
3 (live i.m.
vaccine)
4 (live vaccine
ocularly)
< 1:8
1:46
1:46
1:11
1:40
1:50
+ Neutralization tests were performed as described in section 8.2.8
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Figure 8.2 IBV-specific IggM and IgG ELISA and HI 
antibody responses ^  days post vaccination of chicks 
given live vaccine ocularly
Gel chromatography fractions of sera were assayed by 
ELISA to detect IBV-specific IgM and IgG antibodies. 
Ten fractions, for each case, selected as the ones 
with the highest levels of specific antibody by ELISA, 
were assayed in a HI test for IBV-specific antibodies. 
The results by both tests are shown graphically to 
indicate the IgM and IgG fractions which showed HI 
activity.
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8.4 Discussion
This is the first report on the IgM response to an IBV
inactivated oil-emulsion vaccine. Chickens vaccinated with the
oil-emulsion vaccine, without priming, produced a very low titre of
IBV-specific IgM and IgG. The challenge of these chickens with IBV M41
strain (Massachusetts serotype) resulted in clinical signs and
ciliostasis being detected 4 and 6 days post challenge, a sign of the
susceptibility of the trachea to IBV infection. Challenge of this group
also elicited a serum antibody response as detected by ELISA on day 6
p.i.. Interestingly, the challenge elicited a quantitatively higher IgM
specific antibody response in this group as compared to the other
experimental groups. This could be explained by the way in which the
virus antigens are presented to the immune system in oil-emulsion
preparations. A larger number of clones of immunocompetent cells may
become compromised by the gradual release of antigen, as shown by the
higher and persistent titres of antibodies of gradually increasing
affinity for antigens. Viral antigens are slowly released from the oil
adjuvant and gradually become accessible to the immune system.
Macrophages have a key role in releasing the antigen from the oil. The
oil is engulfed by endocytosis and virus antigens are presented to the
T and B cells. The mode of action of an adjuvant may be described as to
allow the release of optimal concentrations of antigen, avoiding
excessive antigenic stimulus (and subsequent tolerance), providing
an
improved and prolong ed presentation of antigen and as ^ antigenic 
reservoir for an extended stimulation (WHO Scientific Group, 1976). 
The prolonged length of duration of the immune stimulation together
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with minimal required amounts of antigen released has been associated 
with increased affinity of antibodies both of the IgG and to a lesser 
extent IgM classes (Bullock and Mol1er, 1974). The greater production 
of IgM antibodies in response to the challenge may be due to larger 
numbers of B lymphocytes becoming compromised. It could be further 
speculated that a different response could have happened if challenge 
were given later in the process of compromised B-cell differentiation. 
It must be remembered that the primary response was induced by gradual 
presentation of antigen and the challenge provided high quantities of 
antigen rapidly, ordering the compromised and newly compromised IgM 
clones to mitosis and antibody synthesis. On the other hand, virus 
infection produces high quantities of antigen rapidly available to the 
immune system, usually incorporating host cell antigens in the 
envelope, and resulting in rapid synthesis and switch from the 
synthesis of IgM to IgG antibodies. Lutticken et (1987) found that 
the serum IgM and IgG responses were more rapid after infection with 
the M41 strain than after the vaccination with an oil-emulsion vaccine, 
and that no IgA was present in lachrymal fluids after giving the 
oil-emulsion vaccine.
Also, a high level of IgG antibody was detected by ELISA at 
day 6 post challenge in the group given primary oil-emulsion vaccine. 
No HI antibody titres were detected in IgM and IgG fractions at day 24 
p.i. in that group, HI antibody only appearing in IgG fractions on day 
6 post challenge. The concentration of antibodies available for testing 
for HI activity could have been too low, as a consequence of dilution 
during fractionation, although high enough to be detectable by ELISA,
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which is more sensitive. In addition, IgM and IgG IBV-specific 
antibodies in fractions detected by ELISA generated by the oil-emulsion 
vaccine had a poor virus-neutralizing activity, which could have been 
again caused by the dilution factor. Analysis of the detection of IgM 
and IgG antibodies by ELISA in the serum of the group given 
oil-emulsion vaccine compared to the results of resistance to 
challenge, showed that these circulating antibodies did not correlate 
to the protection of the trachea, presumably because secretory 
antibodies are synthesized locally after infection of the upper 
respiratory tract. This stage of defence is provided by the use of 
primary vaccination of chickens with live vaccines given to reach the 
respiratory tract, with circulating antibody titres boosted 
subsequently with oil-emulsion vaccines.
By ELISA, the groups given live vaccines presented a similar 
IBV-specific IgG response. Both groups showed respiratory signs 
following vaccination, an indication of viral replication in the 
trachea. It was observed, however, that the ocularly vaccinated group 
produced IgM and IgG one day earlier than the group given live vaccine 
i.m. (figure 8.1), probably due to the earlier multiplication of IBV in 
the respiratory tract. These chickens developed high titres of HI 
antibodies, as detected in whole serum, a result reported previously 
(Timms and Bracewell, 1981 and 1983; Holmes and Finney, 1985). In the 
group vaccinated by the ocular route, IBV-specific HI antibodies were 
present in IgM and IgG fractions 24 days p.i., but in the group given 
live vaccine i.m. were only detectable in IgG fractions, which 
indicates that a better stimulus occurred via the ocular route. The 
neutralization test in TOC showed that the highest concentrations of
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neutralizing antibodies were produced by chickens administered the live 
vaccine. Both the groups inoculated ocularly or intramuscularly with 
the IBV H120 strain developed a similar concentration of neutralizing 
antibodies, and were protected against challenge with IBV M41 strain. 
These chickens developed also the highest concentrations of 
IBV-specific IgM and IgG antibodies detected by ELISA and HI 
antibodies. The group given inactivated vaccine had no detectable titre 
of neutralizing antibodies and chickens were not protected against 
challenge, indicating the inefficiency of inactivated virus given alone 
to induce protection of the respiratory tract.
Gel chromatography fractions of serum contained no or little 
detectable neutralizing antibody. It is possible that this was because 
the fractions were too diluted by the process of fractionation. In 
order to be able to demonstrate the presence of neutralizing antibody 
in these fractions it would have been necessary to concentrate them 
back to the original volume.
The ciliostasis test (Derbyshire, 1980) used in this study 
has proven to be a very useful method of assessing the protection of 
the trachea against challenge and results were always clear cut.
Programmes of IB vaccination are designed to include both 
live and inactivated-adjuvanted vaccines. The primary vaccination by 
live virus vaccines, induces direct stimulation of lymphocytes at the 
sites of entry of the virus and generates local protection (Davelaar et 
al., 1982; Hawkes et ^ ., 1983; Lutticken et ^ ., 1987). In the present 
study, the primary IBV stimulus was shown to be more effectively 
induced by the live virus vaccine, agreeing with previous reports (Box 
et al., 1980; Gough et al., 1981). Inactivated oil-emulsion vaccines
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are given after administration of live vaccine in order to generate an 
anamnestic humoral response, which boost circulating antibody titres 
after those derived from the primary stimulus have waned. Secondary 
oil-emulsion vaccines generate long-lasting high titre of circulating 
antibodies (Timms and Bracewell, 1981 and 1983; Holmes and Finney, 
1985).
The live attenuated vaccine used in this experiment generated 
a similar response of IBV-specific IgM antibodies to that induced by 
the virulent M41 strain (chapter 4). IgM responses to live vaccine 
given by both routes were short-lived. The detection of IBV-specific 
IgM for the diagnosis of a recent IBV infection could be applied to 
vaccinated chickens.
The IBV-specific IgM response to the oil-emulsion vaccine was 
low and easily distinguishable from a challenge response. However, 
inactivated oil-emulsion vaccines are not given in the field as primary 
vaccination. This experiment included an oil-emulsion vaccine in order 
to obtain a comparison of the effect of different presentation of the 
IBV on the type of immune response elicited, especially of the IgM and
IgG antibody classes. It would be interesting to know the profile of
IBV-specific IgM and IgG antibodies to an oil-emulsion vaccine given 
after a primary live vaccine, as recommended in the field, as far as 
the differentiation of the vaccination and challenge could be achieved. 
This would be a valuable topic for future study.
In conclusion, it was observed that the vaccination of
chickens with live vaccine via the ocular or intramuscular routes 
generated high titres of IgM and IgG antibodies, similar concentrations 
of neutralizing antibodies by 24 days p.i. and protection of the 
trachea against challenge at 24 days p.i.
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Chapter 9
CmCLUSICMS
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Chapter 9. Conclusions
The objective of this chapter is to consider in a more 
general way the contribution of these studies to the knowledge and 
understanding of the antibody responses of chickens to virus infections 
and in practical terms the applicability of methods and knowledge 
achieved in aiding daily tasks in diagnosis and research.
The routine diagnosis of viral infections of chickens depends 
on laboratory procedures which are liable to error. For example, virus 
isolation is often difficult, time consuming and results not always 
reliable. However, serological methods in recent years have advanced to 
allow rapidity, sensitivity and specificity to be achieved. The 
enzyme-linked immunosorbent assays (ELISAs) have become important tools 
because of their sensitivity and they have been exploited in various 
forms of serodiagnosis.
ELISAs have been developed and used to detect antibodies to
various chicken pathogens. These assays have been targeted mostly to
detect the IgG immunoglobulin, which is the most abundant and
persistent antibody in circulation, therefore easier to detect.
However, the demonstration of IgG antibody does not always permit clear
cut results as, for example, when it is necessary to differentiate a
.type
response to vaccination from that against challenge with wild^virus. 
The detection of IgM antibody can be the alternative for such unclear
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cases, as it can be associated to a recent infection. However, the 
assay of IgM encounters difficulties associated to the presence of IgG, 
which is frequently present in higher concentration than IgM. In the 
assays, IgG binds to the antigen and reduces its availability for IgM. 
The detection of very low concentrations of bound IgM requires very 
sensitive assays (such as radio and enzyme immunoassays) and 
furthermore reagents need to be specific so that they do not detect 
IgG. Therefore, in order to achieve the objective of detecting IgM, 
assays had to be developed which specifically trapped IgM and separated 
it from IgG. The classical methods of separating immunoglobulins, such 
as gel chromatography or density gradient centrifugation were not 
applicable when rapidity and simplicity were necessary.
The need for developing such a technique for the rapid 
demonstration of specific IgM has therefore become apparent. This was 
achieved by the use of affinity chromatography to purify serum IgM, in 
association to ELISAs for the detection of virus specific antibodies. 
The method enabled rapid determination of virus specific IgM. The 
availability of M.Abs. specific to chicken immunoglobulins enabled the 
preparation of the immunoadsorbents and also enabled the assay by ELISA 
to be free from IgM and IgG cross-reactivity.
As far as methodology was concerned, the aim to solve the 
problem of the determination of virus-specific IgM was achieved. 
However, soon it was realised that little was known of the antibody 
class response of chickens to most of their viral infections. The 
applicability of the detection of specific IgM and its correlation to
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recent infection needed previous knowledge of the antibody profiles for 
the adequate interpretation of results.
Therefore, the study of the classes of antibody produced in 
response to selected virus infections of chickens was considered to be 
essential. Priorities had to be taken, otherwise this investigation 
could become an enormous task. It was decided to study three unrelated 
viruses, with the aim of comparing viruses with three distinct 
pathogenesis in relation to the antibody response. As new techniques 
needed to be developed during the present study, a virus infection 
about which we had previous knowledge concerning the profiles of serum 
IgM and IgG was chosen. For this purpose, IBV infection was used in the 
investigation of the newly developed method of affinity chromatography 
which was examined in parallel with the classic method of 
immunoglobulin separation, i.e. gel chromatography. It was shown that 
the IBV-specific IgM profile obtained by affinity chromatography was 
similar to that obtained by gel chromatography. The possibility was 
thus opened for the investigation of the responses to other virus 
infections.
IBDV causes immunosuppression in young chicks resulting in 
antibody unresponsiveness and increased susceptibility to several 
pathogens. Older chickens would not undergo an immunosuppression but 
could show increased susceptibility to infection and reduced response 
to vaccination. No information was found in the literature concerning 
the profile of classes of antibodies specific to IBDV. Although the 
diagnosis of IBDV is rapid and straightforward using the available
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methods of virus detection, the scientific interest of studying such 
infection based on its pathogenesis suggested to be targeted to 
IgM-bearing B-lymphocytes justified its selection. The determination of 
the profiles of IgM and IgG antibodies resulted in the finding that the 
response to IBDV was the classical profile, previously shown with IBV. 
The IgM response to IBDV was rapid and short-lived and could be 
associatedviththe recent infection. However, as in diagnosis of the
disease the demonstration of antigen is simple and rapid, demonstration
of IBDV-specific IgM can be only of secondary interest for routine 
diagnosis. However, the findings described in this thesis have 
suggested the need of further investigation of the pathogenesis of 
IBDV, especially related to precisely determine the IBDV target cell 
(or range of cells) and its receptor(s). This is a study planned for 
the future.
The results obtained with ILTV were very interesting. The 
IgM response to ILTV was similarly rapid and appeared previous to IgG
as was found with IBV and IBDV and this was the first report on the
demonstration of ILTV-specific IgM. However, the sequential 
examination, after the decline of IgM, showed that IgM levels 
spontaneously re-started. This finding led to the conclusion that the 
detection of ILTV-specific IgM was not meaningful for the diagnosis of 
recent ILTV infection. Although the IgM profile spoiled the chances for 
an easier diagnosis of ILT, the finding was of considerable scientific 
interest. IgM fluctuation would be worth further investigation to 
determine the causes for this cycling and, if it was associated with 
latency and the episodes of virus shedding. A second experiment was
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performed and confirmed the findings on fluctuating serum ILTV-specific 
IgM. In addition, the determination of ILT-specific antibody classes 
present in the trachea of the infected chickens revealed the presence 
of IgA, IgM and IgG in the mucosa, all presenting a profile of 
production resembling that of serum. Tracheal antibody was detected 
earlier than in the serum, possibly associated to the direct stimulus 
to local lymphocytes by the virus. Many lines of investigation can be 
envisaged based on this intriguing finding. The site of latency of ILTV 
has been described as discrete areas of the trachea, probably related 
to the sites of initial infection (Bagust, 1986). The histological 
features of such areas have not been characterized. It would be 
interesting to characterize the site of latency and the cell 
responsible for harbouring the virus. In addition, the demonstration of 
reactivation of latent virus could be studied in parallel to the 
demonstration of the immune response to the reactivated virus.
Further studies with IBV were decided. It was considered 
important to investigate the effect of administering IBV via a 
different route of inoculation, as compared to the ocular route, 
regarding the profile of serum IgM and IgG antibodies synthesized. It 
was felt that it would also be interesting to study the antibody 
response to inactivated virus, to see if the mode of presentation of 
virus antigens in inactivated, oil-emulsioned form could present a 
different profile of antibody production. The comparison of the ocular 
and i.m. routes resulted in the observation that live virus given by 
these routes resulted in similar profiles of IBV-specific IgM and IgG 
in serum both in duration and amounts detected. It was also shown that
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live IBV given i.m. induced respiratory signs similar to those observed 
in chickens given virus ocularly. The finding that IBV reached the 
trachea after i.m. inoculation raised the question of whether it would 
be capable of generating protective immunity. It was found that live 
IBV given i.m. induced resistance to IBV challenge similar to that 
produced by virus given ocularly.
The study of the responses to the inactivated IBV oil 
emulsion vaccine showed that the IgM and IgG profile was distinct to 
that shown after ocular or i.m. administration of live IBV. A flat, 
low-levelled IgM response was detected which did not produce a peak and 
a slow rising IgG response was detected. Challenge of these chickens 
with virulent IBV resulted in rapid rise of IgM and IgG antibodies, 
indicative of the estabilishment of priming by the oil-emulsion 
vaccine. Challenge, however, showed that the oil emulsion vaccine given 
on its own did not elicit protection of the respiratory tract.
The difference in the profiles of IgM or IgG after live and 
inactivated vaccines was not caused by the different route of 
administration, as it was shown that the live virus induced a similar 
response when given ocularly or i.m.. The difference can result from 
the fact that the availability of the inactivated virus to the immune 
system is restricted by the oil emulsion and that the live virus, in 
addition to directly stimulating a response at inoculation, multiplies 
to enhance the amount of antigen available to the immune system.
Considering that the HI test for antibodies to IBV is
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performed rc^inely, especially for monitoring vaccination programmes, 
it was decided to investigate the HI titres generated by the different 
routes of inoculation of live IBV and after the injection of 
inactivated oil emulsion virus. HI titres were detected in both IgM and 
IgG fractions only in chickens given live virus ocularly. Chickens 
given live virus i.m. developed HI titres in IgG fractions but no 
detectable HI titre was found in IgM fractions. It could be inferred 
that the ocular route is best for stimulating HI titres, and although 
showing no advantage over the i.m. route as far as protection is 
concerned, this is the most cost effective route for the administration 
of live IBV vaccines.
The aim of the experiments described in this thesis was to 
develop a rapid and efficient method of separating IgM from serum, so 
that viral specific IgM levels could be determined by ELISA and 
antibody profiles produced in response to 3 different viral infections 
determined. This was achieved using immunoadsorbents prepared with 
M.Abs. to chicken IgM and enabled IgM and IgG responses to IBV, IBDV 
and ILTV to be determined with interesting results. As well as showing 
that detection of IgM in serum could be used to diagnose IB or IBD (but 
not ILT), the experiments described provided interesting information of 
scientific interest on the antibody responses of chickens to a 
herpesvirus causing latent infection and to a virus causing 
immunosuppression.
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